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ABSTRACT 
RNA interference (RNAi) is an evolutionarily conserved, sequence-specific gene 
silencing pathway found in eukaryotes, in which 21-nucleotide, small interfering RNAs 
(siRNAs) guide destruction of a corresponding target mRNA. RNAi is a natural 
mechanism for both genome surveillance and gene regulation.  Moreover, siRNAs can be 
transfected into cultured mammalian cells, causing the sequence-specific ‘knock down’ 
of an mRNA.  My work in the Zamore lab has centered around the Drosophila in vitro 
system and cultured mammalian cells to study the RNA interference (RNAi) pathway.  
small interfering RNAs (siRNAs) are incorporated into the RNA-induced silencing 
complex (RISC), which culminates in the cleavage of a complementary target mRNA.  
Previous work proved that certain structural features of siRNAs are essential for RNAi in 
flies, including the requirement for 5´ phosphates and 3´ hydroxyl groups.  In cultured 
mammalian cells, the requirement for a 5´ phosphate also holds true, but we found no 
evidence to support the necessity for 3´ hydroxyls in either system.  In addition, siRNAs 
can act as single strands entering the pathway downstream of double-stranded siRNAs, 
both of which are competent in directing the cleavage of its cognate mRNA at a single 
site.
While these key features are a requirement for functional siRNAs, alone they do 
not determine the efficiency to which an siRNA can enter the RISC.  In fact, both strands 
of an siRNA can enter RISC to a different degree as determined by the stabilities of the 
5´ ends of the siRNA strand, a phenomenon termed ‘functional asymmetry’.  This 
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characteristic is also reflected in another class of small RNAs involved in gene silencing 
known as microRNAs (miRNAs), which are processed from long hairpin RNA structures 
into mature, single-stranded non-coding RNAs.  The asymmetric loading of siRNAs 
suggests that miRNAs are initially generated from siRNA-like duplexes cleaved from the 
stem of the hairpins.  The strand whose 5´ end is less tightly paired will be processed into 
the mature miRNA, while the other strand is destroyed.  By applying the rules of siRNA 
asymmetry it is possible to predict which side of the stem will be processed into the 
mature miRNA, a finding verified experimentally by our lab and others.  This discovery 
also has additional implications in designing highly effective siRNAs and in reducing 
siRNA off-target effects. 
We used these results to design siRNAs that target the single nucleotide 
polymorphism in superoxide dismutase that causes the familial form of amyotrophic 
lateral sclerosis (ALS), but leave the wild-type mRNA intact and functional.  Our 
experiments have helped define the ‘rules’ for creating SNP-specific siRNAs.  In 
particular, we found that only siRNAs with a purine:purine mismatch to the allele not 
intended for destruction show good discrimination.  The placement of the mismatch in a 
tiled set of siRNAs shows that mismatches located in the 5´ region of the siRNA, a region 
shown to be responsible for siRNA binding, can not discriminate between alleles.  In 
contrast, mismatches in the 3´ region of the siRNA, the region contributing to catalysis, 
discriminate between wild-type and mutant alleles.  This work is an important step in 
creating allele-specific siRNAs as therapeutics for dominant negative genetic diseases. 
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But how does RISC cleave its target?  By isolating both the 5´ and 3´ cleavage 
products produced by RISC in the Drosophila in vitro system, we discovered that RISC 
acts as a Mg2+-dependent endonuclease that cleaves a single phosphodiester bond in the 
mRNA target, leaving 5´ phosphate and 3´ hydroxyl groups.  These findings were a 
critical step in the demonstration that Argonaute, a protein known to be a component of 
RISC, is the RNAi endonuclease. 
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CHAPTER I: INTRODUCTION
RNA Interference: A Historical Perspective
Disruption of gene expression is the first step in identifying the putative function of a 
gene and its gene product in a particular pathway or developmental process.  In the early 
1980's, Izant and Weintraub decided to use antisense RNA as a molecular tool to
decipher gene function in cultured cell lines as an alternative approach to classical
genetics.  By introducing a construct containing the sequence of a gene of interest in the 
reverse orientation (or complimentary strand), gene expression and activity were reduced 
(Izant and Weintraub, 1984).  Several groups went on to confirm this result in cultured 
cells (Holt et al., 1986; Hunts et al., 1986; Izant and Weintraub, 1985; McGarry and
Lindquist, 1986), Xenopus oocytes (Harland and Weintraub, 1985; Wormington, 1986), 
and Drosophila embryos (Rosenberg et al., 1985). 
In 1991, Moerman and colleagues extended this antisense inhibition technique to 
the organismal level by injecting the construct into worms (Fire et al., 1991).  When 
plasmids targeting unc-22 and unc-54, myofilament proteins found in muscle, were
injected into oocytes of Caenorhabditis elegans, endogenous protein levels dropped and 
phenotypes similar to mutants were observed (Fire et al., 1991).  Four years later Guo and 
Kemphues turned to the antisense inhibition technique when attempts to obtain clones for 
germline transformation rescue failed.  Instead of using plasmids, they injected in vitro
1
synthesized RNA corresponding to their gene of interest, par-1, directly into the gonads 
of the worm (Guo and Kemphues, 1995).  While the mock and unrelated RNA injections 
showed no change in phenotype, both sense and antisense RNA displayed par-1 mutant 
phenotypes (Guo and Kemphues, 1995).
Guo and Kemphues' control experiment posed the puzzle as to why the sense 
RNA would elicit a mutant phenotype.  Three years later, Fire and Mello decided to test 
the potency of sense or anti-sense RNA preparations alone, as well as a preparation of 
double-stranded RNA (dsRNA).  Their hypothesis was that the original transcripts from 
Guo and Kemphues, which were transcribed using bacteriophage RNA polymerase, were 
contaminated with aberrant RNA products resulting in a small population of RNA with 
double-stranded character that may be acting as the silencing trigger for mRNA
destruction.  Fire and Mello made a breakthrough when they observed dsRNA injected 
into the worm was at least 10 times more effective at silencing than either single-stranded
RNA alone, and that in situ hybridizations indicated that levels of targeted mRNAs were 
reduced, albeit to varying degrees (Fire et al., 1998).  They named this gene silencing 
phenomenon RNA Interference, or RNAi.
In worms, RNAi was not only potent; it was specific, and yet the silencing effect 
could cross cellular boundaries as well as be inherited in the progeny.  DsRNA
corresponding to intron and promoter sequences did not elicit a decrease in gene
expression (Fire et al., 1998), dsRNA targeting exon sequences did not alter levels of pre-
mRNAs (Ngo et al., 1998), and cistrons within a polycistronic message could be targeted 
separately (Montgomery et al., 1998), which suggests that the silencing mechanism acts 
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post-transcriptionally.  Interfering RNAs could exhibit silencing activity in a variety of 
worm tissues, whether the RNA was injected just in the worm gonads, or if the worms 
were soaked in RNA solution, and even when the worms ingested dsRNA expressed by 
bacteria (Tabara et al., 1998; Timmons et al., 2001; Timmons and Fire, 1998).  These 
observations suggest a possible mechanism for transporting the effector molecules
between cells, or a mechanism for amplifying the active molecules.  Such mechanisms 
might even explain the interesting observation that silencing by RNAi could be passed on 
to progeny two generations removed from the initial parent subjected to the RNA
treatment (Grishok et al., 2000).
Subsequently, the use of dsRNA to mediate gene silencing was utilized in various 
organisms including Drosophila (Kennerdell and Carthew, 1998; Misquitta and Paterson, 
1999), mouse oocytes (Svoboda et al., 2000; Wianny and Zernicka-Goetz, 2000), planaria 
(Sanchez Alvarado and Newmark, 1999), hydra (Lohmann et al., 1999), zebrafish
(Wargelius et al., 1999) and trypanosomes (Ngo et al., 1998).  Additionally, long dsRNA 
recapitulated silencing in vitro in Drosophila embryo lysates (Tuschl et al., 1999; Zamore 
et al., 2000) and in cultured Drosophila S2 cells (Caplen et al., 2000; Clemens et al., 
2000; Hammond et al., 2000).  While the use of dsRNA was effective in deciphering 
gene function, the exact mechanism in which silencing occurred remained unclear.
In order to dissect the steps of the silencing pathway and address mechanistic 
questions including which protein cofactors are involved, what energy requirements may 
be necessary, and what steps and intermediates exist, an in vitro system that recapitulates 
the gene silencing activity was needed.  The first two such systems were a Drosophila
3
embryo lysate system (Tuschl et al., 1999) and extracts prepared from Drosophila S2
cells (Hammond et al., 2000).  First it was shown that in vitro transcribed and annealed 
renilla or firefly luciferase long dsRNAs specifically targeted and destroyed only the 
corresponding luciferase mRNAs as determined by luciferase activity (Tuschl et al.,
1999).  Additionally, preincubation of the long dsRNA in lysate increased the efficiency 
of gene silencing, possibly allowing for processing of the long dsRNA into an active 
form (Tuschl et al., 1999).  In addition, a minimum length of dsRNA was required for 
robust interference, and an unrelated competitor dsRNA was able to reduce the efficiency 
of related dsRNA by potentially titrating out necessary proteins or cofactors for the 
conversion of the long dsRNA into an active form capable of mediating specific
interference (Tuschl et al., 1999).
Using a similar approach, Hannon and colleagues utilized a lacZ expression
vector to look at specific gene silencing in Drosophila S2 cells co-transfected with
unrelated or specific long dsRNA using β-galactosidase staining as a means for assaying 
gene knock-down (Hammond et al., 2000).  In addition, cyclin E, cyclin A, and fizzy 
could be targeted by this method as well, the first example of RNAi against an
endogenous gene in vitro (Hammond et al., 2000).  Extracts made from the transiently 
transfected cells confirmed that the silencing was specific to homologous mRNAs, and 
that the sequence-specific target degradation must be dependent on a nuclease activity,
termed the RNA-Induced Silencing Complex (RISC) (Hammond et al., 2000).  The group 
postulated that the nuclease complex contained an RNA component based on co-
fractionation experiments revealing the appearance of small RNA species approximately 
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25 nucleotides in length (Hammond et al., 2000), similar in size to the small RNAs 
detected in plants undergoing silencing (Hamilton and Baulcombe, 1999).  The
production of shorter, approximately 21 – 23 nucleotide, double-stranded fragements 
from long dsRNA in a target-independent fashion was shown in Drosophila embryo 
lysates (Zamore et al., 2000), also detected by Northern analysis in S2 lysates (Hammond 
et al., 2000), injection of radiolabeled dsRNA in worms (Parrish et al., 2000), and 
injection of dsRNA in single Drosophila embryos (Yang et al., 2000).  However, Zamore 
and colleagues demonstrated an ATP-dependence requirement for cleavage of the
corresponding mRNA, and that target cleavage occurred at 21 – 23 nt intervals, the same 
length of the processed long dsRNA, indicating that these small RNA fragments were 
guiding the sequence-specific mRNA cleavage (Zamore et al., 2000).
What are the structural characteristics and mechanistic actions of these small
interfering RNAs (siRNAs), and how are they produced?  It had been postulated, based 
on the size of siRNAs, that an RNase III enzyme may be involved in the processing the 
long dsRNA (Bass, 2000).  Chemical analysis of the 5´ and 3´ ends of the siRNAs 
revealed the presence of a terminal 2´, 3´ hydroxyl and a 5´ phosphate, similar to the 
termini observed following RNase III processing (Elbashir et al., 2001b).  The enzyme 
was later identified as Dicer, which contains a helicase domain and two RNase III
domains (Bernstein et al., 2001).  siRNAs from long dsRNA processing reactions were 
directionally cloned and the sequences and size distribution were analyzed.  The majority 
of the siRNAs cloned were 21 nucleotides long, but were as small as 18 nucleotides and 
as a long as 24 nucleotides (Elbashir et al., 2001b).  Previously the size of siRNAs were 
5
predicted to be approximately 21 – 23 nucleotides long (Zamore et al., 2000), as analyzed 
by the processing of radiolabeled dsRNA, but cloning of siRNAs revealed a small portion 
of total siRNAs fall outside of that range (Elbashir et al., 2001b).
To test if the short RNAs were the final determinants for guiding silencing
activity to specific target RNAs, the Tuschl lab chemically synthesized short RNAs that 
resembled siRNAs in structure to further study the requirements for efficient target
mRNA cleavage.  siRNAs with 2 nucleotide overhangs on the 3´ end, a signature of 
RNase III enzyme cleavage, resulted in the most efficient RNAi and play a role in
recognition or binding of the RNA or protein components of RISC (Elbashir et al.,
2001b).  The Zamore group found that 5´ phosphates on the siRNA enhanced entry into 
the RISC, which they conclude may be a licensing step in the pathway, allowing only 
true siRNAs into the silencing pathway (Nykanen et al., 2001).  Subsequently, it was 
found that siRNAs cleave cognate mRNAs across from nucleotides 10 and 11 from the 5´ 
end of the siRNA, and single nucleotide mismatches between the siRNA and mRNA can 
abolish cleavage by the elusive "Slicer" (Elbashir et al., 2001c). 
Experimental results from in vitro studies using fly embryo lysates, and results 
observed in vivo, lead to a revised view of how the RNAi pathway functions.  From these 
first few key papers it became clear that long dsRNA was processed by the RNAse III 
enzyme Dicer into shorter dsRNAs, siRNAs, that acted as the sequence-specific guides 
for target mRNA destruction.  These siRNAs were the key RNA component in the RISC, 
which guides the nuclease responsible for the cleavage that results in gene silencing.
These dsRNA intermediates could be separated into their single-strand components that 
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could target cognate sequences, either sense or anti-sense sequences, and cleave the 
mRNA across from the middle of the siRNA.  The important steps in RNAi were coming 
to light, but the key proteins were still not identified.
Genetic studies in worms and Neurospora, combined with biochemical data from 
in vitro fly systems, would give more clues and insight as to how long dsRNA mediates 
specific gene silencing.  Although cloning of endogenous siRNAs with sequences
corresponding to transposons reaffirmed a role for RNAi in transposon silencing
(Elbashir et al., 2001b), the genetic evidence for this role was first shown in worms 
(Ketting et al., 1999; Tabara et al., 1999).  The Mello group searched for mutants that 
were resistant to RNAi and found two genes, rde-1 and rde-4, that when mutated showed 
no obvious developmental or growth defects yet prevented worms from initiating RNAi
(Tabara et al., 1999).  However, several other RNAi mutants including rde-2, rde-3, mut-
2, and mut-7 exhibited reduced fertility, chromosome loss, and displayed mobilization of 
endogenous transposons, giving a first glimpse as to the natural role of RNA interference 
in repression of transposon hopping or in silencing other potentially harmful and foreign 
molecules such as viruses (Tabara et al., 1999).  Interestingly, the Plasterk group showed 
that when looking for mutants that displayed activation of Tc1 transposons in the
germline, some of these mutants also showed resistance to RNAi (Ketting et al., 1999).
One of the genes identified, mut-7, encodes a protein that shares homology with Werner 
Syndrome helicase and RNase D (Ketting et al., 1999) and was also isolated in the Mello 
screen (Tabara et al., 1999).
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In worms, RNAi can cross cell boundaries and be inherited in first generation 
progeny from injected long dsRNA, and genetic studies have provided insights into these 
characteristics.  For example, a screen for mutant worms that showed a defect in RNAi in
response to dsRNA introduced through feeding, but not by injection, revealed a loci
containing sid-1 (systemic RNAi deficient), which encodes a transmembrane protein
potentially involved in uptake and spreading (Winston et al., 2002).  In order to identify
how the effects of RNAi are inherited in the worm, and if a mechanism for amplification 
leading to the observed long-lasting effect existed, the Mello group found that rde-1 and 
rde-4 were required in the initial stages of RNAi and were not required for transposon 
silencing, while rde-2 and mut-7 acted farther downstream (Grishok et al., 2000).
Although the few known genes involved in RNAi could now be placed at specific steps 
in the pathway genetically, the mechanism of amplification in animals is still a matter of 
controversy (see below).
Previous genetic studies in Neurospora in which 15 mutants defective in quelling 
(Cogoni and Macino, 1997), the post-transcriptional gene silencing pathway in fungi, 
were isolated shed light onto proteins that may be acting in the RNAi pathway in
Neurospora. One such protein could be an RNA-dependent RNA polymerase (RdRP), a 
protein that was shown to play an important role in quelling and is activated in response 
to expression of transgenes and endogenous genes sharing sequence with the transgene.
In fungi, the RdRP homologous gene qde-1 (quelling defective) was isolated in the 
attempts to identify mutants in which transgene silencing was impaired (Cogoni and 
Macino, 1999), which is similar to the RdRP found in tomato that plays a role in the post-
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transcriptional process known as co-suppression in plants (Schiebel et al., 1998).  RdRPs 
in other organisms were known to play roles in silencing, including SDE1 (Dalmay et al., 
2000) and SGS2 (Mourrain et al., 2000) in Arabadopsis thaliana.  In worms, the gene 
found in the germ-line that is homologous to qde-1 and the tomato RdRP was identified 
as ego-1, of which some mutants displayed defects in germ-line development and
resistance to RNAi (Smardon et al., 2000).  Three worm paralogs of ego-1 were
identified and renamed rrf-1, rrf-2, and rrf-3, which may perform redundant functions as 
indicated by partial insensitivity to RNAi exhibited by some mutants (Smardon et al., 
2000), although the RRF-1 protein is found in the soma (Sijen et al., 2001) and EGO-1 is 
found in the germ-line (Smardon et al., 2000).  It appears the rrf-2 may not play a role in 
RNAi, but rrf-3 may be an inhibitor of RNAi (Sijen et al., 2001; Simmer et al., 2002).
There are several lines of reasoning as to why an RdRP would play a role in 
RNAi through comparison to PTGS in plants and quelling in fungi, as well as
observations in flies.  First, the tomato RdRP was shown to transcribe RNA from an 
RNA template in vitro, and therefore may perform a similar function in vivo in PTGS 
(Schiebel et al., 1993), which has been shown to be induced by the presence of RNA 
species such as exogenous dsRNA or transgenes, as well as viruses.  Additionally, the 
degree of homology between the putative RdRP in worms and QDE-1 in fungi raises the 
possibility that these genes function in similar ways (Smardon et al., 2000).  Finally, it 
was observed that only a few molecules of long dsRNA could mediate the silencing (Fire 
et al., 1998; Kennerdell and Carthew, 1998), suggesting that a method of amplification 
existed (Fire, 1999), possibly by the worm RdRP ego-1 (Smardon et al., 2000).
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 A revised version of the RNAi pathway unfolded, in which worm rde-1 and rde-
4 were likely to be involved in the processing of long dsRNA into siRNAs, the specificity 
determinants of the pathway which may recruit the nuclease responsible for mRNA
destruction.  Later it was found that rde-1 mutants, which showed no response to dsRNA, 
produced normal levels of siRNAs (Parrish and Fire, 2001).  In contrast, rde-4 mutants 
produced much lower levels of siRNAs in response to injections of long dsRNA (Parrish 
and Fire, 2001).  Therefore, it was determined that RDE-1 played a role downstream of 
siRNA production, while RDE-4 was essential in dsRNA processing (Parrish and Fire, 
2001). It was also found that Dicer, which is related to RDE-1 and Argonaute family 
members, was responsible for the processing of long dsRNA into siRNAs in flies
(Bernstein et al., 2001) in an ATP-dependent manner (Nykanen et al., 2001).  Later it was 
found that DCR-1, the ortholog of Dicer in flies, was responsible for dsRNA processing 
in worms, and is required for functional RNAi (Ketting et al., 2001; Knight and Bass, 
2001).  DCR-1 is found in a complex with RDE-1 and DRH-1, an RNA helicase,
indicating that these proteins may work together to produce siRNAs (Tabara et al., 2002).
It was hypothesized that the double-stranded siRNAs may then incorporated into a
ribonucleoprotein complex in a step that does not require ATP (Nykanen et al., 2001) and 
unwound into single strands by an unidentified helicase in an ATP-dependent fashion 
(Nykanen et al., 2001; Zamore et al., 2000).  The active RNP, or RISC, can then go on 
and mediate target cleavage in an ATP-independent manner (Nykanen et al., 2001),
leading to cleavage of the cognate mRNA at a single site (Elbashir et al., 2001b).
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Argonaute gene family members, which were identified in various organisms, 
were also shown to play a role in post-transcriptional gene silencing.  In worms, rde-1
was shown to play a role in the initial steps of RNAi (Tabara et al., 1999), in plants 
AGO1 was identified in a screen for mutants impaired for PTGS (Fagard et al., 2000), 
and QDE-2 was isolated in fungi (Catalanotto et al., 2000).  In flies, the Hannon group
identified AGO2 as a component of RISC through size fractionation of soluble RISC 
purified to near homogeneity, and co-migration with siRNAs and sequence-specific
mRNA degradation activity (Hammond et al., 2001).  AGO2, which was identified by 
mass spectrometry, showed homology with AGO1 in plants (Bohmert et al., 1998;
Fagard et al., 2000), eIF2C in humans, QDE-2 in fungi (Catalanotto et al., 2000), and 
rde-1 in worms (Tabara et al., 1999).  Of the four Argonaute proteins that were known to 
exist in flies, only AGO2 was identified as a component of RISC (Hammond et al., 
2001).  Even though AGO2 was identified as a component of RISC, the exact
biochemical function had not been deciphered.  Previous studies looking into the role of 
Dicer, the RNase III protein that processes long dsRNA, had identified a domain with 
unknown function called a PAZ domain (Bernstein et al., 2001).  Interestingly, AGO also 
contained a PAZ domain, and the group hypothesized that it may be essential for
interaction between the two proteins (Hammond et al., 2001).  Although Dicer was not 
identified as a component of RISC, the PAZ domain may provide a means for interaction 
between Dicer and AGO2 to hand off the processed siRNAs to the silencing complex 
(Hammond et al., 2001).
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At this point, several of the key steps in the RNAi pathway were identified, and 
clues from these findings led to the next big breakthrough.  It was known that siRNAs, 
the silencing intermediates, have a specific architecture which includes 19 nucleotides of 
double-stranded RNA, 2 nucleotide 3´ overhangs, 3´ hydroxyls and 5´ phosphates (Boutla 
et al., 2001; Chiu and Rana, 2002; Elbashir et al., 2001b; Nykanen et al., 2001; Zamore et 
al., 2000).  Long dsRNA had been used to mediate silencing in Drosophila S2 cells
(Caplen et al., 2000; Clemens et al., 2000; Hammond et al., 2000; Ui-Tei et al., 2000), 
but a problem arose in using long dsRNA in cultured cells because it did not show a 
specific and potent RNAi knock-down in various cell lines including HEK 293, NIH 3T3,
BHK-21, and CHO-K1 (Caplen et al., 2000; Ui-Tei et al., 2000).  Instead, the dsRNAs 
were inducing the protein kinase response (PKR), also commonly known as the
interferon response (Clemens, 1997).  When dsRNA binds and activates PKR (Manche et 
al., 1992) and 2´, 5 -´oligoadenylate synthatase (Minks et al., 1979), this causes sequence 
non-specific degradation by stalling translation and eventually leads to apoptosis.
When the Tuschl group found that siRNAs can mediate target mRNA cleavage in 
vitro, they postulated that these small RNAs could bypass the long dsRNA induced 
interferon response and be used in cultured cells to target a gene of interest (Elbashir et 
al., 2001b).  Using 21 nucleotide siRNAs directed against firefly and renilla luciferases in 
HEK 293 , COS-7 and HeLa cells, they found that co-transfections using liposome-
mediated technology resulted in a decrease in expression up to 25 fold (Elbashir et al., 
2001a).  Endogenous genes, including lamin A/C, lamin B1, nuclear mitotic apparatus 
protein (NuMA), and vimentin were targeted using siRNAs and assayed for knock-down
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by Western blotting and some knock-downs were more than 90% complete (Elbashir et 
al., 2001a).
This finding opened the door to many possibilities, including investigation into 
gene function through RNAi-mediated knock-down.  In addition, together with earlier
findings that single nucleotide mismatches between the siRNA and the mRNA may block 
silencing (Elbashir et al., 2001b), siRNAs showed promise in selectively targeting a 
mutant form of a gene while keeping the wildtype copy intact.  It was known that a 
central A-form helix was required for siRNAs to function efficiently (Chiu and Rana, 
2002), so disrupting this conformation between a mutant siRNA and a wild-type mRNA 
would block cleavage and allow for normal protein expression from the wild-type
mRNA.  Several groups have taken advantage of this discovery for targeting mutant
genes associated with diseases including amyotrophic lateral sclerosis (ALS) (Ding et al., 
2003; Maxwell et al., 2004; Ralph et al., 2005; Raoul et al., 2005), Alzheimer's (Miller et 
al., 2004), slow channel congenital myasthenic syndrome (SCCMS) (Abdelgany et al., 
2003), Huntington's (Harper et al., 2005), spinocerebellar ataxia type 1 (SCA1) (Xia et 
al., 2004), human immunodeficiency disorder (HIV) (Lee et al., 2005; Li et al., 2005), 
Machado-Joseph disease/spinocerebellar ataxia type 3 (Miller et al., 2003), and cancer 
(Martinez et al., 2002b).  Specifically, purine:purine mismatches between the siRNA and
mRNA increase the chance of discrimination between an siRNA and the wildtype allele 
so as that it is not degraded by disrupting the base pairing between the siRNA guide 
strand and mRNA to the greatest degree (Ding et al., 2003).  While the molecular details
of single nucleotide discrimination are being revealed, the real challenge exists in the 
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delivery, stability, and long-term potentiation of silencing in an animal model or human 
trial.
RNAi can also be used to target viruses and viral RNAs to stop infection in a host 
organism when infected with viruses including Hepatitis C (Kapadia et al., 2003; Korf et 
al., 2005; Kronke et al., 2004; Prabhu et al., 2005; Sen et al., 2003; Seo et al., 2003; 
Takigawa et al., 2004; Wilson et al., 2003; Yokota et al., 2003), Hepatitis B (Giladi et al., 
2003; Hamasaki et al., 2003; McCaffrey et al., 2003; Moore et al., 2005; Ren et al., 2005; 
Shlomai and Shaul, 2003; Wu et al., 2005; Ying et al., 2003), Dengue virus (Adelman et 
al., 2002), HIV encoded RNAs (Capodici et al., 2002; Coburn and Cullen, 2002; Jacque 
et al., 2002; Lee et al., 2003a; Lee et al., 2002; Novina et al., 2002; Park et al., 2003; Park 
et al., 2002b; Song et al., 2003a; Surabhi and Gaynor, 2002), polio virus (Gitlin et al., 
2002; Gitlin et al., 2005), influenza virus (Ge et al., 2004; Ge et al., 2003), and rotavirus 
(Dector et al., 2002).  siRNAs hold great potential in therapeutics, but currently the 
limiting factors include stability, delivery, the emergence of mutated viruses that can
escape RNAi-mediated silencing, and the establishment of a long-lasting effect.
Presently, only one disease, macular degeneration, is being tested in clinical trials using 
siRNA technology to treat the overgrowth of blood vessels in the retina (for news
see:(Check, 2004)). 
MicroRNAs - How RNAi Regulates Eukaryotic Development
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While the story of RNA interference unfolded, a related set of small, non-coding RNAs 
were coming to light.  Unbeknownst to the scientists, studies revolving around the
regulation of the expression of specific genes at particular times in development would be 
linked to an unknown class of tiny RNAs.  The first studies linking tiny RNAs with 
development began as an investigation into the heterochronic mutants which had lesions 
in genes that caused the misexpression of proteins at incorrect stages of development 
resulting in improper execution of cell fates in the developing worm (Ambros and
Horvitz, 1984; Chalfie et al., 1981; Horvitz and Sulston, 1980; Sternberg and Horvitz, 
1984; Sulston and Horvitz, 1981).  Victor Ambros pioneered this study by focusing on 
one of these heterochronic genes with defects in cell lineage, lin-14, which was repressed 
at certain stages of development (Ambros and Horvitz, 1987), and he witnessed a curious 
genetic puzzle unravel.  He found that during the course of worm development, high 
levels of lin-14 gene activity were correlated with expression of early cell fates in larval 
stage 1 (L1), whereas low levels of lin-14 gene activity are correlated with late cell fates 
L2 and beyond (Ambros and Horvitz, 1984; Ambros and Horvitz, 1987).  Ambros also 
observed that another heterochronic mutation in the gene lin-4 appeared to regulate lin-14
as if it was epistatic, however, at the time, a clear model explaining how lin-4 and lin-14
interacted to regulate lin-14 activity could not be established.
A glimpse into the mode of regulation by lin-14 activity came about when the 
mapping, characterization and cloning of the lin-14 locus was performed (Ruvkun et al., 
1989).  Two alleles were isolated in which lin-14 activity was elevated in late stages, and 
sequences from the mature mRNA were deleted in these mutants indicating that these 
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sequences were important in regulation of lin-14 expression (Ruvkun et al., 1989).  Later 
it was found that sequences within the 3´ untranslated region (UTR) of lin-14 were
responsible for the negative regulation of the translated nuclear protein (Wightman et al., 
1991), and this regulation provided the temporal switch determining early and late cell 
fates (Ruvkun and Giusto, 1989).  In an attempt to determine if other heterochronic genes 
may be involved in the regulation of lin-14 expression, the Ruvkun lab found that lin-4 is 
required for the downregulation in L1, and therefore the lin-4 gene product is the most 
likely candidate to interact with the negative regulatory element that resides in the 3´ 
UTR of the lin-14 mRNA (Arasu et al., 1991).
When the Ambros lab finally cloned the lin-4 gene, which they knew genetically 
regulated lin-14, they were surprised to find that the gene product of lin-4 was not a 
protein, but instead two small transcripts of ~22 and 61 nucleotides were identified, the 
longer of which was the precursor of the small RNA, predicted to fold into a stem loop 
structure (Lee et al., 1993).  These small RNAs encoded by lin-4 shared partial homology 
with sequences in the 3´ UTR of the lin-14 mRNA, suggesting that the regulation of lin-
14 expression and translation occurred via an RNA:RNA interaction (Lee et al., 1993; 
Wightman et al., 1993).  The RNA:RNA interactions were thought to occur at seven sites 
within the UTR, four of which do not result in perfect pairing, but instead result in a 
"bulged" interaction at a C nucleotide, illustrating the importance of the RNA secondary 
structure at these sites (Ha et al., 1996).  In addition, developmental profiles of lin-4 show 
that accumulation of the RNA correlates with the downregulation of LIN-14 expression 
(Feinbaum and Ambros, 1999).  The developmental expression profiles of the two genes, 
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the presence of lin-4 complementary sites in the 3´ UTR of lin-14, along with mutational 
analysis, show that lin-4 is controlling the timing of lin-14 expression, although it was 
still unclear as to the molecular details of regulation.
Finally, approximately eight years after the discovery that lin-4 may be involved 
in lin-14 expression, the Ambros group went on to show that lin-14 mRNA synthesis, 
state of polyadenylation, abundance in the cytoplasm, and polysome profiles do not
change (Olsen and Ambros, 1999).  This suggests that the regulation occurs at a step 
following translation initiation, including elongation or release of the mature protein
(Olsen and Ambros, 1999). Lin-28, another heterochronic gene, was later identified as a 
second target of lin-4 regulation because it also contained a sequence in the 3´ UTR that 
is complementary to the lin-4 RNA (Moss et al., 1997).  A similar mechanism of
translational repression was observed for lin-28 regulation by lin-4, suggesting that gene 
expression is fine-tuned at a step following the initiation of translation (Seggerson et al., 
2002).
Despite the advances in understanding the regulation of the lin-4 small RNA, 
many scientists thought that the lin-4 story was a curious one found only in worms.
However, in 2000, the Ruvkun lab identified a second gene encoding a 21 nucleotide 
RNA called let-7 that displayed complementarity to the 3´ UTR of heterochronic genes 
including lin-14, lin-28, lin-41, lin-42 and daf-12 (Reinhart et al., 2000), and may also be 
derived from a stem-loop precursor RNA like lin-4 (Pasquinelli et al., 2000).  The longer 
precursor RNA decreased in abundance over time as the mature, 22 nucleotide let-7
accumulated, indicating that the longer species was a bona fide stem-loop precursor
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(Pasquinelli et al., 2000).  In addition, let-7 is capable of negatively regulating lin-41, an 
event that hypothetically relieves inhibition of another heterochronic gene and
transcription factor lin-29 (Slack et al., 2000).  Now that two small RNAs have been 
identified that regulate developmental timing and expression during cell fate
determination, these molecules were called small temporal RNAs (stRNAs).  The
Ruvkun lab then showed that let-7 is conserved among several species, including
vertebrates, hemichordates, annelids, and arthropods (Pasquinelli et al., 2000). This
suggested that these small RNAs play large roles in complex regulatory networks, and 
hinted that many other small RNAs may exist in a variety of organisms.
The proof that more small RNAs existed arrived in 2001, when three groups used 
cloning and bioinformatics strategies to identify over 100 small RNAs from flies, worms, 
and cultured human cells (Lagos-Quintana et al., 2001; Lau et al., 2001; Lee and Ambros, 
2001).  These RNAs were ~22 nucleotides in length, the same as lin-4 and let-7, while 
genomic and Northern analysis indicated that these RNAs could also be derived from 
stem-loop precursors.  However, not all of the small RNAs were temporally regulated 
like lin-4 and let-7, so a new term, microRNAs (miRNAs) was selected for this new class 
of non-coding RNAs.  Searches revealed that these small RNAs can reside on either arm 
of the stem-loop precursor encoded in the genome, were conserved over evolution to 
varying degrees, and were found in various different tissues (Lagos-Quintana et al., 2001; 
Lau et al., 2001; Lee and Ambros, 2001).
Additional cloning efforts revealed that miRNAs were present in numerous
organisms including worms (Ambros et al., 2003; Lim et al., 2003b), human cells (Dostie
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et al., 2003; Kim et al., 2004; Lagos-Quintana et al., 2003; Mourelatos et al., 2002),
mouse (Lagos-Quintana et al., 2003; Lagos-Quintana et al., 2002), embryonic stem cells 
(Houbaviy et al., 2003), flies (Aravin et al., 2003), plants (Reinhart et al., 2002; Sunkar 
and Zhu, 2004), rice (Sunkar et al., 2005; Wang et al., 2004a), zebrafish (Chen et al., 
2005; Lim et al., 2003a) and even viruses (Bennasser et al., 2004; Pfeffer et al., 2005; 
Pfeffer et al., 2004).
These cloning efforts took advantage of the 2001 finding that Dicer, the enzyme 
responsible for the processing of long dsRNA (Bernstein et al., 2001), was also involved 
in maturation of miRNAs from the stem loop precursors in worms (Grishok et al., 2001) 
as well as flies and humans (Hutvagner et al., 2001).  In worms genetic studies revealed 
that rde-1 homologs alg-1 and alg-2, along with dcr-1, are necessary for the maturation 
of miRNAs lin-4 and let-7 (Grishok et al., 2001).  Studies in flies showed that the long 
stem loop RNA that was suspected to be the precursor for let-7 was the true precursor and 
that only the let-7 RNA sequence from the 5´ arm of the stem loop structure was detected 
as the mature single-stranded miRNA (Hutvagner et al., 2001).  Analysis of the termini of 
the mature miRNAs showed that the 3´ end bore 2´, 3´ terminal hydroxyls and 5´ end 
possessed a monophosphate, indicative of processing by RNasee III enzymes (Hutvagner 
et al., 2001).  The 2001 efforts to clone additional small non-coding RNAs took
advantage of the research showing that stRNAs were processed by Dicer leaving
characteristic termini, which was adapted into the small RNA cloning protocols (Lagos-
Quintana et al., 2001; Lau et al., 2001; Lee and Ambros, 2001).
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miRNAs are derived from longer transcripts that are found in intragenic regions 
or within introns of pre-mRNAs, and can be found singularly or within a cluster as a 
primary miRNAs (pri-miRNAs) that may be related (Lagos-Quintana et al., 2001; Lau et 
al., 2001).  Most of the miRNAs are conserved among closely related species (Lagos-
Quintana et al., 2003; Lim et al., 2003a; Lim et al., 2003b), but some miRNAs show 
broad conservation among more distantly related species (Ambros et al., 2003; Aravin et 
al., 2003; Lagos-Quintana et al., 2003; Lim et al., 2003b).  miRNA expression levels can 
vary from extremely high to very low within an organism, with some miRNAs expressed 
only in individual cell types such as neurons (Johnston and Hobert, 2003; Lim et al., 
2003b).
Although the identification of additional miRNA genes remains an interesting
topic, the next burning question in the field was to find target mRNAs that are regulated 
by all the newly identified miRNAs and to determine if miRNA targets might represent a 
specific type of mRNA.  The mRNA targets of the two founding members of the
miRNAs, lin-4 and let-7, had been identified by genetic studies with mutants defective in 
heterochronic development.  Since the finding of the new non-coding RNA family, only a 
few target/miRNA pairs have been identified experimentally.  This includes the fly
bantam miRNA that targets the apoptotic gene hid (Brennecke et al., 2003), and miR-14
whose target is not identified but is involved in fat metabolism and apoptosis (Xu et al., 
2003).  In mammals, miR-181 was found to play a role in hematopoietic differentiation 
(Chen et al., 2004).  Two additional miRNAs found in worms, lsy-6 and miR-273, were 
found to play a role in left/right neuronal asymmetry by targeting cog-1 and die-1
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transcription factors, respectively (Chang et al., 2004; Johnston and Hobert, 2003).  The 
vertebrate miR-196a was shown to be involved in anterior/posterior patterning by
targeting Hoxb8, Hoxc8, Hoxd8 and Hoxa7 (Mansfield et al., 2004; Yekta et al., 2004).
Although these examples indicate experimental progress in identifying miRNA targets, 
the number of experimentally verified examples is still low compared to the hundreds of 
animal miRNAs identified.
In plants, however, the identification of miRNA targets has proceeded much more 
rapidly than in animals, with several miRNA targets identified to be transcription factors 
that contribute to leaf, flower, and meristem formation (Achard et al., 2004; Aukerman 
and Sakai, 2003; Baker et al., 2005; Chen, 2004; Emery et al., 2003; Juarez et al., 2004; 
Kasschau et al., 2003; Kidner and Martienssen, 2004; Kim et al., 2005; Laufs et al., 2004; 
Llave et al., 2002b; Mallory et al., 2005; Mallory et al., 2004a; Mallory et al., 2004b; 
McHale and Koning, 2004; Palatnik et al., 2003; Rhoades et al., 2002; Tang et al., 2003).
Unlike animal miRNAs, plant miRNAs share near perfect complementarity with 
their targets, making it more straight-forward to identify putative target mRNAs (Jones-
Rhoades and Bartel, 2004; Rehmsmeier et al., 2004; Rhoades et al., 2002; Wang et al., 
2004b; Zhang, 2005).  Some of these predicted plant targets were then verified
experimentally or through phylogenetic searches (Kasschau et al., 2003; Llave et al.,
2002a; Llave et al., 2002b; Park et al., 2002a; Xie et al., 2003).  Whereas most animal 
miRNA:target pairs identified to date result in translational repression, plant miRNAs 
predominantly mediate an mRNA cleavage event (Kasschau et al., 2003; Llave et al., 
2002a; Rhoades et al., 2002; Tang et al., 2003) typically characteristic of siRNAs. Other
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differences between the plant and animal miRNAs exist.  First, plant miRNAs are
thought to derive from precursor stem loops that are larger than their animal counterparts, 
and the extent of base pairing along the stem of the plant miRNA precursors is higher
(Reinhart et al., 2002).  However, while animal pre-miRNAs can be detected by Northern 
blots, plant pre-miRNAs have been difficult to detect.  Second, the majority of plant
miRNAs are only 21 nucleotides in length, as compared to the wider size range
characteristic of animal miRNAs (Reinhart et al., 2002).
But since animal miRNAs do not perfectly pair with their targets, and it was not 
known at the time how miRNAs could specifically pair to the 3´ UTR of the mRNAs that 
they regulate, identifying their targets became more of a challenge because the lower 
degree of base-pairing reduces the signal-to-noise ratio when comparing potential targets 
versus randomized sequence controls.  In addition, some miRNAs are only expressed at 
certain stages of development or within specific cell types or tissues (Baskerville and 
Bartel, 2005; Thomson et al., 2004), making it even more difficult to show if candidate 
target mRNAs are truly being regulated by a miRNA, since co-expression of a miRNA 
and an mRNA in the same cell is required for regulation to occur.  Scientists then turned 
to bioinformatics to compliment the experimental data (Enright et al., 2003; Kiriakidou et 
al., 2004; Lewis et al., 2003; Rajewsky and Socci, 2004; Stark et al., 2003), some of 
which were verified experimentally following computational predictions (Kiriakidou et 
al., 2004; 2003; Lai et al., 2003; Lewis et al., 2003; Stark et al., 2003).  Several different 
groups place more importance on certain factors contributing to miRNA-mediated down-
regulation of gene expression.
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The bioinformatics approaches take several factors into account, including
number of recognition sites for a certain miRNA present in a particular 3´ UTR, where 
some groups consider at least 2 sites to be significant (Lewis et al., 2003)  and others 
require only one response element to be a considered a significant hit (Kiriakidou et al., 
2004).  Most groups place a high level of importance as to where the response elements 
are located within the mRNA, with high importance placed on the 3´ UTR for that is 
where the lin-4 and let-7 binding sites were found.  If the miRNAs are mediating
translational repression at a point following initiation, then a location on the mRNA far 
from ribosome loading and clearing would be key.  This classification may be somewhat 
premature as a single imperfect site capable of mediating translational repression was 
identified in a mammalian construct (Saxena et al., 2003).
Bioinformatic analysis of miRNA sequence conservation has yielded an important 
insight into miRNA and siRNA function.  Clustering of related miRNA family members 
indicated that the base pairs shared in common were in the 5´ end, while some studies 
examined the degree of miRNA sequence conservation across species (Lewis et al.,
2003), or specific conservation of nucleotides (Lewis et al., 2005).  It was observed that 
the conservation at the 5´ end of the miRNA pairing to the target mRNA exhibited the 
strongest conservation, suggesting that this might represent the most critical aspect of 
miRNA recognition of its target (Lai, 2002; Lewis et al., 2005; Lewis et al., 2003; Stark 
et al., 2003).  Nucleotides 2 – 8 at the 5´ end of the miRNA are called the 'seed' region, 
and several lines of experimental evidence have confirmed the functional importance of 
this region (Brennecke et al., 2005; Doench and Sharp, 2004; Haley and Zamore, 2004; 
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Lim et al., 2003b).  Thus, siRNAs targeting a specific gene may mediate miRNA-like
translational repression if the level of base pairing in the 'seed' region is extensive in non-
targeted genes.  This concept has been proposed to explain the off-target effects where 
unintended mRNAs get downregulated by an siRNA that simply binds with the 'seed' 
region (Jackson et al., 2003). In addition, the 5´ end was shown to disproportionately
contribute to miRNA (Brennecke et al., 2005; Doench and Sharp, 2004; Lai et al., 2005; 
Mallory et al., 2004b) or siRNA binding to its target (Haley and Zamore, 2004; Jackson 
et al., 2003).
Increasing amount of evidence blurs the lines between siRNAs and miRNAs.  For 
example, when siRNAs were designed to imperfectly pair with CXCR4 sites engineered 
into the 3´ UTR of a luciferase reporter construct, they were able to act like miRNAs and 
mediate translational repression as measured by the knock-down of renilla luciferase 
protein, but the levels of mRNA remained fairly constant (Doench et al., 2003).  In turn, 
while an siRNA can be designed to function like a miRNA, a miRNA that is
endogenously programmed into an RNP complex is capable of mediating mRNA
cleavage when presented with a target that is perfectly complementary to the miRNA 
sequence (Hutvagner and Zamore, 2002).  These results taken together suggest that the 
extent of complementarity between a target and a small RNA dictates the mode of
regulation, either mRNA cleavage or translational repression (Doench et al., 2003;
Hutvagner and Zamore, 2002; Zeng et al., 2003).  Additional insights came when another 
group identified numerous different miRNAs in a complex called the miRNP (now 
collectively referred to as RISC), which contains eiF2C2 (Mourelatos et al., 2002), a
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member of the Argonaute family previously shown to be a member of RISC (Hammond 
et al., 2001).  Another member of the RNAi pathway, Dicer, was previously shown to 
play roles in both siRNA and miRNA production (Grishok et al., 2001; Hutvagner et al., 
2001).  This information presented the possibility that both silencing pathways have 
several key factors in common.
However, it was still not known exactly how miRNAs mediated translational
repression, at what point translation was affected, and what other proteins may be
involved in the process, and the role that miRNAs may be playing in developmental and 
biological processes as only a few miRNAs have been characterized in which targets 
have been identified.  Two groups came up with a way to determine the function of each 
individual gene by blocking miRNA function with a 2 -´O-methyl oligo (Hutvagner et al., 
2004; Meister et al., 2004a), a method that has been used to look at several miRNAs in 
development (Leaman et al., 2005).  Instead of mutating or knocking out the regions that 
contain miRNA genes, this method can be used to irreversibly block a RISC that contains 
a specific miRNA in order to access what biological role it may normally being playing.
Now that a method existed to assay miRNA function, the next question addressed how 
these miRNAs mature.
When looking for the protein that processes long primary miRNAs (pri-miRNAs),
the Kim group found that the nuclear protein Drosha, an RNAse III enzyme, cleaved the 
stem loop pre-miRNA from these longer capped and polyadenylated transcripts (Lee et 
al., 2003b) which are transcribed by RNA Polymerase II (Bracht et al., 2004; Cai et al., 
2004; Lee et al., 2004a).  This first cut made by Drosha establishes one end of the 
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miRNA (Basyuk et al., 2003; Lee et al., 2003b).  Later, several groups found that Drosha 
required the presence of a dsRNA binding partner, Pasha (DGCR8 in humans), whose 
function remains unknown (Denli et al., 2004; Gregory et al., 2004; Han et al., 2004; 
Landthaler et al., 2004).  Following processing by Drosha, the pre-miRNA is exported to 
the cytoplasm by Exportin 5 in a Ran-GTP dependent manner (Bohnsack et al., 2004; 
Lund et al., 2004; Yi et al., 2003; Zeng and Cullen, 2004) where the second cut is made 
by Dicer (Grishok et al., 2001; Hutvagner et al., 2001; Ketting et al., 2001).
In flies, Dcr-1 was found to have a dsRNA-binding partner, called Loquacious 
(Forstemann et al., 2005) or R3D1 (Jiang et al., 2005), or in humans identified as TRBP 
(Chendrimada et al., 2005), that facilitates the function of Dicer in processing miRNAs 
from pre-miRNAs.  Depletion of these dsRNA-binding partners results in accumulation 
of pre-miRNAs, loss of maintenance of germ-line stem cells and sterility in male and 
female flies (Forstemann et al., 2005; Jiang et al., 2005).  In humans, the Dicer-TRBP
heterodimer was shown to interact with hAgo2 (Chendrimada et al., 2005).  To date, all 
known RNAse III enzymes that play a role in RNA silencing and production of small 
RNAs have been shown to function via interaction with a dsRBD partner.
siRNA Function and RISC Composition
While it was known that siRNAs cleaved homologous targets, several questions still
remained, including which proteins form the final silencing complex and whether
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siRNAs contribute to an amplification step in flies and humans.  Beyond Argonaute 
proteins, it was shown that dFXR, the fly homolog of the human fragile X mental
retardation protein (FMRP), is another component of RISC which associates with
miRNAs, siRNAs, and characteristic nuclease activity (Caudy et al., 2002; Ishizuka et al., 
2002).  dFXR was also shown to interact with vasa intronic gene (VIG), which contains a 
domain for RNA binding (Caudy et al., 2002).  The exact role of these proteins in RNA 
silencing still remains under investigation.  The Hannon group identified an additional 
protein, Tudor-SN (TSN), a homolog of Staphylococcus nuclease, found to be associated 
with RISC (Caudy et al., 2003).  Tudor-SN is conserved in humans, worms, and flies, and 
contains a nuclease domain, which lead researchers to postulate that this protein may 
contribute to the 'slicer' activity characteristic of RISC (Caudy et al., 2003).
miRNAs and siRNAs were also shown to be associated with the human
Argonatue2 homolog, eiF2C2, in addition to Gemin3, a known DEAD-box helicase, and 
Gemin4, a protein of unknown function (Mourelatos et al., 2002).  Finally, it was shown 
that eiF2C1 and/or eiF2C2 contained single-stranded RNA when double-stranded siRNA 
was added to lysate, showing that the siRNA must be unwound by an unidentified
helicase (Martinez et al., 2002a).
Amplification of siRNAs in flies and humans was once a controversial topic.  An 
RNA-dependent RNA Polymerase (RdRP), a component that had been identified in
worms, fungi, and plants, had not been identified in humans or flies.  An RdRP would act 
to amplify the silencing signal, but no evidence of an RdRP existed in the sequenced 
genome of flies or humans.  One group asserted that siRNAs were acting as primers for 
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synthesis of additional dsRNA molecules, which would then be processed by Dicer into 
siRNAs to amplify the silencing signal (Lipardi et al., 2001).  However, it was shown that 
replacing the 3´ OH, which would be required for polymerization, on the siRNA with 
groups that would inhibit addition of nucleotides on the 3´ end had no effect on efficiency 
of silencing (Schwarz et al., 2002).  In fact, single-stranded siRNAs could be added 
directly to fly embryo lysate, HeLa S100 lysate or transfected into cultured human cells 
and still elicit RNA cleavage when perfectly paired to the substrate mRNA, although the 
response was much less robust due to higher instability of unprotected single-stranded
RNA (Martinez et al., 2002a; Schwarz et al., 2002).  Both groups noted the importance of 
a 5´ phosphate on the single-strand siRNA to mediate efficient mRNA destruction, with 
an absolute requirement for a 5´ phosphate in fly lysate (Martinez et al., 2002a; Schwarz 
et al., 2002), which was previously shown to be a requirement for duplexed siRNAs in fly 
lysates as well (Nykanen et al., 2001).
But were there any other requirements for efficient assembly of an siRNA into 
RISC?  Previously, it was shown that both strands of a double-stranded siRNA can be 
incorporated into RISC separately and drive the cleavage of a homologous target, either 
sense or anti-sense (Elbashir et al., 2001b; Elbashir et al., 2001c; Nykanen et al., 2001).
Because siRNAs are double-stranded prior to unwinding and incorporation into RISC as 
single strands, an equal population of sense-containing and anti-sense-containing RISCs 
could exist (Elbashir et al., 2001b).  However, several groups have discovered that not all 
siRNAs deliver the same extent of silencing, which should not be the case if each strand 
of an siRNA has the same chance to incorporate into RISC.
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Differences in structure, sequence or target accessibility may play a role in the 
varied efficiencies of different siRNAs.  However, each strand of an siRNA is not equally 
eligible for entry into RISC, but the relative stabilities of the 5´  ends of the siRNA 
strands is what determines the ability of each strand to be assembled into RISC
(Khvorova et al., 2003; Schwarz et al., 2003).  Nearest neighbor calculations allowed for 
the determination of free energy differences (Borer et al., 1974; Gralla and Crothers, 
1973a; Gralla and Crothers, 1973b; Tinoco et al., 1973; Tinoco et al., 1971) between the 
two ends by calculating the contribution that each of the last four nucleotides contribute 
to the overall thermodynamic properties of the siRNA (Figure 1).  For each siRNA, the 
strand whose 5´ end is less tightly paired is assembled into RISC while the other strand is 
degraded (Schwarz et al., 2003).  If the difference in free energy between both ends is 
great enough, siRNAs can be functionally asymmetric with only one strand capable of 
entry into RISC (Khvorova et al., 2003; Schwarz et al., 2003).  By unpairing the 5´ most 
nucleotide on a guide strand of an siRNA and creating a single nucleotide mismatch at 
the termini, that strand can enter RISC to the near exclusion of the other strand (Schwarz 
et al., 2003).
Asymmetric loading of the short double-stranded RNAs into the silencing
complex may explain one important step in the biogenesis of the other short RNAs 
capable of post-transcriptional gene silencing, including miRNAs.  miRNAs can derive 
from either the 5´ or 3 ´ side of the stem loop from which they reside, or in some cases 
two miRNAs are processed from the same predicted fold-back structure based on the 
frequency of cloning (Lagos-Quintana et al., 2001; Lau et al., 2001).  However, the
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Figure I - 1.  Free energy calculations of siRNA ends.  Thermodynamic calculations 
were based on the last 4 paired nucleotides of an siRNA end plus the free energy
contributed by the 3' overhang.  Free energy (kcal/mol) was added together to determine 
the total free energy for a particular siRNA end.  Values were based on Xia et al., 
‘Chapter 2.  Thermodynamics of RNA Secondary Structure Formation’ in RNA pp 21 –
48.
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majority of mature miRNA sequences are represented by only one strand from one of the 
arms of the stem-loop precursor.  The precursor miRNA (pre-miRNA) can be viewed as 
an intermediate that resembles an siRNA if the loop portion is ignored (Hutvagner and 
Zamore, 2002; Lim et al., 2003b; Reinhart et al., 2002).  In this siRNA-like intermediate, 
the free energy of the 5´ end of the strand that is more weakily paired to its complement 
can be incorporated into the silencing complex while the other strand is destroyed, 
explaining why miRNAs accumulate as single-strands in vivo (Khvorova et al., 2003; 
Schwarz et al., 2003) (Figure 2).  If the free energies of the 5´ ends of the intermediate 
are relatively equal then both strands may be incorporated into the complex, but for each 
complex only one strand may be incorporated.  This concept could also explain why, for 
some miRNAs, both arms of the precursor can be processed into mature miRNAs
(Khvorova et al., 2003; Schwarz et al., 2003) and be detected in cloning experiments (the 
more abundant miRNA is referred to as miR while the less abundant sequence is called 
miR*) (Lau et al., 2001).
The asymmetric loading concept can be utilized to predict which arm of a pre-
miRNA could be processed into the mature miRNA, and can be incorporated into new 
approaches for designing effective siRNAs based on thermodynamics (Khvorova et al., 
2003; Reynolds et al., 2004; Schwarz et al., 2003).  A difference in a single nucleotide at 
the end of the siRNA can flip the asymmetry; therefore, a point mutation in a stem loop 
structure could also alter miRNA expression profiles.  Advantages of rational design 
include increasing the potential to create an effective siRNA, and also the possibility of 
lowering the concentration of delivery, as well as potentially decreasing unwanted off-
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Figure I - 2.  microRNA (miRNA) processing in Drosophila.  miRNAs are processed in 
the nucleus by the RNase III enzyme Drosha leaving 5' phosphates and 3' hydroxyls with 
a 2 nucleotide, 3' overhang.  The precursor miRNA (pre-miRNA) is exported out of the 
nucleus to the cytoplasm by Exportin 5 where it is bound by Dcr-1 and Loquacious.  Dcr-
1 makes the second cut on the stem, near the loop structure, liberating an siRNA-like
intermediate called miR/miR*.  The siRNA with the end that is less tightly paired will 
enter the silencing complex and become the mature miRNA whereas the strand with the 
more tightly paired end will be degraded.  Once the mature miRNA is loaded into the 
Ago1 silencing complex it can then go on mediate translational repression.
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target effects by exclusively allowing only one strand of the duplex to enter the silencing 
complex.  While it is clear that there must be an enzyme capable of sensing the
asymmetry of the siRNA by determining which end displays weaker pairing, this enzyme 
had yet to be identified.
A Detailed RISC Assembly Pathway 
What protein factors might be good candidates for the enzyme that measures asymmetric 
unwinding of siRNAs?  Flies are known to possess two dicer proteins — Dcr-1, which 
has been shown to play a role in miRNA maturation, and Dcr-2, which plays a role in 
siRNA production (Lee et al., 2004b).  Dcr-2 has been show to play an additional role 
beyond long dsRNA processing, which is in loading one of the siRNA strands into RISC 
(Lee et al., 2004b).  The single human Dicer may also function in loading siRNAs into 
RISC as seen in Dicer knock-down cells that can no longer elicit efficient gene silencing 
following siRNA transfections (Doi et al., 2003).  An additional protein was found to 
associate with DCR-2 in Drosophila S2 cells when scientists were trying to determine 
how siRNAs are handed off from Dicer to RISC (Liu et al., 2003).  This protein was 
called R2D2 for its two RNA binding domains (R2) and its association with Dcr-2 (D2) 
(Liu et al., 2003), and is similar to the worm protein RDE-4 (Grishok et al., 2000; Tabara 
et al., 2002).
Knowing some of the key proteins and steps in the pathway, two groups proposed 
revised pathways for RISC assembly in Drosophila (Pham et al., 2004; Tomari et al., 
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2004a) (Figure 3).  The siRNA is bound by R2D2, which recognizes the more stable end, 
and Dcr-2 in a complex known as the RISC Loading Complex (RLC) (Pham et al., 2004; 
Tomari et al., 2004a; Tomari et al., 2004b).  Therefore, this heterodimer acts as a protein 
sensor in which R2D2 binds to the siRNA end that displays the highest double-stranded
character, and forces Dcr-2 to bind the weaker end (Tomari et al., 2004b).  The
R2D2/Dcr-2 complex then may recruit the holo-RISC, which contains Dcr-1, VIG,
dFMR, Tudor-SN (TSN), and Ago2 (Pham et al., 2004).  The R2D2/Dcr-2/siRNA
complex may bind the PIWI domain of Ago2, which is required for siRNA unwinding 
(Okamura et al., 2004), through the RNAse III domain, as seen in human Dicer (Tahbaz 
et al., 2004).  Once the siRNA is unwound, by an as-yet-identified protein, the passenger 
strand is released and degraded (Schwarz et al., 2003), which leads to the formation of 
mature RISC that contains single-stranded RNA (Martinez et al., 2002a; Pham et al., 
2004; Tomari et al., 2004a).
Once mature RISC is formed, it can then go on to mediate mRNA cleavage, but 
the protein that directs the cleavage had not been identified at that time.  Clues as to what 
protein may be mediating this activity came from the analysis of the cleavage products 
that resulted from the RNA cleavage.  RISC had previously been proposed to act as an 
endonuclease, but proof came when both a 5´ and 3´ cleavage product resulting from
siRNA-directed mRNA cleavage were detected in a single experimental system (Schwarz 
et al., 2004).  Cleavage was shown to occur at a single scissile phosphate, which could be 
blocked by a phosphorothioate substitution or reduced by a 2 -´O-methyl substitution, in a 
Mg2+-dependent manner liberating a 5´ cleavage product bearing a free 3´ hydroxyl
36
OH
HO P
P
OH
HO P
P
Dcr-2R2D2
OH
HO
P
P
Ago2
Ago2
OH
HO P
P
HO P
degraded
AAA...An7mGpppG
7mGpppG AAA...AnOH P
Mg2+
Mg2+
XRN1Exosome,
Ski complex
Degrade 5’ to 3’Degrade 3’ to 5’
Figure 3
37
Figure I - 3.  siRNA loading in RISC.  siRNAs strands whose end is less tightly paired 
will be bound by R2D2, and the end that is less tightly paired will be bound by Dcr-2.
The Dcr-2/R2D2/siRNA complex is called the RISC loading complex, or RLC.  Ago2 
will bind the siRNA, through an interaction with Dcr-2.  It has been postulated that Ago2 
can cleave the passenger strand of the siRNA, the strand that is more tightly paired,
ultimately leading to the degradation of that strand and incorporation of the guide strand 
into RISC.  Ago2 can then go on and cleave a perfectly paired target in a Mg2+-dependent
fashion.  The resulting 5' cleavage product is then degraded by the Exosome/Ski complex 
and the 3' cleavage product is degraded by XRN1.
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group, and a 3´ cleavage product bearing a 5´ phosphate (Martinez and Tuschl, 2004; 
Schwarz et al., 2004).  This cleavage occurs at the same scissile phosphate as previously 
predicted (Elbashir et al., 2001b; Elbashir et al., 2001c).
Although the termini of the mRNA cleavage products were known, the protein 
that performs the cleavage had yet to be identified.  Minimal Human RISC was shown to 
contain Argonaute family members eiF2C2 and/or eIF2C1, single-strand siRNA, and an 
unidentified endoribonuclease, although the size of the total complex was only 160 kDa 
(Martinez et al., 2002a; Martinez and Tuschl, 2004).  In flies, RISC was shown to contain 
Ago2 and siRNA (Hammond et al., 2000; Hammond et al., 2001), although it was
possible that an endonuclease could be recruited at a later step.  One proposal suggested 
that Tudor-SN, a homolog of micrococcal nuclease, is the protein acting as the
endonuclease that mediates target cleavage (Caudy et al., 2003).  However, the presence 
of 3´ hydroxyls and 5´ phosphates on the termini of the cleavage products, in addition to 
insensitivity to 2 -´deoxythymidine 5´, 3 -´bisphosphate (pdTp), a known inhibitor of
staphylococcal nucleases (Cuatrecasas et al., 1967), argues against the proposal that
Tudor-SN is Slicer (Martinez and Tuschl, 2004; Schwarz et al., 2004).  In fact, Tudor-SN
was later shown to play a role in the binding of hyper-edited double-strand RNA
promoting its cleavage, indicating a potential link between RNA editing and RNA
silencing (Scadden, 2005).
It would take the combination of recombinant protein biochemistry and crystal 
structure analysis of Argonaute proteins to finally reveal which protein possessed the 
enigmatic Slicer activity.  Argonaute proteins are the core components of all identified 
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RNA silencing complexes (Hammond et al., 2001; Hutvagner and Zamore, 2002;
Martinez et al., 2002a; Mourelatos et al., 2002; Tabara et al., 1999).  The number of 
Argonaute homologs identified in different species varies.  For example, flies have five 
Argonaute protein family members (Williams and Rubin, 2002), and humans have eight 
Argonaute family members (Sasaki et al., 2003).  The Argonaute family has been
subdivided into two groups based on amino acid sequence called the Piwi and Ago 
subfamilies (Carmell et al., 2002).  Argonaute proteins contain two domains, the PIWI 
domain (Carmell et al., 2002) and the PAZ domain (Cerutti et al., 2000).  Recognition 
and RNA binding of the 3´ overhang and the base-paired ends of the siRNA are carried 
out by the PAZ domain (Lingel et al., 2003; Lingel et al., 2004; Ma et al., 2004; Song et 
al., 2003b; Yan et al., 2003), while it is believed that the PIWI domain is responsible for 
protein-protein interactions with Dicer, potentially facilitating the hand-off of an siRNA 
into an Argonaute complex (Doi et al., 2003; Pham et al., 2004; Tahbaz et al., 2004).
Different Argonaute proteins appear to perform different functions in relation to 
RNA silencing.  For example, Drosophila Ago1 has been shown to be required for 
miRNA accumulation, Ago2 is required for RNAi mediated by dsRNA (Okamura et al., 
2004).  Both Ago1 and Ago2 have been shown to be associated with miRNAs (Caudy et 
al., 2002; Ishizuka et al., 2002; Williams and Rubin, 2002), but the cleavage activity of 
these complexes was not tested.  Other Argonaute family members, including aubergine
and piwi, have been shown to play a role in RNA silencing (Aravin et al., 2001;
Kennerdell et al., 2002; Pal-Bhadra et al., 2002).  While it was known in humans that 
eiF2C1 and eiF2C2, human Argonaute homologs 1 and 2, are associated with RNA 
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silencing (Hutvagner and Zamore, 2002; Martinez et al., 2002a; Mourelatos et al., 2002), 
the function of the two other members in the Ago subfamily had not been investigated.
Over-expression studies of epitope-tagged Argonautes in human cultured cells suggested 
that Agos 1 – 4 all bind miRNAs, but only Ago2 possess the ability to mediate siRNA-
and miRNA-dependent target cleavage (Meister et al., 2004b).  Given the high levels of 
conservation in the PIWI and PAZ domains of the four human Argonaute family
members, one might reason that the distinct residues required for RNA catalysis must 
reside elsewhere in the protein.  However, the Hannon group showed that mutations in 
three key residues within the Piwi (or RNase H) domain actually abolish the 'slicer'
activity of human Ago2 in cultured cells (Liu et al., 2004).  In vitro data also confirmed a 
previous study in which a divalent metal requirement exists for cleavage activity (Liu et 
al., 2004; Schwarz et al., 2004).  Additionally, recombinant hAGO bound to single-
stranded siRNA exhibits cleavage activity (Rivas et al., 2005).
Verification of catalytic ability of Ago2 can be drawn from recent structural
studies.  For example, insights on the nature of mechanism of human Ago2 can be drawn 
from crystal structures of Ago-like proteins from archaea and eubacteria (Parker et al., 
2004; Song et al., 2004).  It appears that the Piwi domain (similar to an RNase domain) 
contains key catalytic residues which could potentially contribute to the 'slicer' activity 
(Parker et al., 2004; Song et al., 2004), which also show metal dependence (Nowotny et
al., 2005; Wintersberger, 1990) and production of 5´ phosphates and 3´ hydroxyls
(Wintersberger, 1990).  Interestingly, structure studies suggest that the binding of the 3´ 
end of the siRNA by the PAZ domain would position the mRNA in the Piwi active site
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such that the scissile phosphate that is cleaved would be located at close proximity to the 
putative catalytic residues (Elbashir et al., 2001b; Song et al., 2004).  Recently, it has also 
been postulated that Ago2 is also responsible for cleaving the passenger strand, the strand 
that is not incorporated into RISC, leading to its degradation (Matranga et al., manuscript 
submitted).
Finally, structures of a Piwi protein solved with siRNA mimics give further
insight into the cleavage reaction.  The exclusion of the first base pair from contributing a 
role in miRNA and siRNA target recognition was first observed bioinformatically due to 
lack of conservation among miRNAs in different species (Lewis et al., 2005; Lewis et al., 
2003), and was observed empirically in siRNA-mediated target cleavage (Haley and 
Zamore, 2004).  The 5´ phosphate of the guide strand has been shown to be anchored into 
a binding pocket, and hence is not able to interact or base pair with the mRNA at this 
position (Ma et al., 2005).  This finding now explains why the first base pair of miRNAs 
or siRNAs is excluded from the 'seed' sequence, nucleotides 2-8.
Despite our understanding of the target mRNA cleavage mechanism by siRNAs, 
and the functional identification of the members involved in the RNAi pathway,
including the atomic details of some of these proteins, several questions remained.
For example, it is not clear how the target mRNA is degraded following the
endonucleolytic cleavage induced by RISC.  One group has evidence showing that the 5´ 
cleavage products are degraded by the exosome and the Ski complex in Drosophila in a 
3´ to 5´ direction (Orban and Izaurralde, 2005).  In addition, the 3´ cleavage products 
were shown to be degraded by XRN1 in a 5´ to 3´ direction (Orban and Izaurralde, 2005).
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Taken together, these results suggest that the mRNA degradation occurs without a
decapping or deadenylation step.
Several unresolved questions still remain including how the two cleavage
products are released from RISC, what kinase phosphorylates exogenously added
siRNAs, how siRNAs are unwound, and what role different Argonaute proteins play in 
RNAi and if certain miRNAs are pre-destined to be loaded into a specific Argonaute.  In 
addition, it is still unknown what the exact mechanism of translational repression is, or if 
the mRNA may be regulated at the step of RNA stability.  Recent findings suggest that 
miRNA-mediated regulation may include shuttling of mRNAs to processing bodies, or p 
bodies, sites of RNA storage and degradation (Liu et al., 2005; Sen and Blau, 2005).
These findings may aid in the study of how miRNAs regulated post-transcriptional gene 
silencing, but as of now that answer is unclear.
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RNAi 2001
In 1998 when Fire and Mello determined that dsRNA mediates RNAi and results in a 
decrease in mRNA levels, several groups started to dissect the pathway in Drosophila
embryo lysates.  Key discoveries were made showing that long dsRNA is processed into 
21 nucleotide intermediates called small interfering RNAs (siRNAs) by the RNaseIII
enzyme Dicer.  Dicer was also shown to be involved in the processing of another class of 
small RNAs called microRNAs (miRNAs) from longer stem loop RNA precursors.
Although siRNAs and miRNAs are related in size, they appeared to be regulating gene 
expression in very different ways.  siRNAs mediate post-transcriptional gene silencing by 
degrading mRNA, whereas miRNAs function at the level of translational repression.  In 
addition, while siRNAs are double-stranded, mature miRNAs accumulate as single
strands.
In 2001 when I joined the Zamore lab, several exciting discoveries were made 
showing that miRNAs were much more abundant than previously predicted and were 
detected in plants, worms, humans, and flies.  siRNAs, which were known to be the 
intermediates in the RNAi pathway, found a new role in vivo when the Tuschl lab
showed that synthetic siRNAs could be transfected into cultured cells and used to target 
any gene of interest.  Several labs adopted this rapid method for gene knock-down, but it 
became clear that while some siRNAs were extremely potent others, showed very little 
silencing potential.  In addition, it was still unknown how siRNAs mediated mRNA 
cleavage and what proteins may be involved.
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In worms, it was known that an RNA-Dependent RNA polymerase amplifies the 
silencing signal through the binding of the single-stranded siRNA to a target RNA and 
generating dsRNA through the action of an RdRP, which can then be processed by Dicer 
into a secondary set of siRNAs.  One of my first projects in the lab was to determine if an 
RdRP was functioning in flies and humans by looking for structural requirements of
siRNAs that would be conducive to polymerization, specifically the requirement for a 3´ 
hydroxyl that would be necessary for the addition of NTPs (Chapter 2).  We found no 
requirement for a 3´ hydroxyl, but an absolute requirement for 5´ phosphates, in fly and 
human systems.  In addition we found that single-stranded siRNAs, while not as stable as 
double-stranded siRNAs, also enter the RNAi pathway and mediate the destruction of 
complementary mRNA.
The next question that we had concerned the finding that some siRNAs mediated 
a more robust RNAi response with some clues coming from miRNAs, the other class of 
small non-coding RNAs.  A survey of mature miRNA sequences identified a preference 
for a 5´ U, leading to an analysis for a potential role of specific sequences in siRNA 
efficiency (Chapter 3).  We found that the thermodynamics of the ends of the siRNAs 
determine the degree to which each strand incorporates into the active silencing complex, 
also giving clues as to how miRNAs are processed.
While it was known that siRNA treatment resulted in the destruction of a
complementary mRNA, it was not known how this cleavage event occurred, if it was an 
endonucleolytic process, and if a metal dependence existed.  At the time, a
Staphylococcal nuclease family member TudorSN was shown to be associated with the 
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mature silencing complex and would require Ca2+, could be inhibited by a specific
Staphylococcal nuclease inhibitor, and would produce specific ends on the RNA products 
that resulted from the cleavage event.  We found that RNAi required Mg2+, could not be 
inhibited by the SN-specific inhibitor, and that cleavage products possessed 5´
phosphates and 3´ hydroxyls, all of which would be inconsistent with TudorSN mediating 
cleavage.  It was later found that Argonatue2, a known component of the silencing
complex, was the elusive "Slicer".
The last part of my research in the Zamore lab revolved around what we knew 
about the biochemistry of the RNAi pathway and how siRNAs recognized and cleaved 
target RNAs, and how we could apply siRNAs in the silencing of mutant alleles in
dominant disease cases and single nucleotide polymorphisms (Chapters 5 and 6).  We 
found that certain mismatches (such as purine:purine) are capable of discriminating
between 2 different alleles that differed at a single nucleotide, and that the position of this 
mismatch could lead to varying levels of discrimination.
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Evidence that siRNAs Function as Guides, Not Primers, 
in the Drosophila and Human RNAi Pathways
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The work presented in the following chapter was a collaborative effort.  Gyorgy
Hutvagner performed experiments demonstrating the requireme nt for 5´ phosphates on 
single-stranded and double-stranded siRNAs in Drosophila embryo lysates and HeLa 
S100.  I carried out experiments showing that siRNAs are phosphorylated in HeLa S100 
lysates, that the 3´ hydroxyl on single-stranded and double-stranded siRNAs of various 
lengths is dispensable, and that single-stranded siRNAs are degraded in lysates within 
minutes.  Gyorgy Hutvagner and I both performed HeLa transfections demonstrating the 
requirement for a 5´ phosphate on siRNAs, that single-stranded siRNAs can mediate 
RNAi, and that 3´ hydroxyls on single-stranded and double-stranded siRNAs are
dispensable in cultured cells.  Phillip Zamore and I wrote the manuscript.
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CHAPTER II
Summary
In Drosophila, two features of small interfering RNA (siRNA) structure—5´ phosphates 
and 3´ hydroxyls—are reported to be essential for RNA interference (RNAi).  Here, we 
show that in both Drosophila and mammalian cell extracts, as well as in vivo in human 
HeLa cells, a 5´ phosphate is required for siRNA function.  In contrast, we find no 
evidence in flies or humans for a role in RNAi for the siRNA 3´ hydroxyl group.  Our in 
vitro data suggest that in both flies and mammals each siRNA guides endonucleolytic 
cleavage of the target RNA at a single site.  We conclude that the underlying mechanism 
of RNAi is conserved between flies and mammals and that RNA-dependent RNA
polymerases are not required for RNAi in these organisms.
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Introduction
In diverse eukaryotes, double-stranded RNA (dsRNA) triggers the destruction of mRNA
sharing sequence with the double-strand (Hutvágner and Zamore, 2002b; Hannon, 2002).
In animals and basal eukaryotes, this process is called RNA interference (RNAi) (Fire et 
al., 1998).  There is now wide agreement that RNAi is initiated by the conversion of 
dsRNA into 21-23 nt fragments by the multi-domain RNase III enzyme, Dicer (Billy et 
al., 2001; Bernstein et al., 2001; Grishok et al., 2001; Ketting et al., 2001; Knight and 
Bass, 2001; Martens et al., 2002).  These short RNAs are known as small interfering
RNAs (siRNAs), and they direct the degradation of target RNAs complementary to the 
siRNA sequence (Zamore et al., 2000; Elbashir et al., 2001c; Elbashir et al., 2001b; 
Elbashir et al., 2001a; Nykänen et al., 2001; Elbashir et al., 2002).  In addition to its role 
in initiating RNAi, Dicer also cleaves ~70 nt precursor RNA stem-loop structures into 
single-stranded 21-23 nt RNAs known as microRNAs (miRNAs; Hutvágner et al., 2001; 
Grishok et al., 2001; Ketting et al., 2001; Reinhart et al., 2002).  Like siRNAs, miRNAs 
bear 5´ monophosphate and 3´ hydroxyl groups, the signatures of RNase III cleavage 
products (Hutvágner et al., 2001; Elbashir et al., 2001b).  miRNAs are hypothesized to 
function in animals as translational repressors (Lee et al., 1993; Wightman et al., 1993; 
Ha et al., 1996; Moss et al., 1997; Olsen and Ambros, 1999; Reinhart et al., 2000; Zeng et 
al., 2002; Seggerson et al., 2002).  The conversion of dsRNA into siRNAs requires 
additional protein co-factors that may recruit the dsRNA to Dicer or stabilize the siRNA 
products (Tabara et al., 1999; Hammond et al., 2001; Grishok et al., 2001; Tabara et al., 
2002).  How siRNAs direct target cleavage and whether a single mechanism explains the 
function of siRNAs in post-transcriptional gene silencing in plants, quelling in fungi, and 
RNAi in animals remain unknown.  Furthermore, how siRNAs are permitted to enter the 
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RNAi pathway while other 21-23 nt RNAs seem to be excluded cannot yet be fully
explained.
Three models have been proposed for RNAi in Drosophila.  Each model seeks to 
explain the mechanism by which siRNAs direct target RNA destruction.  In one model 
(Figure 1), target destruction requires an RNA-dependent RNA polymerase (RdRP) to 
convert the target mRNA into dsRNA (Lipardi et al., 2001).  The RdRP is hypothesized 
to use single-stranded siRNAs as primers for the target RNA-templated synthesis of 
complementary RNA (cRNA).  The resulting cRNA/target RNA hybrid is proposed to 
then be cleaved by Dicer, destroying the mRNA and generating new siRNAs in the 
process.  Key features of this model are that the ATP-dependent, dsRNA-specific
endonuclease Dicer acts twice in the RNAi pathway, that target destruction should
require nucleotide triphosphates to support the production of cRNA, and that a 3´
hydroxyl group is essential for siRNA function, since siRNAs are proposed to serve as 
primers for new RNA synthesis.
A second model proposes that single-stranded siRNAs do not act as primers for 
an RdRP, but instead assemble along the length of the target RNA and are then ligated 
together by an RNA ligase to generate cRNA (Lipardi et al., 2001; Nishikura, 2001).  The 
cRNA/target RNA hybrid would then be destroyed by Dicer.  This model predicts that 
target recognition and destruction should require ATP (or perhaps an NAD-derived high 
energy cofactor) to catalyze ligation, as well as to support Dicer cleavage.  Like the first 
model, the ligation hypothesis predicts that an siRNA 3´ hydroxyl group should be
required for RNAi.  Furthermore, a 5´ phosphate should be required for siRNA ligation, 
but ribonucleotide triphosphates other than ATP should not be required for target
destruction.
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Figure II - 1.  Two models proposed for the RNAi pathway in Drosophila.  Both models 
postulate that dsRNA is converted to siRNA by the ATP-dependent endoribonuclease 
Dicer, but the models differ as to the subsequent function of siRNAs.  In the ‘random 
degradative PCR’ model (at left), siRNAs are postulated to function as primers for the 
target RNA-templated synthesis of cRNA by an RdRP.  The resulting dsRNA is then 
proposed to be cleaved by Dicer into a new crop of siRNAs, which can prime the 
conversion of additional target RNAs into dsRNA.  In the endonucleolytic cleavage
model for RNAi (at right), siRNAs are proposed to be incorporated into an endonuclease 
complex distinct from Dicer, the RISC.  Assembly of the RISC is proposed to be ATP-
dependent, whereas endonucleolytic cleavage of the target RNA is postulated to require 
no high energy cofactors.
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A third model (Figure 1) hypothesizes that two distinct enzymes or enzyme 
complexes act in the RNAi pathway (Hammond et al., 2000; Zamore et al., 2000;
Nykänen et al., 2001).  As in the first model, Dicer is proposed to generate siRNAs from 
dsRNA.  These siRNAs are then incorporated into a second enzyme complex, the RNA-
induced silencing complex (RISC), in an ATP-dependent step or series of steps during 
which the siRNA duplex is unwound into single strands.  The resulting single-stranded
siRNA is proposed to guide the RISC to recognize and cleave the target RNA in a step or 
series of steps requiring no nucleotide cofactors whatsoever.  The absence of a nucleotide 
triphosphate requirement for target recognition and cleavage is a key feature of this 
model.
We have previously demonstrated by two different experimental protocols that 
both recognition and endonucleolytic cleavage of a target RNA proceeds efficiently in the 
presence of less than 50 nM ATP, a concentration likely to be insufficient to support 
either the synthesis of new RNA or the ligation of multiple siRNAs into cRNA (Nykänen 
et al., 2001).  However, our data also revealed an absolute requirement for a 5´ phosphate
for siRNAs to direct target RNA cleavage in Drosophila embryo lysates, a finding we 
interpreted as reflecting an authentication step in the assembly of the RNAi-enzyme
complex, the RISC.  We envisioned that the 5´ phosphate was involved in obligatory non-
covalent interactions with one or more protein components of the RNAi pathway.
Nonetheless, the 5´ phosphate requirement might formally reflect a requirement for the 
phosphate group in covalent interactions, such as the ligation of multiple siRNAs to 
generate cRNA (Nishikura, 2001).
Here, we more fully define the mechanism of RNAi in flies and mammals by 
examining the requirement for a 5´ phosphate and a 3´ hydroxyl group on the anti-sense
strand of the siRNA duplex.  First, we analyze the role of these functional groups in 
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siRNA function in vitro, using both Drosophila and human cell-free systems that
recapitulate siRNA-directed target RNA destruction.  Then, we validate our findings in 
vivo in human HeLa cells.  Our data support a model for the RNAi pathway in which 
siRNAs function as guides for an endonuclease complex that mediates target RNA
destruction.  We find that the requirement for a 5´ phosphate is conserved between
Drosophila and human cells and that an siRNA 3´ hydroxyl is dispensable in both
systems.  Our data argue against an obligatory role for an RdRP in Drosophila or human 
RNAi, despite the clear requirement for such enzymes in PTGS in plants, quelling in 
Neurospora crassa, and RNAi in C. elegans and Dictyostelium discoideum (Cogoni and 
Macino, 1999; Smardon et al., 2000; Dalmay et al., 2000; Mourrain et al., 2000; Sijen et 
al., 2001; Martens et al., 2002).  In this respect, the mechanism of RNAi in flies and 
mammals appears to be distinct from that of PTGS, quelling, and RNAi in worms and 
Dictyostelium, suggesting that the pathway in flies and mammals may be more restricted 
in the range of triggers that can elicit an RNAi response.
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Results and Discussion
Requirement for the siRNA 5´ phosphate in human RNAi
Synthetic siRNAs bearing a 5´ hydroxyl can efficiently mediate RNAi both in vitro in 
Drosophila embryo lysates and in vivo in cultured human cells (Elbashir et al., 2001b; 
Elbashir et al., 2001a; Nykänen et al., 2001).  However, in the Drosophila in vitro
system, an endogenous kinase rapidly converts the 5´ hydroxyl group to a phosphate 
(Nykänen et al., 2001).  Blocking siRNA phosphorylation by substituting the 5´ hydroxyl 
with a methoxy moiety completely blocks RNAi in Drosophila embryo lysates (Nykänen 
et al., 2001).  Furthermore, 5´ phosphorylated siRNAs more efficiently trigger RNAi in 
vivo in Drosophila embryos than do 5´ hydroxyl-containing siRNAs (Boutla et al., 2001).
5´ hydroxyl-containing, synthetic siRNAs that trigger RNAi in cultured mammalian cells 
(Elbashir et al., 2001a; Elbashir et al., 2002), in mice (McCaffrey et al., 2002; Lewis et 
al., 2002), and perhaps even plants (Klahre et al., 2002) may likewise be phosphorylated 
by a cellular kinase prior to entering the RNAi pathway.
To determine if a 5´ phosphate is required for RNAi in mammals, we first
analyzed mammalian RNAi in vitro, using HeLa cell S100 extract.  These reactions 
accurately recapitulate the known features of siRNA-directed RNAi in mammalian cell 
culture: exquisite sequence-specificity (Elbashir et al., 2001a) and target RNA cleavage 
(Holen et al., 2002).  RNAi reactions were performed in HeLa S100 extracts using
siRNA duplexes in which the antisense strand, which we refer to as the guide strand, 
contained either a 5´ hydroxyl or a 5´ methoxy group (Figure 2A) and a chimeric target 
RNA in which nucleotides 62 to 81 were complementary to the siRNA (Figure 2B).
When the guide strand of the siRNA duplex contained a 5´ hydroxyl group, and could, 
therefore, be phosphorylated, it directed cleavage of the target RNA within the sequence
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Figure II - 2.  RNAs used in this study.  (A) Photinus pyralis (firefly) luciferase (blue) 
and let-7 (red) siRNAs used in this study.  The guide strand (antisense strand) is shown 
5´-to-3´ as the upper strand of each siRNA.  Single-stranded siRNAs used in Figures 4, 5, 
and 6 correspond to the indicated guide strands.  ddC, dideoxy Cytosine; AM, amino
modifier.  siRNAs corresponding to firefly luciferase sequence are blue; those
corresponding to let-7 sequence are red.  (B) A schematic representation of the chimeric 
target RNA, indicating the relative positions of firefly luciferase sequences and sequences
complementary to the let-7 miRNA found naturally in HeLa cells.
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complementary to the siRNA (Figure 3).  Target cleavage directed by this siRNA
occurred at the same site in the HeLa S100 as in Drosophila embryo lysate.  These data 
suggest that endonucleolytic cleavage of the target RNA is a common feature of RNAi in 
flies and mammals.  siRNAs with a 5´ methoxy group cannot be phosphorylated by
nucleic acid kinases and cannot direct RNAi in lysates of Drosophila embryos (Nykänen 
et al., 2001).  Such siRNAs were likewise unable to direct cleavage of the target RNA in 
the HeLa S100 reaction (Figure 3A).  Although the exogenous, methoxy-blocked siRNA 
did not trigger sequence-specific target cleavage, an endogenous HeLa RISC complex 
that contains the miRNA let-7 (Hutvágner and Zamore, 2002a) cleaved the chimeric
target RNA within the let-7 complementary sequence near its 3´ end (Figure 2B) in all of 
the human in vitro RNAi reactions.  This diagnostic 5´ cleavage product (indicated by an 
asterisk) serves as an internal control for these and subsequent in vitro HeLa S100 
reactions.  Our data suggest that mammalian RNAi, like RNAi in Drosophila (Nykänen 
et al., 2001; Boutla et al., 2001), requires the siRNA 5´ phosphate for target cleavage and 
suggest that 5´ hydroxyl-containing siRNA duplexes must be phosphorylated by a
cellular kinase before they become competent to mediate RNAi in human cells.
Consistent with this idea, 5´ hydroxyl-containing siRNAs are rapidly 5´ phosphorylated 
after only 5 min incubation in the HeLa S100 (Figure 3B).  Thus, like Drosophila, human 
cells contain a nucleic acid kinase that can add a 5´ phosphate to a synthetic siRNA.
Role of the siRNA 3´ hydroxyl group in flies and mammals
Both siRNAs produced by enzymatic cleavage of dsRNA and those prepared by chemical 
synthesis contain 3´ hydroxyl termini (Elbashir et al., 2001b).  Experiments using
nuclease-treated siRNAs suggested that a 3´ phosphate blocks RNAi in Drosophila
embryo lysates (Lipardi et al., 2001), a finding consistent with authentication of siRNA
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Figure II - 3.  The siRNA 5´ phosphate group is required for siRNA-directed target 
cleavage in HeLa S100 extracts.  (A) RNAi in vitro in human HeLa cell S100 extract.  At 
left, a time course of in vitro RNAi for a standard siRNA; at right, for an siRNA duplex 
bearing a 5´ methoxy guide strand.  The asterisk indicates the position of a 5´ cleavage 
product catalyzed by an endogenous, human let-7-programmed RISC complex, which 
cleaves this target RNA within a let-7 complementary sequence located near the 3´ end of 
the RNA (Hutvágner and Zamore, 2002a).  This cleavage product serves as an internal 
control.  (B) Phosphorylation status of the guide strand of an siRNA duplex upon
incubation in HeLa S100.  An siRNA duplex containing a guide strand 3 -´end-labeled
with α-32P cordycepin (3´ deoxyadenosine triphosphate) was incubated in a standard 
HeLa S100 RNAi reaction, then analyzed on a 15% sequencing gel.  Phosphorylation 
accelerates the gel mobility of the labeled siRNA strand, because it adds two additional 
negative charges.  The radiolabeled RNA is 3´ deoxy; therefore, we infer that the added 
phosphate is on the 5´ end.
84
3´ structure by the RNAi machinery, with siRNAs acting as primers for cRNA synthesis, 
or with RNA-templated ligation of multiple siRNAs into cRNA.  To determine if the 
siRNA 3´ hydroxyl group plays an essential role in RNAi, we synthesized two siRNAs in 
which the 3´ hydroxyl group of the guide strand was blocked (Figure 2).  In one siRNA, 
the 3´ hydroxyl was replaced by a 2 ,´3´ dideoxy terminus.  In the other, the 3´ position 
contained 3-amino-propyl phosphoester (3´ ‘amino modifier’).  Each of the blocked
siRNA guide strands was analyzed by electrospray mass spectrometry to confirm its 
identity and purity.  The two modified siRNA guide strands, as well as a 3´ hydroxyl-
containing control strand, were annealed to a standard 21 nt siRNA sense strand.  The 
three resulting siRNA duplexes were tested for their ability to direct cleavage of a 
complementary target RNA in an in vitro RNAi reaction containing Drosophila embryo 
lysate.  Figure 4A shows that the two 3 -´blocked siRNAs produced the same degree of 
target cleavage as the 3´ hydroxyl-containing siRNA control.
Next, we repeated the experiment in HeLa S100 extract to determine if an siRNA 
3´ hydroxyl group is required for RNAi in mammalian cells.  3´ modification of an
siRNA has been reported to be permitted for RNAi in mammalian cells (Holen et al., 
2002), but it was not shown in those experiments that all of the siRNA was 3´ modified.
In contrast to the 5´ methoxy modification, which completely blocked target RNA
cleavage in the HeLa S100 reaction, 3´ modification had no effect on the efficiency or 
specificity of RNAi (Figure 4B).  The identity and purity of these siRNAs was confirmed
by electrospray mass spectrometry.  However, we could envision that a fraction of the 
siRNA guide strand was cleaved within the single-stranded, two nucleotide, 3´ overhang 
by a nuclease in the HeLa S100, regenerating the 3´ hydroxyl.  If this occurred, the
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Figure II - 4.  The siRNA 3´ hydroxyl is dispensable for siRNA-directed target cleavage 
in Drosophila and human cell extracts.  (A) 3 -´blocked siRNAs trigger RNAi in
Drosophila embryo lysates with the same efficiency as 3 -´hydroxyl-containing siRNAs.
ddC, 2´,3´ dideoxy C; AM, amino modifier.  (B) 3 -´blocked siRNAs trigger RNAi in 
HeLa S100 extracts with the same efficiency as standard, 3 -´hydroxyl-containing
siRNAs.  An over-exposure of the region of the gel containing the 5´ cleavage product is
shown in the lower panel.  The asterisk marks the internal control 5´ cleavage product 
described in Figure 3.
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cleaved siRNAs could then act as primers.  To exclude this possibility, we performed 
RNAi reactions using progressively shorter guide siRNAs blocked at the 3´ end by either 
a 2´,3´ dideoxy or a 3´ amino modifier group.  The 20 or 19 nt guide strands were
annealed to the same 21 nt sense siRNA strand.  Figure 4B shows that target RNA 
cleavage occurred in all cases, although the efficiency of cleavage decreased as the 
siRNA guide strand was shortened, even when it contained a 3´ hydroxyl terminus.  If the 
3´ blocked 21 nt siRNA was active because it had been shortened to a 20-mer, it could 
not have attained the activity of the 3´ hydroxyl 21 nt siRNA.  Similarly, if nucleolytic 
removal of the 3´ block accounted for the activity of the 20 nt guide siRNA, it should 
have only been as active as the 19 nt, 3´ hydroxyl-containing siRNA.  These results 
suggest that the 3´ hydroxyl group of the siRNA guide strand does not play an obligatory 
role in siRNA-directed RNAi in flies or mammals.
Single-stranded siRNAs
All current models for RNAi—including those that propose siRNA to function as guides 
for an endonuclease and models that propose siRNAs to act as primers for target-RNA
templated RNA synthesis—predict that siRNAs ultimately function as single strands.  In 
fact, in Drosophila embryos, single-stranded antisense siRNAs corresponding to the
Notch mRNA elicited Notch phenotypes in 12% of injected embryos, although the
expressivity was quite low (Boutla et al., 2001).  Furthermore, single-stranded RNAs of 
various lengths trigger RNAi in C. elegans, but only when they contain a 3´ hydroxyl 
group, suggesting that single-stranded siRNA functions in that organism as a primer for 
an RdRP (Tijsterman et al., 2002).  Consistent with single-stranded siRNAs acting in 
nematodes as primers that direct the production of new dsRNA, they fail to trigger RNAi 
in the absence of Dicer (Dcr-1) (Tijsterman et al., 2002).
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We exami ned if the guide siRNA strand alone could trigger target cleavage in an 
in vitro RNAi reaction containing either Drosophila embryo lysate or human HeLa cell 
S100.  We first examined if single-stranded siRNA could direct target RNA cleavage in 
Drosophila embryo lysates (Figure 5A).  For this experiment, we used siRNA with the 
sequence of the miRNA let-7 (Figure 2A).  Cleavage of the target RNA (Figure 2B) by a 
let-7-containing siRNA duplex produces a diagnostic 522 nt 5´ product (Hutvágner and 
Zamore, 2002a).  When the synthetic siRNA was used as a single strand, the target RNA 
was not cleaved (Figure 5A).  Similarly, a single-stranded siRNA of the same sequence 
but bearing a 2´ deoxy thymidine (dT) instead of uracil as its first nucleotide, was also a 
poor trigger of target cleavage.  However, both these siRNAs contain a 5´ hydroxyl, and a 
5´ phosphate is required for siRNA duplexes to trigger target RNA cleavage in
Drosophila embryo lysates (Nykänen et al., 2001).  Therefore, we considered that the 
defect with the single-stranded siRNAs might be that they lacked a 5´ phosphate and 
cannot obtain one because they are not substrates for the Drosophila kinase.  In support 
of this hypothesis, when the single-stranded siRNA starting with dT was pre-
phosphorylated with polynucleotide kinase, it directed target cleavage.
To confirm these findings, we examined the activity of a second single-stranded
siRNA, complementary to the luciferase portion of the target RNA.  When pre-
phosphorylated, this single-stranded siRNA again directed target cleavage in Drosophila
embryo lysate, albeit less efficiently than the same molar concentration of an siRNA 
duplex (Figure 5B).  Cleavage occurred at precisely the same site in the target RNA for 
both single-stranded and double-stranded siRNAs, suggesting that the single-stranded
siRNA entered the RNAi pathway, rather than triggered RNA destruction by a different 
route.  The same single-stranded siRNA sequence bearing a 5´ methoxy group did not 
direct target RNA cleavage (Figure 5B). Together, the experiments in Figure 5
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Figure II - 5.  Single-stranded siRNA guides target cleavage in Drosophila embryo 
lysates.  (A) Single-stranded siRNAs with the sequence of the miRNA let-7 triggered 
target cleavage in Drosophila  embryo lysate, but only if the 5´ end was pre-
phosphorylated.  (B) Single-stranded siRNAs complementary to firefly luciferase
sequence triggered target cleavage in Drosophila embryo lysate, even if the 3´ end was 
blocked (2´,3´ddC).  No target cleavage was observed using an siRNA with a 5´ methoxy 
group.  (C) Rate of degradation of single-stranded siRNA in the Drosophila embryo 
lysate.  siRNA single-strands were 3´ end-labeled with α-32P cordycepin and their
stability measured with (filled circles) or without (open squares) a 5  ´ phosphate.  The 
curves represent the best-fit to a single exponential, consistent with pseudo first-order
kinetics for single-stranded siRNA decay.  The difference in rates is 1.4-fold (with versus 
without a 5´ phosphate).
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demonstrate that single-stranded siRNAs—like the guide strands of siRNA duplexes—do
not function in the RNAi pathway unless they bear a 5´ phosphate.
To determine if single-stranded siRNAs trigger target destruction in Drosophila
embryo lysates by acting as primers, we modified the 3  ´ end of the siRNA to 2´,3´ 
dideoxy.  As with double-stranded siRNAs, blocking the 3´ end of the single-stranded
siRNA had no effect on the efficiency or specificity with which the target was cleaved 
(Figure 5B).  We note that the efficiency of target cleavage by single-stranded siRNAs is 
significantly less than that of siRNA duplexes.  The lower efficiency might simply reflect 
the remarkably short lifespan of single-stranded siRNA in the Drosophila embryo lysate: 
the vast majority is destroyed within the first 2 min of incubation.  One explanation for 
the requirement for a 5´ phosphate might be that without it, the single-stranded siRNA is 
destroyed even faster.  This explanation is unlikely, because the rate of single-stranded
RNA destruction is only 1.4-fold faster for 5´ hydroxy siRNAs (Figure 5C).  More likely 
is that the 5´ phosphate of the single-stranded siRNA is required for its entry into the 
RISC, and that because a small fraction of 5´ phosphorylated, single-stranded siRNA 
enters the RISC it is protected from degradation, enhancing its stability in the lysate.
Next, we examined if single-stranded siRNAs could function to trigger RNAi in 
HeLa S100 extracts.  Again, single-stranded siRNAs directed target cleavage at the same 
site as the corresponding siRNA duplex (Figure 6A).  Pre-phosphorylation of single-
stranded siRNA was not required for it to function in target cleavage in HeLa S100, but 
blocking the 5´ end with a methoxy group completely eliminated RNAi (Figure 6B).
These results suggest that a 5´ phosphate is required for mammalian RNAi, but that the 
nucleic acid kinase(s) responsible for phosphorylating siRNAs in HeLa S100 acts on 
single-stranded siRNA, unlike its Drosophila counterpart.  Blocking the 3´ end of the 
single-stranded siRNA had no effect on the ability of the single-stranded siRNA to cleave
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Figure II - 6.  A 5´ phosphate, but not a 3´ hydroxyl is required for single-stranded
antisense siRNAs to trigger RNAi in HeLa S100 extract.  (A) Single-stranded siRNA 
triggered target cleavage in HeLa S100, even if the 3´ end of the siRNA was blocked 
(2´,3´ dideoxy).  (B)  Blocking the 5´ end of the siRNA with a methoxy group eliminated 
the ability of the single-stranded RNA to trigger RNAi.  The asterisk marks the control 5´ 
cleavage product described in Figure 3.
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the target RNA in HeLa S100 (Figure 6A).  Thus, the structural requirements for single-
stranded siRNA function in target cleavage are conserved between flies and mammals: a 
5´ phosphate is required, but a 3´ hydroxyl is not.
Together these data support the view that siRNAs do not direct target RNA 
destruction by priming the synthesis of new RNA, nor are siRNAs ligated together to 
generate cRNA.  Both processes should require a 3´ hydroxyl group, which is dispensable 
for target cleavage in either Drosophila or human cell extracts.  Instead, our data suggest 
that siRNAs act as guides to direct a protein endoribonuclease to cleave the target RNA.
The finding that single-stranded siRNAs can function as guides in the RNAi pathway 
suggests that each individual RISC contains only one siRNA strand.  Consistent with this 
view, in HeLa cell S100 extracts, the single stranded miRNA, let-7, is in an endogenous 
RISC that catalyzes multiple rounds of cleavage of a perfectly complementary target
RNA (Hutvágner and Zamore, 2002a).
Previously, it was proposed that the siRNA 5´ phosphate was recognized twice 
during the assembly of the siRNA-containing endoribonuclease complex (Nykänen et al., 
2001) (Figure 1).  That study placed one 5´ phosphate recognition event before siRNA 
duplex unwinding, but could not distinguish whether the 5´ phosphate is required
subsequently at the unwinding step itself or after unwinding is complete.  The absence of 
target cleavage by single-stranded siRNAs lacking a 5´ phosphate suggests that the
second phosphate recognition step occurs after the siRNA duplex is unwound.  In both 
Drosophila embryo lysates and human HeLa S100, cleavage directed by single-stranded
siRNA was less efficient than RNAi triggered by siRNA duplexes.  This inefficiency 
correlated with the general instability of short RNA in the in vitro extracts, as determined 
by measuring single-stranded siRNA half-life using 3´ radiolabeled siRNAs (Figure 5C) 
and by Northern hybridization (data not shown).
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siRNAs need not function as primers to trigger RNAi in HeLa cells
To assess if our in vitro results accurately predict the RNAi mechanism in vivo, cultured 
human cells were used to assess the structural requirements for siRNA function.
Synthetic siRNAs were co-transfected into HeLa cells with plasmids expressing target 
(Photinus pyralis, Pp) and control (Renilla reniformis, Rr) luciferase mRNAs.  Luciferase 
expression was measured, and target (firefly) luciferase levels were normalized to the 
Renilla control.  The results of these experiments are shown in Figure 7.
First, the requirement for a 5´ phosphate observed in Drosophila and HeLa
extracts was conserved in vivo (Figure 7A).  A 5´ hydroxyl-containing siRNA duplex 
triggered efficient gene silencing in vivo, reducing expression of the target luciferase 
>90%.  In contrast, a 5´ methoxy-modified siRNA reduced firefly luciferase levels by 
only two-fold.  This small reduction may reflect inhibition of translation, perhaps by an 
anti-sense mechanism.  Alternatively, some of the methoxy blocked siRNA may
inefficiently enter the RNAi pathway in vivo.  An siRNA in which the guide strand 
contained a 5´ amino modifier group—6-amino-hexyl phosphoester—was significantly 
more effective in suppressing target mRNA expression than the siRNA with the 5´
methoxy group (Figure 7A).  This finding is consistent with the idea that a 5´ phosphate 
group is required for siRNA function, but that the 5´ phosphate participates in non-
covalent interactions only, since the modified 5´ phosphate should be less able to act as 
an electron acceptor.  The in vivo studies agree with the in vitro results: a 5´ phosphate is 
essential for efficient siRNA function in flies and mammals.  However, in flies only
duplex siRNAs can be 5´ phosphorylated by cellular kinases, whereas in mammals, both 
single-stranded and double-stranded siRNAs are phosphorylated.
Consistent with the view that the core function of siRNA in human cells is as
guides, not primers, blocking the 3´ end of the siRNA guide strand had no effect on
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RNAi in vivo.  siRNA duplexes in which the guide strand contained a 3´ hydroxyl, a 
2´,3´ dideoxy, or a 3´ amino modifier were all equally effective in triggering RNAi in 
vivo (Figure 7A).  The silencing activity in vivo of a 21-nt, 3 -´blocked siRNA guide
strand was greater than that of a 20-nt, 3´ hydroxy siRNA guide strand, indicating that the 
3´ block was not removed in vivo.  We believe that these data exclude an obligatory role 
for the siRNA 3´ hydroxyl group in RNAi in mammalian cells, and argue that siRNAs do 
not normally trigger target destruction in human cells by functioning as primers.
These experiments were conducted at siRNA concentrations where the siRNA is 
not limiting for RNA silencing.  An siRNA function in priming the synthesis of dsRNA
might be used when siRNAs are limiting.  We tested the relative ability of siRNA 
duplexes in which the guide strand either contained a 3´ hydroxyl or a 2´,3´ dideoxy 
group at low siRNA concentrations (Figure 7B).  We find that the efficacy of the two 
types of siRNAs did differ when siRNA was rate limiting for target mRNA silencing, but 
never by more than 1.8-fold.  The observed difference in efficacy between the two types 
of siRNAs does not seem sufficiently great to support the view that the 3´ hydroxyl group
of the siRNA is used to prime the synthesis of dsRNA from the target mRNA.  If the 
siRNA were used to prime dsRNA synthesis, the production of new dsRNA by an RdRP 
using the siRNA as a primer should have amplified the silencing activity of the 3´
hydroxy but not the 2´,3´ dideoxy siRNA at limiting concentrations.  For example, if the 
3´ hydroxy guide strand had primed synthesis of one molecule of dsRNA (~130 bp long 
based on the site of siRNA/target complementarity) for each target mRNA molecule, and 
this new dsRNA was then Diced into just two of the possible six new siRNAs, at least a 
two-fold difference between the two siRNAs should have been observed.  This analysis 
fails to take into account the new crop of siRNAs acting in a subsequent cycle of priming,
which would further amplify the difference between 3´ deoxy and 3´ hydroxy siRNA at
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Figure II - 7.  A 5´ phosphate, but not a 3´ hydroxyl is required for siRNA duplexes to 
trigger RNAi in vivo in cultured human HeLa cells.  (A) siRNA duplexes were examined
for their ability to silence the Photinus pyralis (Pp; firefly) luciferase target reporter, 
relative to the Renilla reniformis (Rr) luciferase control reporter.  ddC, 2´,3´ dideoxy C; 
AM, amino modifier.  (B) Relative efficacy at limiting siRNA concentrations for siRNA 
duplexes with guide strands bearing either hydroxy (black symbols) or ddC (red symbols) 
3´ termini.  Data are the average ± standard deviation for three trials.
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limiting concentrations.  The simplest interpretation of our finding that 3´ hydroxy
siRNAs trigger no significant amplification of RNA silencing relative to 3´ blocked
siRNAs is that an siRNA-primed, RdRP-dependent cycle of siRNA amplification plays 
no productive role in RNAi in cultured HeLa cells, even at low siRNA concentrations.
The small difference in efficacy between 3´ OH and 2´,3´ dideoxy siRNAs likely
indicates that the blocked siRNAs have a subtle defect such as a lower affinity for 
components of the RNAi machinery, slightly reduced intracellular half-life, or a minor
reduction in phosphorylation rate.  This defect may result from the 2´ deoxy modification 
of the terminal nucleotide, rather than the 3´ block, since siRNAs with 2´ deoxythymidine 
tails have been reported to be less efficient than those containing uracil in HeLa cells 
(Hohjoh, 2002).
Our in vitro studies suggest that single-stranded siRNAs can enter the RNAi 
pathway, albeit inefficiently.  To test if single-stranded siRNAs could trigger mRNA 
silencing in vivo, we substituted various concentrations of single-stranded, sense or 
antisense siRNA for siRNA duplexes in our HeLa cell co-transfections (Figure 8A).  As 
the concentration of antisense single strand was increased, the expression of the firefly 
luciferase decreased relative to the Renilla internal control.  Note that single-stranded
siRNAs are less efficient than siRNA duplexes: it takes nearly 8-times more single-
stranded siRNA to approach the potency of the corresponding duplex.  This inefficiency 
may simply reflect rapid degradation of the majority of the transfected single-stranded
siRNA before it can enter the RISC complex.  Cells may possess a mechanism that
stabilizes siRNA duplexes and shuttles them to the RISC as single-strands without
exposing them to degradatory enzymes.  Thus, if endogenous siRNAs are double-
stranded in vivo, they may be double-stranded so as to facilitate their entry into the RNAi 
pathway and to exclude them from a competing pathway that degrades small, single-
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stranded RNA.  Alternatively, single-stranded siRNAs may bypass a key step in RISC 
assembly, making them less efficient than duplexes in triggering RNAi.  The dramatic 
instability of single-stranded siRNAs in vitro may simply reflect their inefficiency in
assembling into a RISC, which could protect them from degradation.
Gene silencing by single-stranded siRNA was sequence-specific, and single-
stranded sense siRNA did not alter the expression of the target RNA (Figure 8B).  Thus, 
it is unlikely that siRNAs themselves are copied by an RdRP in mammalian cells, since 
copying the sense siRNA should generate the anti-sense siRNA strand.  However,
copying sense siRNA into a duplex would not generate the characteristic 3´ overhanging 
ends of siRNAs.  Such 3´ overhangs might be required for siRNA unwinding and/or
efficient RISC assembly.  Pre-phosphorylation of single-stranded siRNA did not enhance 
its potency in HeLa cells, consistent with our observations in HeLa S100 extracts, but 
blocking phosphorylation with a 5´ methoxy group abolished silencing, pointing to the 
importance of 5´ phosphorylation for single-stranded siRNA function in vivo (Figure 
8B).  Our findings are not entirely unexpected, since endogenous, single-stranded
miRNAs enter the RNAi pathway in HeLa cells (Hutvágner and Zamore, 2002a).
Superficially, the finding that single-stranded siRNAs can elicit RNA silencing blurs the 
distinction between RNAi and antisense effects.  We have presented here evidence that 
single-stranded siRNAs trigger the same pathway as siRNA duplexes: both guide
endonucleolytic cleavage of target RNAs at the same site, and both require 5´ phosphates, 
but not 3´ hydroxyl groups, to function.  Our data support the view that single-stranded
siRNAs function in the same pathway as siRNA duplexes, the RNAi pathway.
Our in vitro experiments with Drosophila embryo lysates and HeLa S100 extracts 
and our in vivo experiments in HeLa cells argue against siRNAs functioning as primers 
in the RNAi pathway.  These findings are consistent with the absence of any genes
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Figure II - 8.  Single-stranded siRNA triggers gene silencing in HeLa cells.  (A) Single-
stranded siRNA silencing as a function of siRNA concentration.  (B) Blocking the 5´ end 
of single-stranded siRNAs prevented their triggering target gene silencing.  Gray bars 
indicate the average ± standard deviation for three trials.  Un, siRNA unrelated in
sequence to the target RNA; sp, specific siRNA corresponding to the target RNA; s, 
sense strand; as, anti-sense strand.
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encoding canonical RdRPs in the currently available release of either the Drosophila or 
human genome.  A hallmark of the involvement of RdRPs in post-transcriptional
silencing is the spread of silencing beyond the confines of an initial trigger dsRNA or 
siRNA into regions of the target RNA 5´ to the silencing trigger.  In C. elegans, this
spreading (‘transitive RNAi’) is manifest in the production of new siRNAs corresponding 
to target sequences not contained in the exogenous trigger dsRNA (Sijen et al., 2001).
Furthermore, small RNAs as long as 40 nt can initiate silencing in worms, but only if 
they contain 3´ hydroxyls, suggesting that they act as primers for the synthesis of cRNA 
(Tijsterman et al., 2002).  In contrast, 5´ spreading is not detected in Drosophila, either in 
vitro (Zamore et al., 2000), in cultured Drosophila S2 cells (Celotto and Graveley, 2002), 
or in vivo in flies (Jean-Yves Roignant and Christophe Antoniewski, personal
communication).  Our data support the view that, in both flies and mammals, siRNAs 
trigger target RNA destruction not by acting as primers, but rather by guiding a protein 
endoribonuclease to a site on the target RNA that is complementary to one strand of the 
siRNA.  The observation that the target cleavage site is across from the center of the 
complementary siRNA (Elbashir et al., 2001c; Elbashir et al., 2001b) is consistent with 
an enzyme other than Dicer acting in target RNA destruction and not with models that 
propose that Dicer destroys target RNAs.  Furthermore, mammalian extracts depleted of 
Dicer still catalyze siRNA-directed target cleavage (Martinez et al., 2002).
Will it be possible to design siRNAs to degrade just one of several mRNA
isoforms that differ at only a single nucleotide?  If siRNAs do not act as RdRP primers in 
flies and mammals, then there is no fear that the silencing signal will spread 5´ to a region 
of sequence common to the entire family of mRNAs.  Despite earlier concerns that such 
siRNAs would not be possible (Nishikura, 2001), our data suggest that isoform- and 
polymorphism-specific siRNAs will be used in mammals in the future to dissect the 
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function of individual gene isoforms and perhaps even to treat inherited autosomal
dominant human diseases.
105
Experimental Procedures
General methods
Drosophila embryo lysate preparation, in vitro RNAi reactions, and cap-labeling of target
RNAs using Guanylyl transferase were carried out as previously described (Zamore et al., 
2000).  Human S100 extracts were prepared as described (Dignam et al., 1983).  HeLa 
S100 was substituted for Drosophila embryo lysate in an otherwise standard RNAi 
reaction, except that incubation was at 37° instead of 25°C.  Cleavage products of RNAi 
reactions were analyzed by electrophoresis on 8% denaturing acrylamide gels.  3´ end 
labeling with α-32P cordycepin and determination of 5´ phosphorylation status were
according to Nykänen et al. (Nykänen et al., 2001).  Gels were dried, exposed to image 
plates (Fuji), which were scanned with a Fuji FLA-5000 phosphorimager.  Images were 
analyzed using Image Reader FLA-5000 version 1.0 (Fuji) and Image Gauge version 3.45 
(Fuji).
siRNA preparation
Synthetic RNAs (Dharmacon) were deprotected according to the manufacturer’s protocol 
and processed as previously described (Nykänen et al., 2001).  siRNA strands were
annealed (Elbashir et al., 2001a) and used at 100 nM final concentration unless otherwise 
noted.  siRNA single strands were phosphorylated with polynucleotide kinase (New 
England Biolabs) and 1 mM ATP according to the manufacturer’s directions.
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Tissue culture
siRNA transfections were as described (Elbashir et al., 2001a).  Briefly, cultured HeLa 
cells were propagated in Dulbecco’s modified Eagle’s medium (DMEM) supplemented 
with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (Life Technologies).
Cells were trypsinized and seeded at 1 x 105 cells/ml in 24 well plates (5 x 104 cells/well) 
in DMEM supplemented with 10% FBS.  Twenty four hours after seeding, 1 μg pGL2 
control firefly luciferase (Pp-luc GL2; Promega) and 0.1 μg pRL-TK Renilla luciferase 
(Rr-luc; Promega) plasmids and the luciferase siRNA (25 nM) were co-transfected with 
LipofectAMINE 2000 reagent (Invitrogen) in DMEM (Life Technologies) lacking serum 
and antibiotics according to manufacturer’s instructions.  Media was replaced 4 h after 
transfection with DMEM containing 10% fetal bovine serum (Life Technologies); one 
day after transfection, the cells were lysed in 1x Passive Lysis Buffer (Promega)
according to the manufacturer’s instructions.  Luciferase expression was determined by 
the Dual luciferase assay kit (Promega) using a Mediators PhL luminometer.  Data 
analysis was performed using Excel (Microsoft) and IgorPro 5.0 (Wavemetrics).
Experiments were performed in triplicate, and error was propagated through all
calculations.
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Asymmetry in the Assembly of the RNAi Enzyme 
Complex
114
The experiments presented in the following chapter were a collaborative effort.  Gyorgy 
Hutvagner performed RISC pull-out assays, target unwinding assays, and target cleavage 
assays in Figure 1C - E, 2K - M.  Tingting Du carried out the Northern blot analysis in 
Figure 6.  I performed the rest of the experiments in the figures as well as experiments 
listed as data not shown.
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CHAPTER III
Summary
A key step in RNA interference (RNAi) is assembly of the RISC, the protein-siRNA
complex that mediates target RNA cleavage.  Here, we show that the two strands of an 
siRNA duplex are not equally eligible for assembly into RISC.  Rather, both the absolute 
and relative stabilities of the base pairs at the 5´ ends of the two siRNA strands determine 
the degree to which each strand participates in the RNAi pathway.  siRNA duplexes can 
be functionally asymmetric, with only one of the two strands able to trigger RNAi.
Asymmetry is the hallmark of a related class of small, single-stranded, non-coding
RNAs, microRNAs (miRNAs).  We suggest that single-stranded miRNAs are initially 
generated as siRNA-like duplexes whose structures predestine one strand to enter the 
RISC and the other strand to be destroyed.  Thus, the common step of RISC assembly is 
an unexpected source of asymmetry for both siRNA function and miRNA biogenesis.
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Introduction
Two types of ~21 nt RNAs trigger post-transcriptional gene silencing in animals: small 
interfering RNAs (siRNAs) and microRNAs (miRNAs).  Both siRNAs and miRNAs are 
produced by the cleavage of double-stranded RNA (dsRNA) precursors by Dicer, a
member of the RNase III family of dsRNA-specific endonucleases (Bernstein et al.,
2001; Billy et al., 2001; Grishok et al., 2001; Hutvágner et al., 2001; Ketting et al., 2001; 
Knight and Bass, 2001; Paddison et al., 2002; Park et al., 2002; Provost et al., 2002; 
Reinhart et al., 2002; Zhang et al., 2002; Doi et al., 2003; Myers et al., 2003).  siRNAs 
result when transposons, viruses or endogenous genes express long dsRNA or when
dsRNA is introduced experimentally into plant or animal cells to trigger gene silencing, a 
process known as RNA interference (RNAi) (Fire et al., 1998; Hamilton and Baulcombe, 
1999; Zamore et al., 2000; Elbashir et al., 2001a; Hammond et al., 2001; Sijen et al., 
2001; Catalanotto et al., 2002).  In contrast, miRNAs are the products of endogenous, 
non-coding genes whose precursor RNA transcripts can form small stem-loops from
which mature miRNAs are cleaved by Dicer (Lagos-Quintana et al., 2001; Lau et al., 
2001; Lee and Ambros, 2001; Lagos-Quintana et al., 2002; Mourelatos et al., 2002;
Reinhart et al., 2002; Ambros et al., 2003; Brennecke et al., 2003; Lagos-Quintana et al., 
2003; Lim et al., 2003a; Lim et al., 2003b).  miRNAs are encoded in genes distinct from 
the mRNAs whose expression they control.
siRNAs were first identified as the specificity determinants of the RNAi pathway, 
where they act as guides to direct endonucleolytic cleavage of their target RNAs
(Hamilton and Baulcombe, 1999; Hammond et al., 2000; Zamore et al., 2000; Elbashir et 
al., 2001a).  Prototypical siRNA duplexes are 21 nt, double-stranded RNAs that contain 
19 base pairs, with two-nucleotide, 3´ overhanging ends (Elbashir et al., 2001a; Nykänen
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et al., 2001; Tang et al., 2003).  Active siRNAs, like miRNAs, contain 5´ phosphates and 
3´ hydroxyls (Zamore et al., 2000; Boutla et al., 2001; Hutvágner et al., 2001; Nykänen et 
al., 2001; Chiu and Rana, 2002; Mallory et al., 2002).  Recent evidence suggests that 
siRNAs and miRNAs are functionally interchangeable, with the choice of mRNA
cleavage or translational repression determined solely by the degree of complementarity 
between the small RNA and its target (Hutvágner and Zamore, 2002; Doench et al., 
2003).  siRNAs and miRNAs are found in similar, if not identical complexes, suggesting 
that a single, bifunctional complex—the RNA-induced silencing complex (RISC)—
mediates both cleavage and translational control (Caudy et al., 2002; Hutvágner and 
Zamore, 2002; Martinez et al., 2002; Mourelatos et al., 2002).
Each RISC contains only one of the two strands of the siRNA duplex (Martinez et 
al., 2002).  Both siRNA strands can be competent to direct RNAi (Elbashir et al., 2001a; 
Elbashir et al., 2001b; Nykänen et al., 2001).  That is, the anti-sense strand of an siRNA 
can direct cleavage of a corresponding sense RNA target, whereas the sense siRNA strand 
directs cleavage of an anti-sense target.  Here, we show that small changes in siRNA 
sequence have profound and predictable effects on the extent to which the individual 
strands of an siRNA duplex enter the RNAi pathway, a phenomenon we term siRNA 
functional asymmetry.  We designed siRNAs that are fully asymmetric, with only one of 
the two siRNA strands forming RISC in vitro.  Such highly asymmetric siRNA duplexes 
resemble intermediates previously proposed for the miRNA biogenesis pathway
(Hutvágner and Zamore, 2002; Reinhart et al., 2002; Lim et al., 2003b).  Our data suggest 
that RISC assembly is governed by an enzyme that selects which strand of an siRNA is 
loaded into RISC.  This strand is always the one whose 5´ end is less tightly paired to its 
complement.  We propose that for each siRNA duplex that is unwound, only one strand 
enters the RISC complex, whereas the other strand is degraded.  For miRNAs, it is the 
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miRNA strand of a short-lived, siRNA duplex-like intermediate that assembles into a 
RISC complex, causing miRNAs to accumulate in vivo as single-stranded RNAs.
Designing siRNAs to be more like these double-stranded miRNA intermediates produces 
highly functional siRNAs, even when targeting mRNA sequences apparently refractory to 
cleavage by siRNAs selected by conventional siRNA design rules.
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Results and Discussion
Functionally asymmetric siRNA duplexes
To assess if the two strands of an siRNA duplex are equally competent to direct RNAi, 
we measured the in vitro rates of sense and anti-sense target cleavage for an siRNA 
duplex directed against firefly luciferase mRNA (Figure 1A).  For this siRNA, the anti-
sense siRNA strand directed more efficient RNAi against its sense target RNA than the 
sense siRNA strand did towards the anti-sense target (Figure 1B).  (Throughout this paper 
anti-sense siRNA strands and their sense target RNAs are presented in black, and sense 
siRNAs and their anti-sense targets, in red.)  Control experiments showed that using
siRNA duplexes with 5´ phosphates did not alter this result (data not shown), indicating 
that different rates of 5´ phosphorylation for the two strands cannot explain the
asymmetry.
Single-stranded siRNA can direct RNAi, but is >10-fold less effective than siRNA 
duplexes, reflecting the reduced stability of single-stranded RNA in vitro and in vivo 
(Schwarz et al., 2002).  Surprisingly, the two strands of the luciferase siRNA duplex, used 
individually as 5´ phosphorylated single-strands, had identical rates of target cleavage 
(Figure 1C).  Thus, the difference in the cleavage rates of the sense and anti-sense strands 
cannot reflect a difference in the inherent susceptibility of the two targets to RNAi.
Instead, the finding that the two siRNA strands are equally effective as single-strands, but 
show dramatically different activities when paired to each other, suggests that the
asymmetry in their function is established at a step in the RNAi pathway before the 
encounter of the programmed RISC with its RNA target.
Differential RISC assembly and siRNA functional asymmetry
120
????????
B
(20)
(21)
     Pp luc sense target:  5´-…cgaggugaacaucacguacgcggaauacuucgaaaugucc…-3´
Pp luc anti-sense target: 3´-…gcuccacuuguagugcaugcgccuuaugaagcuuuacagg…-5´
A
    5´-CGUACGCGGAAUACUUCGAAA-3´
       •••••••••••••••••••
  3´-GUGCAUGCGCCUUAUGAAGCU-5´
0.6
0.4
0.2
0f
ra
ct
io
n 
ta
rg
et
 c
le
av
ed
604530150
time (min)
(21)
(21)
E
    5´-UGUACGCGGAAUACUUCGAAA-3´
       •••••••••••••••••••
  3´-GUGCAUGCGCCUUAUGAAGCU-5´
0.6
0.4
0.2
0f
ra
ct
io
n 
ta
rg
et
 c
le
av
ed
604530150
time (min)
C
(21)
(21)
5´-pCGUACGCGGAAUACUUCGAAA-3´
5´-pUCGAAGUAUUCCGCGUACGUG-3´
0.04
0.03
0.02
0.01
0f
ra
ct
io
n 
ta
rg
et
 c
le
av
ed
604530150
time (min)
D
0.4
0.2
0
fra
ct
io
n 
to
ta
l s
iR
NA
sas
siRNA E
s
siRNA B
as
121
Figure III - 1.  The two strands of an siRNA duplex do not equally populate the RISC.
(A) Firefly luciferase sense and anti-sense target RNA sequences.  (B) In vitro RNAi 
reactions programmed with the siRNA duplex indicated above the graph.  (C) In vitro 
RNAi reactions as in (B), but programmed with either the anti-sense or sense single-
stranded, 5  ´ phosphorylated siRNAs indicated above the graph.  (D) Fraction of anti-
sense (black) and sense (red) siRNA strands assembled into RISC (open columns) or 
present as single-strands (filled columns) after incubation with Drosophila embryo lysate 
for the siRNA duplexes shown in (B) and (E).  The average of four trials ± standard 
deviation is shown.  (E) In vitro RNAi reactions programmed with the siRNA duplex 
indicated above the graph and the target RNAs in (A).  Throughout the figures, the 
number of Watson-Crick base pairs formed between the siRNA guide strand and the 
target RNA is indicated in parentheses and siRNA bases that mismatch with the target 
RNA are noted in blue.
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siRNA unwinding correlates with siRNA function (Nykänen et al., 2001; Martinez 
et al., 2002), likely because siRNA duplex unwinding is required to assemble a RISC 
competent to base pair with its target RNA.  We measured the accumulation of single-
stranded siRNA from the luciferase siRNA duplex after 1 h incubation in an in vitro 
RNAi reaction in the absence of target RNA.  In this reaction, ~ 22% of the anti-sense
strand of the luciferase siRNA was converted to single-strand (Figure 1D, ‘siRNA B,’
solid black bar).  Remarkably, we did not detect a corresponding amount of single-
stranded sense siRNA (Figure 1D, ‘siRNA B,’ solid red bar).  Since the production of 
single-stranded anti-sense siRNA must be accompanied by an equal amount of single-
stranded sense siRNA, the missing sense-strand of the siRNA must have been destroyed 
after unwinding.
We also used a novel ‘RISC-capture assay’ to measure the fraction of each siRNA 
strand that was assembled into RISC (GH, Martin Simard, Craig Mello, and PDZ,
manuscript in preparation).  Double-stranded siRNA was incubated in an RNAi reaction 
for 1 h, then we added a complementary 2 -´O-methyl RNA oligonucleotide tethered to a 
magnetic bead via a biotin-streptavidin linkage.  2 -´O-methyl oligonucleotides are not 
cleaved by the RNAi machinery, but can bind stably to complementary siRNA within the 
RISC, so the amount of radioactivity stably associated with the beads is a direct measure 
of the amount of RISC formed.  The assay was performed with siRNA duplexes in which 
either the sense or the anti-sense strand was 5´-32P-radiolabeled.  All RISC activity
directed by the siRNA strand complementary to the tethered oligonucleotide was
captured on the beads; no RISC was captured by an unrelated 2 -´O-methyl
oligonucleotide (data not shown).  The RISC-capture assay recapitulated our unwinding 
measurements: ten-fold more anti-sense siRNA-containing RISC was detected than
sense-strand RISC (Figure 1D, ‘siRNA B,’ open bars).  The simplest explanation is that 
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the two strands of the siRNA duplex are differentially loaded into the RISC and that 
single-stranded siRNA not assembled into RISC is degraded.
siRNA structure and RISC assembly
The finding that the two siRNA strands can have different capacities to form
RISC when paired suggests that some feature unique to the duplex determines functional 
asymmetry.  For the siRNA in Figure 1B, the 5´ end of the anti-sense siRNA strand
begins with U and is thus paired to the sense siRNA strand by an U:A base pair (2
hydrogen bonds).  In contrast, the 5´ nucleotide of the sense siRNA strand is linked to the 
anti-sense strand by a C:G base pair (3 hydrogen bonds).  A simple hypothesis is that the 
siRNA strand whose 5´ end is more weakly bound to the complementary strand more 
readily incorporates into RISC.
As an initial test of this idea, we changed the first nucleotide of the siRNA sense
strand from C to U, replacing a C:G pair with a less stable U:G wobble, because the 
sequence of the anti-sense siRNA was not altered (Figure 1E).  This single nucleotide 
substitution increased the rate of cleavage directed by the sense strand, and virtually
eliminated RNAi directed by the anti-sense strand (Figure 1E).  That is, the single C-to-U
substitution inverted the functional asymmetry of the siRNA.  Assembly of the two 
strands of the siRNA into RISC was also reversed: nearly 30% of the sense siRNA strand
was converted to single-strand after 1h incubation, but no single-stranded anti-sense
strand was detected (Figure 1D, ‘siRNA E’).
We calculated the stability of the initial four base pairs of the siRNA strands in 
Figure 1 using the nearest-neighbor method and the mfold algorithm (Mathews et al., 
1999; Zuker, 2003).  The 5´ end of the sense siRNA strand in Figure 1E, but not that in 
1B, is predicted to exist as an equilibrium of two conformers of nearly equal energy.  In 
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one conformer, the 5´ nucleotide of the sense strand is bound to the anti-sense strand by a 
U:G wobble pair, whereas in the other conformer the 5´ end of this siRNA strand is 
unpaired (Figure 2A-C).  The analysis suggests that RISC assembly favors the siRNA 
strand whose 5´ end has a greater propensity to fray.
To test our hypothesis, we examined the strand-specific rates of cleavage of sense 
and anti-sense human Cu, Zn-superoxide dismutase (sod1) RNA targets (Figure 3A)
triggered by the siRNA duplexes shown in Figure 3.  In Figure 3B, the 5´ ends of both 
siRNA strands of the duplex are in G:C base pairs and the two strands are similar in their 
rates of target cleavage.  In Figure 3C, the C at position 19 of the sense strand was
changed to A, causing the anti-sense strand to begin with an unpaired nucleotide.  This 
change, which was made to the sense-strand of the siRNA, caused the rate of target
cleavage guided by the anti-sense siRNA strand to be dramatically enhanced and the 
sense strand rate to be suppressed (Figure 3C).  Because the enhancement of sense target 
cleavage was caused by a mutation in the sense siRNA strand, which does not participate 
in the recognition of this target, the effect of the mutation must be on a step in the RNAi 
pathway that is spatially or temporally coupled to siRNA unwinding.  However, the 
suppression of anti-sense target cleavage might have resulted from the single-nucleotide
mismatch between the sense strand and its target RNA generated by the C-to-U
substitution.
To exclude this possibility, we used a different strategy to unpair the 5´ end of the
anti-sense strand.  In Figure 3D, the sense-strand is identical to that in Figure 3B, but the 
first nucleotide of the anti-sense strand was changed from G to U, creating a U-C
mismatch at its 5´ end, in place of the G-A of Figure 3C.  This siRNA duplex still showed 
pronounced asymmetry, with the anti-sense strand guiding target cleavage to the nearly 
complete exclusion of the sense strand (Figure 3D).  Thus, the suppression of the
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Figure III - 2.  The relative thermodynamic stability of the first four base pairs of the 
siRNA strands explains siRNA functional asymmetry.  (A-C) Thermodynamic analysis 
of siRNA strand 5´ ends for the siRNAs in Figures 1B and 1E. ΔG (kcal/mole) was 
calculated in 1M NaCl at 37°C.  (D-M) Altering the functional asymmetry of siRNA 
duplexes.  (D) Sense and anti-sense sod1 target RNA sequences.  (E) Thermodynamic 
analysis of siRNA strand 5´ ends for the siRNA duplex in (F). ΔG (kcal/mole) was
calculated in 1M NaCl at 37°C.  (F) In vitro RNAi reactions programmed with the siRNA 
indicated above the graph using the target RNAs in (D).  (G) In vitro RNAi reactions 
programmed with the siRNA indicated above the graph, in which the 5´ terminal C of the 
anti-sense strand in (F) was changed to U.  (H) In vitro RNAi reactions programmed with 
anti-sense or sense single-stranded, 5´ phosphorylated siRNAs as indicated.  (I) Sense 
and anti-sense huntingtin (htt) target RNA sequences.  (J)  Thermodynamic analysis of 
siRNA strand 5´ ends for the siRNA duplex in (K). ΔG (kcal/mole) was calculated in 1M 
NaCl at 37°C.  (K) In vitro RNAi reactions programmed with the siRNA indicated above 
the graph using the target RNAs in (I).  (L) In vitro RNAi reactions programmed with the 
siRNA indicated above the graph, in which C19 of the sense siRNA strand and G1 of the 
anti-sense strand were changed to A and U, respectively.  (M) In vitro RNAi reactions 
programmed with the siRNA indicated above the graph, in which the sense strand was 
that used in (L) and the anti-sense strand was that used in (K).
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Figure III - 3.  5´ terminal, single-nucleotide mismatches make siRNA duplexes
functionally asymmetric.  (A) The sequences at the cleavage site of the 560 nt sod1 RNA 
sense or  578 nt sod1 anti-sense target RNAs.  The siRNAs in this figure and in Figure 3 
cleave the sense target to yield a 320 nt 5´ product and the anti-sense target to yield a 261 
nt 5´ product.  (B-H) In vitro RNAi reactions programmed with the siRNA indicated
above each graph using the target RNAs diagrammed in (A).  (I) In vitro RNAi reactions 
programmed with anti-sense or sense single-stranded, 5´ phosphorylated siRNAs (the 
single nucleotide mismatch with target RNA is underlined): black squares, 5 -´pGUC
ACA UUG CCC AAG UCU CdTdT-3´; black circles, 5´-pUUC ACA UUG CCC AAG 
UCU CdTdT-3´; red squares, 5´-pGAG ACU UGG GCA AUG UGA AdTdT-3´; red 
circles, 5´-pGAG ACU UGG GCA AUG UGA CdTdT-3´. (J-M) A single hydrogen 
bond difference can cause the two strands of an siRNA duplex to assemble differentially 
into RISC.  (J-L) In vitro RNAi reactions programmed with the siRNA indicated above 
each graph using the target RNAs in (A).  (M) In vitro RNAi reactions as in (J-L), but 
programmed with anti-sense or sense single-stranded, 5´ phosphorylated siRNAs: black 
circles, 5´-IUC ACA UUG CCC AAG UCU CdTdT-3´; red circles, 5´-IAG ACU UGG 
GCA AUG UGA CdTdT-3´.
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cleavage rate of the sense-strand in Figure 3C was not a consequence of the position 19 
mismatch with the anti-sense target.  This finding is consistent with previous studies that 
suggest that mismatches with the target RNA are well tolerated if they occur near the 3´ 
end of the siRNA guide strand (Amarzguioui et al., 2003).  When we paired the sense 
strand of Figure 3C with the anti-sense strand of Figure 3D to create the duplex in Figure 
3E, the resulting siRNA directed anti-sense target cleavage significantly better than the 
siRNA in Figure 3C, although the two siRNAs contain the same sense strand (Figure 3E).
Figures 3F, G, and H show a similar analysis in which the 5´ end of the sense 
strand or position 19 of the anti-sense strand of the siRNA in Figure 3B was altered to 
produce siRNA duplexes in which the 5´ end of the sense strand was either fully unpaired 
(Figures 3F and G) or in an A:U base pair (Figure 3H).  Again, unpairing the 5´ end of an 
siRNA strand—the sense strand, in this case—caused that strand to function to the
exclusion of the other strand.  When the sense strand 5´ end was present in an A:U base 
pair and the anti-sense strand 5´ end was in a G:C pair, the sense strand dominated the 
reaction (Figure 3H), but the anti-sense strand retained activity similar to that seen for the 
original siRNA (Figure 3B).  We conclude that the relative ease with which the 5´ ends of 
the two siRNAs can be liberated from the duplex determines the degree of asymmetry.
Additional data supporting this idea is shown in Figure 2.  Figure 2F shows an 
siRNA that cleaved the two sod1 target RNAs (Figure 2D) with modest functional
asymmetry that reflects the collective base pairing strength of the first four nucleotides of 
each siRNA strand (2E; see below).  Asymmetry was dramatically increased when a G:U 
wobble was introduced at the 5´ end of the anti-sense strand of the siRNA (Figure 2G),
but no asymmetry was seen when the individual single-strands strands were used to 
trigger RNAi (Figure 2H), demonstrating that differential RISC assembly, not target
accessibility, explains the functional asymmetry of the siRNA duplex.
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A single hydrogen bond can determine which siRNA strand directs RNAi
How small a difference in siRNA base pairing can the RISC-assembly machinery 
sense?  To explore this question, we altered the siRNA in Figure 3B by introducing 
inosine (I) in place of the initial guanosines of the siRNA strands.  These siRNAs cleave 
the same sites on the two target RNAs as the siRNA in Figure 3B, but contain I:C pairs 
instead of G:C.  An I:C pair is similar in energy to an A:U (Turner et al., 1987).  When 
the sense strand began with I, it directed target cleavage more efficiently than the anti-
sense strand (Figure 3J).  An inosine at the 5´ end of the anti-sense strand had the 
opposite effect (Figure 3K).  Thus, a difference of a single hydrogen bond has a
measurable effect on the rate of RISC assembly.  When both siRNA strands began with I, 
the relative efficacy of the two siRNA strands (Figure 3L) was restored to that measured 
for the individual single strands (Figure 3M).  Thus, the small difference in rates in 
Figure 3L reflects a difference in the intrinsic capacity of the two strands to guide
cleavage, not a difference in their assembly into RISC.  We note that the absolute rates 
are faster for the siRNA in Figure 3L than that in Figure 3B, suggesting that production of 
RISC from an individual strand is governed not only by the relative propensity of the two 
5´ ends to fray but also by their absolute propensities to fray.
We hypothesize that siRNA end fraying provides an entry site for an ATP-
dependent RNA helicase that unwinds siRNA duplexes (Figure 5A).  The involvement of 
a helicase in RISC assembly is supported by previous observations: (1) both siRNA 
unwinding and production of functional RISC require ATP in vitro (Nykanen et al., 2001)
and (2) several proteins with sequence homology to ATP-dependent RNA helicases have 
been implicated in RNA silencing (Wu-Scharf et al., 2000; Dalmay et al., 2001;
Hutvágner and Zamore, 2002; Ishizuka et al., 2002; Kennerdell et al., 2002; Tabara et al., 
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2002; Tijsterman et al., 2002).  However, other mechanisms are possible, including strand 
selection by an ATP-dependent nuclease or the concerted action on the siRNA of an
ATPase and single-stranded RNA-binding proteins and/or nucleases.
Four-to-six bases of single-stranded nucleic acid are bound by the well-studied
helicases PcrA (Velankar et al., 1999) and NS3 (Kim et al., 1998).  Therefore, we tested 
the effect of single-nucleotide mismatches in this region of the siRNA, using a series of 
siRNAs containing a mismatch at the second, third, or fourth position of each siRNA 
strand.  We also analyzed siRNAs bearing G:U wobble pairs at the second, third, or both 
second and third positions (Figure 4).  These siRNAs were again based on the siRNA in 
Figure 3B and targeted the sod1 sense and antisense RNAs in Figure 3A.  The results of 
this series demonstrate that mismatches, but not G:U wobbles, at positions 2-4 of an
siRNA strand alter the relative loading of the two siRNA strands into RISC.  Mismatches 
at position five have very modest effects on the relative loading of the siRNA strands into 
RISC (data not shown).  In contrast, the effects of internal mismatches at positions 6-15
cannot be explained by their influencing the symmetry of RISC assembly (data not
shown).  In sum, these data are consistent with the action of a non-processive helicase 
that can bind about four nucleotides of RNA.
Implications of siRNA asymmetry for miRNA biogenesis
miRNAs are derived from the double-stranded stem of hairpin precursor RNAs by 
cleavage catalyzed by the double-stranded RNA-specific endonuclease, Dicer (Lee et al., 
1993; Pasquinelli et al., 2000; Reinhart et al., 2000; Grishok et al., 2001; Hutvágner et al., 
2001; Ketting et al., 2001; Lagos-Quintana et al., 2001; Lau et al., 2001; Lee and
Ambros, 2001; Lagos-Quintana et al., 2002; Reinhart et al., 2002).  pre-miRNA
processing by Dicer may generate a product with the essential structure of an siRNA
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Figure III - 4.  The first four base pairs of the siRNA duplex determine strand-specific
activity.  Internal, single-nucleotide mismatches (A-F) near the 5´ ends of an siRNA 
strand generate functional asymmetry, but internal G:U wobble pairs (G-I) do not.  Target 
RNAs were as in Figure 3A.
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duplex, as first suggested by Bartel and colleagues (Reinhart et al., 2002; Lim et al., 
2003b).  Using a small RNA cloning strategy to identify mature miRNAs in C. elegans,
they recovered small RNAs corresponding to the non-miRNA side of the precursor’s
stem (Lim et al., 2003b).  Although these ‘miRNA*’ sequences were recovered at about
100 times lower frequency than the miRNAs themselves, they could always be paired
with the corresponding miRNA to give ‘miRNA duplexes’ with 2 nt overhanging 3´ ends 
(Lim et al., 2003b).  Their data suggest that miRNAs are born as duplexes, but
accumulate as single-strands because some subsequent process stabilizes the miRNA, 
destabilizes the miRNA*, or both.
We propose that incorporation of miRNA into RISC is this process.  Our results 
with siRNA suggest that preferential assembly of a miRNA into the RISC would be 
accompanied by destruction of its * strand (Figure 5A).  To favor miRNA accumulation, 
miRNA duplexes would present the miRNA in a structure that loads the miRNA strand, 
but not the miRNA*, into RISC.
Is this idea plausible?  We deduced the miRNA duplex that might be generated by 
processing of pre-let-7 (‘conceptual dicing’; Figure 5B).  pre-miRNA stems are only 
partially double-stranded; the typical animal pre-miRNA contains mismatches, internal 
loops, and G:U base pairs predicted to distort an RNA helix.  As a consequence, miRNA 
duplexes should also contain terminal and internal mismatches and G:U base pairs.  For 
pre-let-7, the 5´ end of let-7 is unpaired in the predicted miRNA duplex, whereas the 5´ 
end of the * strand is paired.  The results presented in Figures 1 and 3 predict that this 
structure should cause the let-7 strand to enter the RISC and the let-7* strand to be 
degraded.  Emboldened by this thought experiment, we extended the analysis to other 
Drosophila miRNA genes (Lagos-Quintana et al., 2001).  For each, we inferred from its 
precursor structure the double strand predicted to be produced by Dicer.  These
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Figure III - 5.  Asymmetric RISC assembly can explain siRNA and miRNA strand 
choice.  (A) A model for RISC assembly.  Dicing of both pre-miRNAs and dsRNA is 
proposed to generate a duplex intermediate that is a substrate for an ATP-dependent RNA 
helicase that directs only one of the two strands into RISC; the other strand is degraded.
(B, C) Asymmetric RISC assembly from double-stranded intermediates explains why 
miRNAs accumulate in vivo as single-strands.  (B) pre-let-7 might be processed by Dicer 
into a miRNA duplex in which the 5´ end of let-7, but not that of let-7* is unpaired.  (C) 
The miRNA duplexes predicted to result from Dicer cleavage of Drosophila miRNA 
precursors.  The end bearing features predicted to promote asymmetric siRNA strand 
incorporation into RISC is highlighted in yellow, and the mature miRNA sequence is in 
italics.  Analysis of the predicted miR-10/miR-10* duplex, for which both ends are
highlighted in purple, provides little information as to why miR-10 would predominate in 
vivo.  miRNA sequences are from Lagos-Quintana et al. (2001) and Brennecke et al. 
(2003), with minor sequence corrections from Aravin et al. (2003); miRNA* sequences 
for miR-2a-2, miR-4, miR-8, miR-10, and miR-13a are as reported by Aravin et al. 
(2003).
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conceptually diced miRNA duplexes are shown in Figure 5C.  For 20 of the 27 duplexes 
analyzed (including pre-let-7), the difference in the base pairing of the first five
nucleotides of the miRNA versus the miRNA* strand accurately predicted the miRNA, 
and not the miRNA*, to accumulate in vivo.  The analysis succeeded irrespective of
which side of the pre-miRNA stem encoded the mature miRNA.  In this analysis, we 
relied on our observations that single mismatches in the first four nucleotides of an
siRNA strand, an initial G:U wobble pair, but not internal G:U wobbles, directed the 
asymmetric incorporation of an siRNA strand into RISC (Figures 1, 2, 3, and 4).
However, our experiments with siRNA predict that both the miRNA and the miRNA* 
strand should accumulate for miR-2a-2, miR-4, miR-5, one of the three miR-6 paralogs, 
miR-8, miR-10, and miR-13a.  Recently, Tuschl and colleagues reported an exhaustive 
effort to clone and sequence miRNAs from Drosophila (Aravin et al., 2003).  They found 
that miR-2a-2*, miR-4*, miR-8*, miR-10*, and miR-13a* are all expressed in vivo.  We 
have confirmed by Northern hybridization that both miR-10 and miR-10* are expressed
in adult Drosophila males and females, and in syncitial blastoderm embryos (Figure 6).
Thus, of the seven miRNAs we predict to accumulate as both miRNA and miRNA*
species, five have now been confirmed experimentally.  No miRNA* species were cloned
by Tuschl and colleagues for any of the miRNAs we predicted to accumulate
asymmetrically (Aravin et al., 2003).  These data strengthen our proposal that pre-
miRNAs specify on which side of the stem the miRNA resides by generating miRNA 
duplexes from which only one of the two strands is assembled into RISC.  When these 
double-stranded miRNA intermediates do not contain structural features enforcing
asymmetric RISC assembly, both strands accumulate in vivo.  It is tempting to speculate 
that pre-miRNAs such as pre-miR-10, which generates roughly equal amounts of small
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Figure III - 6.
Northern analysis of Drosophila miR-10 (filled columns) and miR-10* (unfilled
columns) in adult males or females, or in syncitial blastoderm embryos shows that both 
miR-10 and miR-10* RNAs accumulate in vivo.
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RNA products from both sides of the precursor stem, regulate target RNAs with partial 
complementary to either small RNA product.
Implications for RNA silencing
Our observations have dramatic implications for the design of functional siRNAs 
for mammalian RNAi.  We have shown that siRNA structure can profoundly influence 
the entry of the anti-sense siRNA strand into the RNAi pathway.  A review of the 
published literature suggests that the structure of the siRNA duplex, rather than that of 
the target site, explains most reports of ineffective siRNAs duplexes.  Such inactive 
duplexes may be coaxed back to life simply by modifying the sense strand of the siRNA.
An example of this is shown in Figure 2 for an ineffective siRNA directed against the 
huntingtin (htt) mRNA (Figure 2K).  Changing the G:C (Figure 2K) to an A:U pair
(Figure 2L) or a G-A mismatch (Figure 2M) dramatically improved its target cleavage 
rate in vitro and its efficacy in vivo (Eftim Milkani, NA, and PDZ, unpublished
observations).  Because RNAi is a natural cellular pathway, siRNAs should be designed 
to reflect the biological requirements for entry of the anti-sense strand into RISC.  In 
cultured HeLa cells, siRNAs designed according to the mechanism-based rules presented 
in this paper show maximum suppression of target mRNA expression at concentrations ~ 
100-fold lower than those typically used in mammalian RNAi studies (Schwarz et al., 
2002 and our unpublished data).  Khvorova and colleagues have similarly found that a 
low base-pairing stability at the 5´ end of the antisense strand, but not the sense strand, 
characterizes functional siRNAs in cultured cells (Anastasia Khvorova, Angela Reynolds, 
and Sumedha D. Jayasena, this issue).  siRNAs designed to function asymmetrically may 
also be used to enhance RNAi specificity.  Expression profiling studies show that the 
sense strand of an siRNA can direct off-target gene silencing (Jackson et al., 2003).  A 
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potential remedy for such sequence-specific, but undesirable effects is to redesign the 
siRNA so that only the anti-sense strand enters the RNAi pathway.
Our observations also suggest a need to revise the current design rules for the 
construction of short hairpin RNA (shRNA) vectors, which produce siRNAs
transcriptionally in cultured cells or in vivo (Brummelkamp et al., 2002; McManus et al., 
2002; Paddison et al., 2002; Paul et al., 2002; Sui et al., 2002; Yu et al., 2002).  We 
suggest that shRNAs be designed to place the 5´ end of the anti-sense siRNA strand in a 
mismatch or G:U base pair.  Moreover, a recent report suggests that some shRNAs may 
induce the interferon response (Bridge et al., 2003).  Mismatches and G:U pairs could be 
designed into these shRNAs simultaneously to promote entry of the correct siRNA strand
into the RNAi pathway and to diminish the capacity of the shRNA stem to trigger non-
sequence specific responses to double-stranded RNA.  Redesigning shRNAs to more 
fully reflect the natural mechanism of miRNA incorporation into RISC should make them
more effective, allowing lower levels of shRNA to silence target mRNAs in vivo.
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Experimental Procedures
General methods
In vitro RNAi reactions and analysis was carried out as previously described 
(Tuschl et al., 1999; Zamore et al., 2000; Haley et al., 2003).  Target RNAs were used at 
~ 5 nM concentration so that reactions were mainly under single-turnover conditions.
Target cleavage under these conditions was proportionate to siRNA concentration.
siRNA unwinding assays were as published (Nykänen et al., 2001).
siRNA preparation
Synthetic RNA (Dharmacon) was deprotected according to the manufacturer’s
protocol.  siRNA strands were annealed (Elbashir et al., 2001a) and used at a final 
concentration of = 50 (Figures 1B, 2F - H, 3, 4) or = 100 nM (Figures 1D,1E and 2K-M).
siRNA single strands were phosphorylated with polynucleotide kinase (PNK; New
England Biolabs) and 1 mM ATP and used at 500 nM final concentration.
Target RNA preparation
Target RNAs were transcribed with recombinant, histidine-tagged, T7 RNA
Polymerase from PCR products as described (Nykänen et al., 2001; Hutvágner and
Zamore, 2002), except for sense sod1 mRNA, which was transcribed from a plasmid 
template (Crow et al., 1997) linearized with Bam HI.  PCR templates for htt sense and 
anti-sense and sod1 anti-sense target RNAs were generated by amplifying 0.1 ng/μl (final 
concentration) plasmid template encoding htt or sod1 cDNA using the following primer 
pairs: htt sense target, 5 -´GCG TAA TAC GAC TCA CTA TAG GAA CAG TAT GTC 
TCA GAC ATC-3´ and 5 -´UUCG AAG UAU UCC GCG UAC GU-3´; htt anti-sense
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target, 5 -´GCG TAA TAC GAC TCA CTA TAG GAC AAG CCT AAT TAG TGA 
TGC-3´ and 5 -´GAA CAG TAT GTC TCA GAC ATC-3´; sod1 anti-sense target, 5 -´
GCG TAA TAC GAC TCA CTA TAG GGC TTT GTT AGC AGC CGG AT-3´ and 5 -´
GGG AGA CCA CAA CGG TTT CCC-3´.
Immobilized 2´-O-methyl oligonucleotide capture of RISC
The 5´ end of the siRNA strand to be measured was 32P-radiolabeled with PNK.
10 pmol biotinylated 2 -´O-Methyl RNA was immobilized on Dynabeads M280 (Dynal) 
by incubation in 10 μl lysis buffer containing 2mM DTT for 1 h on ice with the
equivalent of 50 μl of the suspension of beads provided by the manufacturer.  The beads 
were then washed to remove unbound oligonucleotide.  50 nM siRNA was pre-incubated
in a standard 50 μl in vitro RNAi reaction for 15 min at 25°C. Then, all of the
immobilized 2´-O-Methyl oligonucleotide was added to the reaction and the incubation 
continued for 1 h at 25°C.  After incubation, the beads were rapidly washed three times 
with lysis buffer containing 0.1% (w/v) NP-40 and 2 mM DTT followed by a wash with 
the same buffer without NP-40.  Input and bound radioactivity were determined by
scintillation counting (Beckman).  The 5 -´biotin moiety was linked via a six-carbon
spacer arm.  2´-O-methyl oligonucleotides (IDT) were: 5´-biotin-ACA UUU CGA AGU 
AUU CCG CGU ACG UGA UGU U-3´ (to capture the siRNA sense strand) 5´-biotin-
CAU CAC GUA CGC GGA AUA CUU CGA AAU GUC C-3´ (to capture the anti-sense
strand).
Northern hybridization
Northern hybridization was essentially as described (Hutvágner et al., 2001).  50 
μg total RNA was loaded per lane.  5´ 32P-radiolabeled synthetic RNA probes
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(Dharmacon) were: 5´-ACA AAU UCG GAU CUA CAG GGU-3´ (to detect miR-10)
and 5 -´AAA CCU CUC UAG AAC CGA AUU U-3´ (to detect miR-10*).  The amount 
of miR-10 or miR-10* detected was normalized to the non-specific hybridization of the 
probe to 5S rRNA.  Normalizing to hybridization of the probe to a known amount of a 
miR-10 or miR-10* synthetic RNA control yielded essentially the same result.
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The RNA-Induced Silencing Complex is a Mg2+-
dependent Endonuclease
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The work in the following chapter was a collaborative effort.  Yukihide Tomari
performed phosphorothioate substitution experiments in Figure 3 and Figure 6.  I
performed all other experiments, wrote the manuscript and prepared the figures.
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CHAPTER IV
Summary
In the Drosophila and mammalian RNA interference (RNAi) pathways, target RNA
destruction is catalyzed by the siRNA-guided RNA-induced silencing complex (RISC).
RISC has been proposed to be an siRNA-directed endonuclease, catalyzing cleavage of a 
single phosphodiester bond on the RNA target.  Although 5´ cleavage products are
readily detected for RNAi in vitro, only 3´ cleavage products have been observed in vivo.
Proof that RISC acts as an endonuclease requires detection of both 5´ and 3´ cleavage
products in a single experimental system.  Here, we show that siRNA-programmed RISC 
generates both 5´ and 3´ cleavage products in vitro; cleavage requires Mg2+ but not Ca2+,
and the cleavage product termini suggest a role for Mg2+ in catalysis.  Moreover, a single 
phosphorothioate in place of the scissile phosphate blocks cleavage; the phosphorothioate 
effect can be rescued by the thiophilic cation, Mn2+, but not by Ca2+ or Mg2+. We
propose that, during catalysis, a Mg2+ ion is bound to the RNA substrate through a non-
bridging oxygen of the scissile phosphate.  The mechanism of endonucleolytic cleavage 
is not consistent with the mechanism of the previously identified RISC nuclease, Tudor-
SN.  Thus, the RISC-component that mediates endonucleolytic cleavage of the target
RNA remains to be identified.
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Results and Discussion
The RISC is an endonuclease 
In vitro, 5´ cleavage products are readily detected for both siRNA-programmed (Chiu and 
Rana, 2003; Elbashir et al., 2001a; Elbashir et al., 2001b; Hutvagner and Zamore, 2002; 
Martinez et al., 2002; Nykanen et al., 2001; Schwarz et al., 2002; Tuschl et al., 1999; 
Zamore et al., 2000) and microRNA-programmed (Hutvagner and Zamore, 2002; Tang et 
al., 2003) RISC.  In contrast, only stable 3´ cleavage products are detected in vivo in 
plants (Llave et al., 2002; Palatnik et al., 2003; Xie et al., 2003) and in cultured
mammalian cells (Holen et al., 2002).  Although the proposal that RISC is an
endonuclease is appealing (Elbashir et al., 2001a), current evidence is also consistent 
with a highly processive 5´-to-3´ or 3 -´to-5´ exonuclease that stops at the center of the 
siRNA.  In fact, a Staphylococcal family exonuclease, Tudor-SN (TSN) has been
identified as a component of RISC in Drosophila melanogaster, mammals, and
Caenorhabditis elegans (Caudy et al., 2003).  The cysteine-alkylating agent, N-
ethylmaleimide (NEM) reduces non-sequence specific ribonuclease activity present in 
Drosophila embryo lysates (Figure 1A).  NEM also blocks the assembly, but not the 
activity, of RISC (Nykanen et al., 2001; Tomari et al., 2004).  We assembled siRNA into 
RISC in Drosophila embryo lysate, treated the reactions with NEM, then added either a 
5´ or a 3´ 32P-radiolabeled luciferase target RNA and monitored target RNA cleavage.
The 3 -´radiolabeled target RNA contained a 7-methylguanosine "cap" at its 5´ end and 
was 3´ end-labeled with α-32P, 3´-deoxyadenosine 5´ triphosphate (3´-dATP) and yeast 
poly(A) polymerase (Figure 1A).  The 3 -´radiolabeled RNA corresponded to the
antisense sequence of the 5 -´radiolabeled RNA target.  The siRNA used in this study 
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generates both sense- and antisense-strand RISCs.  The 5´ cleavage product for this 
antisense target RNA and siRNA has been characterized previously (Elbashir et al.,
2001a; Nykanen et al., 2001).
If RISC is an endonuclease, then the 5´ cleavage product of the 5´-radiolabeled
sense target RNA and the 3´ cleavage product of the 3 -´radiolabeled antisense target 
RNA should be the same length.  By using the 5 -´radiolabeled sense and 3´-radiolabeled
antisense target RNAs, we detected both 5´ and 3´ products of siRNA-directed target 
RNA cleavage.  No 3´ cleavage products were detected in the absence of NEM treatment 
or if dithiothreitol, which quenches NEM, was added before, rather than after, NEM 
(Figure 1A, "– NEM" and "mock"), likely because both the 3 -´radiolabeled target RNA 
and the 3´ cleavage product are unstable in these conditions.  Because the 5´ cleavage 
product of the sense target and the 3´ cleavage product of the antisense target co-migrate,
we conclude that RISC is an endonuclease that cleaves at a single, unique site, as first 
proposed by Tuschl and colleagues (Elbashir et al., 2001a).  A 3´ cleavage product was 
also detected for a different siRNA:target pair (Figure 2).
The termini of the products of nucleases often provide clues to the mechanisms of 
nuclease catalysis.  We purified each cleavage product by polyacrylamide gel
electrophoresis, and then the purified cleavage products were enzymatically probed to 
determine if their termini contained hydroxyl or phosphate groups (Figures 1B and 1C).
To identify the nature of its 3´ end, the 5´ cleavage product was treated with T4
polynucleotide kinase (PNK) or poly(A) polymerase and 3 -´dATP.   When treated with 
PNK, the gel mobility of the 5´ cleavage product was indistinguishable from the
untreated sample, suggesting that it does not contain a 3´ phosphate (Figure 1B).  (In 
addition to its 5´ kinase activity, PNK is a 3´ monophosphatase.)  In contrast, incubation 
of the 5´ cleavage product with poly(A) polymerase and 3 -´dATP converted it to a slower 
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Figure IV - 1.  RISC is an endonuclease.  (A)  In vitro RNAi reactions programmed with 
a firefly luciferase-specific siRNA.  As shown previously (Elbashir et al., 2001a;
Nykanen et al., 2001), this siRNA directs cleavage of a 5 -´32P-radiolabeled sense
luciferase target RNA to yield a 72 nt 5´ cleavage product.  When the same reaction was 
performed using a 7mG(5´)ppp(G) capped, 3´-32P-radiolabeled antisense luciferase target 
RNA, no cleavage product was detected (– NEM).  When the lysate was treated with 
NEM after RISC assembly, a 3´ cleavage product was readily detected.  This 3´ cleavage 
product was 72 nt long, the length predicted if RISC is an endonuclease.  (B)  The 
5´cleavage product was gel isolated and analyzed to determine the structure of its 3´ 
terminus.  The 5´ cleavage product could be extended one nucleotide by treatment with 
poly(A) polymerase (PAP) and 3´ -dATP; its mobility was unaltered by treatment with 
PNK.  Therefore, it contains a 3´ hydroxy terminus.  (C)  The 3´ cleavage product was gel 
isolated and analyzed to determine the structure of its 5´ terminus.  Treating the
3´cleavage product with calf intestinal phosphatase (CIP), produced a species with a 
slower gel mobility.  The mobility of this RNA was restored to that of the original 3´ 
cleavage product after further treatment with PNK and ATP.  The mobility of the 3´ 
cleavage product was unaltered by treatment with PNK alone.  Thus, the 5´ end of the 3´ 
cleavage product must bear a monophosphate.
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Figure IV - 2.  When the RISC was treated with NEM before addition of target RNA, a 
3´ cleavage product was also detected for a 3 -´32P-radiolabeled sod1 target RNA.  The 3´ 
cleavage product has the size expected for endonucleolytic cleavage.
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migrating form, consistent with the addition of a single adenosine to its 3´ end.  This 
result implies the presence of a free 3´ hydroxyl group on the 5´ cleavage product (Figure 
1B).  We note that while poly(A) polymerase can add 3 -´dATP to the 3´ end of an RNA 
chain, it cannot extend the 3´ hydroxyl group present on the 7-methyl
guanosine(5´)ppp(5´) cap (data not shown).
The 3´ cleavage product was treated with calf intestinal phosphatase (CIP), PNK, 
or CIP then PNK.  CIP treatment alone converted the 3´ cleavage product to a slower 
migrating form, compared to the untreated RNA, consistent with the original 3´ cleavage 
product containing one or more 5´ phosphate groups.  Treatment of the dephosphorylated 
sample with PNK and ATP restored its mobility to that of the untreated sample.  No 
change was observed when the RNA was treated with PNK alone.  Together, these results 
indicate that the 3´ cleavage product begins with a single 5´ phosphate group and the 5´ 
cleavage product ends with a 3´ hydroxyl group.
These termini are not consistent with a 2´ hydroxyl group on the target RNA 
acting as a nucleophile to attack the scissile phosphate; such a mechanism would be 
expected to leave a 2´,3´ cyclic phosphate and a 5´ hydroxyl.  Control experiments 
demonstrate that 2´,3´cyclic phosphate and 5´ hydroxyl termini are stable in the in vitro 
RNAi reaction but are nonetheless not found on the cleavage products of RISC (data not 
shown).  After 1 h incubation in NEM-treated lysate in standard RNAi conditions, an 80 
nt, 5 -´7-methyl-guanosine cap-radiolabeled RNA bearing a 2´,3´-cyclic phosphate at its 
3´ terminus was unaltered.  Similarly, a 3 -´radiolabeled RNA bearing a 5´ hydroxyl 
group, but otherwise identical to the 3´ cleavage product described in this manuscript, 
was not converted to a 5´ phosphorylated form.  Thus, the 5´ phosphate and 3´ hydroxy 
termini we observed on the cleavage products of RISC are unlikely to result from
modification after the initial cleavage reaction.
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RISC exhibits dependence on divalent cations
Instead of the 2´ hydroxyl group, a water or hydroxide ion may serve as a nucleophile for 
endonucleolytic cleavage by RISC.  Such enzyme mechanisms often use divalent cations 
to assist in catalysis.  To test whether a divalent metal ion is required for RISC
endonuclease function, siRNA was incubated with Drosophila embryo lysate to assemble 
RISC, and then RISC assembly was inactivated with NEM.  Finally, the siRNA-
programmed RISC was mixed with target RNA and EGTA (to chelate calcium), EDTA 
(to chelate magnesium), or 1,10-phenanthroline (to chelate zinc).  Compared to a reaction 
with no chelator added, the reactions containing either EGTA or 1,10-phenanthroline
showed no decrease in cleavage efficiency.  In contrast, reactions that contained EDTA 
showed a marked decrease in cleavage efficiency at 2 mM chelator; at 5 mM and 10 mM 
EDTA, no cleavage was detected (Figure 3A).
RISC function could be rescued by adding additional Mg2+ after EDTA,
demonstrating that inactivation of RISC by EDTA reflected Mg2+ chelation, not an
unrelated effect (Figure 3B).  Furthermore, EDTA did not cause RISC disassembly, 
because RISC could be incubated with the RNA target in the presence of EDTA for 1 hr 
prior to the addition of Mg2+ (Figure 3C).  RISC was assembled, the assembly was 
quenched with NEM, then EDTA and target RNA added.  The reaction was incubated for 
1hr; no target cleavage occurred.  Next, Mg2+ was added, and the incubation continued
for another hour.  Addition of Mg2+ resurrected RISC activity.  We note that RISC could 
not have fully disassembled in the presence of EDTA and then reassembled when Mg2+
was added because the initial NEM treatment inactivates RISC assembly (Nykanen et al., 
2001; Tomari et al., 2004).  Of course, these data alone cannot exclude that RISC was
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Figure IV - 3.  Endonucleolytic cleavage by siRNA-programmed RISC requires Mg2+.
(A) Standard in vitro RNAi reactions were assembled and pre-incubated for 1 hour at 
25°C, treated with NEM to block further RISC assembly, then 2 mM, 5 mM, or 10 mM 
chelator was added together with 5 -´radiolabled target RNA.  Reactions were incubated 
for an additional 1.5 h.  (B)  Reactions were assembled as in (A) but in one set, additional 
magnesium acetate was added.  (C)  Reactions were assembled as in (A) with 5 mM 
EDTA.  After 1 h incubation of RISC with target RNA in the presence of EDTA, 
magnesium acetate was added and incubation continued for another hour.
165
partially disassembled to an intermediate state whose maturation does not require any 
NEM-sensitive factors and then reassembled to the active form upon Mg2+ addition.
However, such a possibility is inconsistent with our observation below that a nonbridging 
oxygen of the scissile phosphate is likely a ligand for at least one divalent cation.
The scissile phosphate is a Mg2+ ligand
RISC cleaves its cognate mRNA target across from siRNA nucleotides 10 and 11,
measured from the 5´ end of the siRNA guide strand (Elbashir et al., 2001a; Elbashir et 
al., 2001b).  That is, the scissile phosphate of the target RNA lies between nucleotides 11 
and 12, where nucleotide 1 is the target base paired to the twenty-first nucleotide of the 
siRNA guide strand (Figure 4A).  To test whether one or more phosphate groups on the 
target RNA might bind Mg2+ during endonucleolytic cleavage, we prepared five different 
target RNAs, each bearing a single phosphorothioate substitution (Figure 4A).
Phosphorothioate linkages contain a sulfur atom in place of one of the two nonbridging 
oxygens of the phosphodiester bond (Eckstein, 1985) (Figure 4B).  Sulfur, unlike oxygen, 
does not bind well to Mg2+ (Eckstein, 1985; Pecoraro et al., 1984).  Although
phosphorothioate linkages are chiral, we did not resolve the Rp and Sp isomers but, 
instead analyzed the racemic mixture for each substrate RNA.  Of the five singly
substituted phosphorothioate target RNAs, only the RNA with a phosphorothioate
between nucleotides 11 and 12 was detectably impaired for cleavage (Figure 4C).  This 
position corresponds to the scissile phosphate originally identified by Tuschl and
colleagues (Elbashir et al., 2001a; Elbashir et al., 2001b).  Although the
phosphorothioate-substituted target RNA contained both Rp and Sp isomers, cleavage
was blocked by much more than 50%.  Therefore, our data suggest that both the pro-Rp
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Figure IV - 4.  A nonbridging oxygen of the scissile phosphate binds at least one Mg2+
ion.  (A)  Scheme for single phosphorothioate substitution.  The phosphorothioate-
substituted phosphates in the target are indicated by ‘p’ and the scissile phosphate is in 
bold.  (B) An Sp phosphorothioate linkage.  (C) In vitro RNAi reactions were
programmed with a let-7 siRNA duplex. The target RNA contained a 21 nt sequence with
complete complementarity to let-7.  The effect on target cleavage of substituting each 
phosphate indicated in (A) was assessed.  Only when the scissile phosphate was replaced 
by a phosphorothioate was target cleavage impaired.  (D)  The inhibition of cleavage
observed when the scissile phosphate was replaced with a phosphorothioate could be 
rescued by Mn2+, but not by Ca2+ or additional Mg2+.  Mn2+ and Ca2+ reactions also 
contained 1.2 mM Mg2+; indicated Mg2+ concentrations are the concentration added in 
addition to the 1.2 mM basal level contained in a standard RNAi reaction.  Triangles, 
Mg2+; circles, Mn2+; squares, Ca2+.  (E) Rescue of cleavage by Mn2+ requires siRNA.
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and pro-Sp nonbridging oxygens of the scissile phosphate of the RNA target play a role
in siRNA-directed endonucleolytic cleavage of mRNA.
Substitution of a nonbridging oxygen with sulfur might block RISC activity
simply because sulfur is larger than oxygen.  Alternatively, one or both nonbridging
oxygens may be a ligand for Mg2+.  Such a Mg2+ ion might play a role in generating the 
nucleophile (e.g., hydroxide ion) at the active site or in stabilizing the transition state.  If 
a nonbridging oxygen acts as a Mg2+ ligand, then sulfur substitution should be rescued by 
Mn2+, which binds more strongly to sulfur than does Mg2+ (Eckstein, 1985; Pecoraro et 
al., 1984).  Addition of Mn2+, but not Mg2+ or Ca2+, partially rescued the effect of
phosphorothioate substitution at the scissile phosphate (Figure 4D).  Rescue by Mn2+ was 
specific for the phosphorothioate-substituted RNA target; addition of 2 mM Mn2+ did not 
increase the rate of cleavage of a target RNA containing only phosphodiester linkages 
(Figure 5).  Efficient cleavage occurred only in the presence of a complementary siRNA; 
in the absence of siRNA, Mn2+ did not induce target cleavage (Figure 4E).  The simplest 
explanation for our results is that RISC is a Mg2+-dependent endonuclease in which at 
least one nonbridging oxygen of the scissile phosphate directly interacts with the divalent 
cation.
Effects of pdTp inhibitor on endonucleolytic cleavage
The Tudor-SN (TSN) protein is the only purified protein component of RISC that
displays single-stranded, RNA-specific ribonuclease activity.  TSN is a component of the 
RISC in Drosophila, C. elegans, and mammals (Caudy et al., 2003) and is present in 
Drosophila embryo lysates (György Hutvágner and PDZ, unpublished observations).
Three lines of evidence suggest that the nuclease activity of TSN does not mediate
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Figure IV - 5.  Mn2+ does not affect the rate of cleavage of a target RNA containing only 
phosphodiester linkages.  2 mM Mn2+ was added to a standard target cleavage reaction 
after RISC assembly, together with the target RNA.  RISC was programmed with let-7
siRNA duplex, and the target RNA, which had no phosphorothiate linkages, contained a 
21 nt sequence complementary to let-7 (as in Figure 4C).  Open circles, reaction without 
Mn2+; filled circles, reaction with 2 mM Mn2+.  Both reactions contained 1.2 mM Mg2+.
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siRNA-directed endonucleolytic cleavage of target RNA.  First, Staphylococcal nuclease 
homologs are not known to be endonucleases, nor are they expected to leave 3´ hydroxy 
and 5´ phosphate termini after cleavage.  In fact, RNA or DNA hydrolysis by members of 
this class of nucleases yields 3´-phosphomononucleotides and dinucleotides
(Cunningham et al., 1956; Reddi, 1958; Reddi, 1960), inconsistent with the 3´ hydroxy 
terminus we observe for the 5´ cleavage product of RISC.  Second, as a member of the 
Staphylococcal nuclease family, TSN is expected to require Ca2+ for activity (Cuatrecasas 
et al., 1967a).  Our data show that Mg2+, but not Ca2+, is required for siRNA-directed
endonucleolytic cleavage.  Third, 2 -´deoxythymidine 5´,3 -´bisphosphate (pdTp), a
general inhibitor of staphylococcal nucleases (Cuatrecasas et al., 1967a), inhibits TSN 
activity (Caudy et al., 2003), but does not inhibit endonucleolytic cleavage by RISC 
(Figure 6).  We assembled siRNA into RISC and then incubated it with target RNA in the 
presence of 50 μM or 100 μM pdTp, 50 μM or 100 μM 2´-deoxythymidine 3 -´
monophosphate (dTp), or no inhibitor (Figure 6).  5´ cleavage products were efficiently 
formed in all conditions, even though the pdTp concentration was more than 2,000-fold
higher than RISC and ~ 2-fold greater than the Ki reported for inhibition of
Staphylococcus nuclease (Cuatrecasas et al., 1967b).  100 μM pdTp was shown
previously to block TSN activity and RISC-directed target RNA degradation in vitro 
(Caudy et al., 2003).  Our data suggest that if the nuclease activity of TSN functions in 
target RNA destruction, the protein must act after the siRNA-directed, Mg2+-dependent
endonucleolytic cleavage of the target RNA.
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Figure IV - 6.  Endonucleolytic cleavage by siRNA programmed RISC is unaltered by 
the TSN-inhibitor pdTp (2´-deoxythymidine 5´,3´-bisphosphate).  Standard RNAi
reactions were carried out in the absence or presence of 50 μM or 100 μM pdTp, or in the 
presence of 50 or 100μM dTp (2 -´deoxythymidine 3 -´monophosphate).  An sod1-specific
siRNA and sod1 target RNA were used.
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Materials and Methods
General methods
In vitro RNAi reactions using Drosophila embryo lysate were as described
previously (Haley et al., 2003).  Synthetic RNAs (Dharmacon) were deprotected
according to manufacturer’s instructions and annealed as described previously (Elbashir 
et al., 2001a).  The luciferase target RNAs were transcribed with recombinant histidine-
tagged T7 RNA polymerase from a PCR-generated DNA template as described (Haley et 
al., 2003; Hutvagner and Zamore, 2002; Nykanen et al., 2001). sod1 sense target RNA 
was transcribed from a plasmid template (Crow et al., 1997) linearized with BamHI (New 
England Biolabs) as described previously (Schwarz et al., 2003).  Target RNAs were 
used at ~5 nM final concentration and siRNAs were used at 50 nM final concentration.
Chelating agents were prepared with acetate as the counter ion.
siRNA
The luciferase-specific siRNA was composed of the antisense strand 5 -´UCG
AAG UAU UCC GCG UAC GUG-3´ and the sense strand 5 -´CGU ACG CGG AAU 
ACU UCG AUU.  For the sod1 target RNA, the siRNA was composed of the antisense 
strand 5 -´CAC AUU GCG CAA GUC UCC AdTdT-3´and the sense strand 5 -´UGG
AGA CUU GCG CAA UGU GdTdT-3´.  The siRNA corresponding to the sequence of 
the miRNA, let-7, was as described previously (Hutvagner and Zamore, 2002): let-7
strand, 5 -´UGA GGU AGU AGG UUG UAU AGU-3´ and passenger strand, 5 -´UAU
ACA ACC UAC UAC CUC AUU-3´.
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Analysis of cleavage product termini
5´ and 3´ cleavage products were isolated from an 8% denaturing polyacrylamide 
gel.  Reactions were performed with T4 Polynucleotide Kinase (PNK) (New England 
Biolabs) and Calf Intestinal Phosphatase (CIP) (New England Biolabs), according to 
manufacturer’s instructions.  3 -´dATP (Sigma) was used to 3´ end-label RNA (Martin 
and Keller, 1998) using yeast poly(A) polymerase (USB) according to manufacturer’s 
instructions.
Construction of target RNAs bearing a single phosphorothioate substitution.
Target RNAs containing a single phosphorothioate substitution were prepared by 
three-way splinted ligation (Moore and Query, 2000; Moore and Sharp, 1992).  The 5´ 
fragment was in vitro transcribed from a PCR template generated using a plasmid
containing the human sod1 gene (pcDNA3SOD1) (Ding et al., 2003) and the primers 5 -´
AGC TTG GTA CCG AGC TCG-3´ and 5 -´TGT ATA GTC CAA GTC TCC AAC ATG 
CCT CT-3´ (the underlined nucleotides correspond to the first 8 nucleotides of the target 
site for the let-7 siRNA).  The central (5 -´pACC UAC UAC CUC A-3´) and 3´ (5´-pUCG
AAG UAU UCC GCG UAC GUG AUG UUC ACC-3´) fragments were synthesized 
(Dharmacon) and deprotected according to the manufacturer’s protocol.  RNA fragments 
were ligated using high concentration T4 DNA ligase (New England Biolabs) and a DNA 
splint (5´-CGC GGA ATA CTT CGA TGA GGT AGT AGG TTG TAT AGT CCA 
AGT-3´) (IDT).  For example, phosphorothioate substitution between the first and second
bases of the central fragment created an RNA bearing a phosphorothioate linkage
between the ninth and tenth bases of the target site of let-7 siRNA.  The ligation product 
was subsequently 5´ cap 32P-radiolabeled.
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Synthesis of 2´-deoxythymidine 5´,3´-bisphosphate (pdTp)
pdTp was synthesized in a standard kinase reaction containing 1 mM 2 -´deoxythymidine
3´-monophosphate (dTp; Sigma), T4 Polynucleotide Kinase (3´-phosphatase free;
Roche), and 1mM ATP.  dTp controls correspond to reactions carried out in the absence
of dTp, to which 1mM dTp was added after the kinase was heat inactivated at 65°C.
Synthesis was confirmed by thin-layer chromatography PEI-cellulose plates (Baker) in 
0.2M ammonium sulfate.  In this solvent system, the Rf for dTp was 0.64, and the Rf for
pdTp was 0.34.
Acknowledgements
We thank the members of the Zamore lab, Nelson Lau, and Nick Rhind for helpful 
discussions and comments on the manuscript, Zuoshang Xu for sod1 plasmids, and Amy 
Caudy for advice on synthesis of pdTp.  P.D.Z. is a Pew Scholar in the Biomedical 
Sciences and a W.M. Keck Foundation Young Scholar in Medical Research.  This work 
was supported in part by grants from the National Institute of Health to P.D.Z.
(GM62862-01 and GM65236-01).
177
References
Caudy, A. A., Ketting, R. F., Hammond, S. M., Denli, A. M., Bathoorn, A. M., Tops, B. 
B., Silva, J. M., Myers, M. M., Hannon, G. J., and Plasterk, R. H. (2003). A micrococcal 
nuclease homologue in RNAi effector complexes. Nature 425, 411-414.
Chiu, Y. L., and Rana, T. M. (2003). siRNA function in RNAi: a chemical modification 
analysis. Rna 9, 1034-1048.
Crow, J. P., Sampson, J. B., Zhuang, Y., Thompson, J. A., and Beckman, J. S. (1997). 
Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase 
mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J Neurochem
69, 1936-1944.
Cuatrecasas, P., Fuchs, S., and Anfinsen, C. B. (1967a). Catalytic properties and 
specificity of the extracellular nuclease of Staphylococcus aureus. J Biol Chem 242,
1541-1547.
Cuatrecasas, P., Fuchs, S., and Anfinsen, C. B. (1967b). The interaction of nucleotides 
with the active site of staphylococcal nuclease. Spectrophotometric studies. J Biol Chem
242, 4759-4767.
Cunningham, L., Catlin, B. W., and Privat de Garilhe, M. (1956). A deoxyribonuclease of 
Micrococcus pyogenes. J Am Chem Soc 78, 4642-4645.
Ding, H., Schwarz, D. S., Keene, A., Affar el, B., Fenton, L., Xia, X., Shi, Y., Zamore, P. 
D., and Xu, Z. (2003). Selective silencing by RNAi of a dominant allele that causes 
amyotrophic lateral sclerosis. Aging Cell 2, 209-217.
Eckstein, F. (1985). Nucleoside phosphorothioates. Annu Rev Biochem 54, 367-402.
Elbashir, S. M., Lendeckel, W., and Tuschl, T. (2001a). RNA interference is mediated by 
21- and 22-nucleotide RNAs. Genes Dev 15, 188-200.
Elbashir, S. M., Martinez, J., Patkaniowska, A., Lendeckel, W., and Tuschl, T. (2001b). 
Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster 
embryo lysate. Embo J 20, 6877-6888.
Haley, B., Tang, G., and Zamore, P. D. (2003). In vitro analysis of RNA interference in 
Drosophila melanogaster. Methods 30, 330-336.
Holen, T., Amarzguioui, M., Wiiger, M. T., Babaie, E., and Prydz, H. (2002). Positional 
effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor. 
Nucleic Acids Res 30, 1757-1766.
178
Hutvagner, G., and Zamore, P. D. (2002). A microRNA in a multiple-turnover RNAi 
enzyme complex. Science 297, 2056-2060.
Llave, C., Xie, Z., Kasschau, K. D., and Carrington, J. C. (2002). Cleavage of Scarecrow-
like mRNA targets directed by a class of Arabidopsis miRNA. Science 297, 2053-2056.
Martin, G., and Keller, W. (1998). Tailing and 3'-end labeling of RNA with yeast poly(A) 
polymerase and various nucleotides. Rna 4, 226-230.
Martinez, J., Patkaniowska, A., Urlaub, H., Luhrmann, R., and Tuschl, T. (2002). Single-
stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 110, 563-574.
Moore, M. J., and Query, C. C. (2000). Joining of RNAs by splinted ligation. Methods 
Enzymol 317, 109-123.
Moore, M. J., and Sharp, P. A. (1992). Site-specific modification of pre-mRNA: the 2'-
hydroxyl groups at the splice sites. Science 256, 992-997.
Nykanen, A., Haley, B., and Zamore, P. D. (2001). ATP requirements and small 
interfering RNA structure in the RNA interference pathway. Cell 107, 309-321.
Palatnik, J. F., Allen, E., Wu, X., Schommer, C., Schwab, R., Carrington, J. C., and 
Weigel, D. (2003). Control of leaf morphogenesis by microRNAs. Nature 425, 257-263.
Pecoraro, V. L., Hermes, J. D., and Cleland, W. W. (1984). Stability constants of Mg2+ 
and Cd2+ complexes of adenine nucleotides and thionucleotides and rate constants for 
formation and dissociation of MgATP and MgADP. Biochemistry 23, 5262-5271.
Reddi, K. K. (1958). Action of micrococcal phosphodiesterase on tobacco mosaic virus 
nucleic acid. Nature 182, 1308.
Reddi, K. K. (1960). Mode of action of micrococcal phosphodiesterase. Nature 187, 74-
75.
Schwarz, D. S., Hutvagner, G., Du, T., Xu, Z., Aronin, N., and Zamore, P. D. (2003).
Asymmetry in the assembly of the RNAi enzyme complex. Cell 115, 199-208.
Schwarz, D. S., Hutvagner, G., Haley, B., and Zamore, P. D. (2002). Evidence that 
siRNAs function as guides, not primers, in the Drosophila and human RNAi pathways. 
Mol Cell 10, 537-548.
Tang, G., Reinhart, B. J., Bartel, D. P., and Zamore, P. D. (2003). A biochemical 
framework for RNA silencing in plants. Genes Dev 17, 49-63.
179
Tomari, Y., Du, T., Haley, B., Schwarz, D. S., Bennett, R., Cook, H. A., Koppetsch, B. 
S., Theurkauf, W. E., and Zamore, P. D. (2004). RISC assembly defects in the Drosophila 
RNAi mutant armitage. Cell 116, 831-841.
Tuschl, T., Zamore, P. D., Lehmann, R., Bartel, D. P., and Sharp, P. A. (1999). Targeted 
mRNA degradation by double-stranded RNA in vitro. Genes Dev 13, 3191-3197.
Xie, Z., Kasschau, K. D., and Carrington, J. C. (2003). Negative feedback regulation of 
Dicer-Like1 in Arabidopsis by microRNA-guided mRNA degradation. Curr Biol 13, 784-
789.
Zamore, P. D., Tuschl, T., Sharp, P. A., and Bartel, D. P. (2000). RNAi: double-stranded
RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell
101, 25-33.
180
Selective silencing by RNAi of a dominant, disease-
causing ALS allele
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CHAPTER V
Abstract
RNA interference (RNAi) can achieve sequence-selective inactivation of gene 
expression in a wide variety of eukaryotes by introducing double-stranded RNA
corresponding to the target gene.  Here we explore the potential of RNAi as a therapy for 
amyotrophic lateral sclerosis (ALS) caused by mutations in the Cu, Zn superoxide
dismutase (SOD1) gene.  Although the mutant SOD1 is toxic, the wild-type SOD1 
performs important functions.  Therefore, the ideal therapeutic strategy should be to 
selectively inhibit the mutant, but not the wild-type, SOD1 expression.  Because most 
SOD1 mutations are single nucleotide changes, to selectively silence the mutant requires 
single nucleotide specificity.  By coupling rational design of small interfering RNAs 
(siRNAs) with their validation in RNAi reactions in vitro and in vivo, we have identified 
siRNA sequences with this specificity.  A similarly designed sequence, when expressed 
as small hairpin RNA (shRNA) under the control of a RNA polymerase III (pol III) 
promoter, retains the single-nucleotide specificity.  Thus, RNAi is a promising therapy 
for ALS and other disorders caused by dominant, gain-of-function gene mutations.
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Introduction
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that causes motor 
neuron degeneration, skeletal muscle atrophy and paralysis.  This disease is progressive 
and invariably fatal, resulting in the death of the patient within 1 to 5 years after
diagnosis.  At present there is no cure (Rowland and Shneider, 2001).  A fraction of ALS 
is caused by mutations in the Cu, Zn superoxide dismutase (SOD1) gene (Rosen et al., 
1993).  These mutations cause motor neuron degeneration because the mutant protein has 
acquired some toxic property (Cleveland and Rothstein, 2001).  Neither the molecular 
basis of this toxic property nor the way in which the toxic protein triggers motor neuron 
degeneration is understood.  In mice, expression of mutant SOD1, but not complete 
elimination of SOD1, causes ALS.  Nonetheless, SOD1-knockout mice show reduced 
fertility (Matzuk et al., 1998), motor axonopathy (Shefner et al., 1999), age-associated
loss of cochlear hair cells (McFadden et al., 2001) and neuromuscular junction synapses 
(Flood et al., 1999), as well as enhanced susceptibility to a variety of noxious assaults on 
the nervous system, such as axonal injury (Reaume et al., 1996), ischemia (Kawase et al., 
1999; Kondo et al., 1997), hemolysate exposure (Matz et al., 2000) and irradiation
(Behndig et al., 2001).  Given the toxicity of the mutant protein and the functional
importance of the wild-type, the ideal therapy for ALS would selectively block
expression of the mutant while retaining expression of wild-type protein.
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Sequence-selective inactivation of gene expression can be achieved in a wide
variety of eukaryotes by introducing double-stranded RNA corresponding to the target 
gene, a phenomenon termed RNA interference (RNAi) (Hannon, 2002; Hutvagner and 
Zamore, 2002; McManus and Sharp, 2002).  Early mechanistic studies of the RNAi 
pathway (Elbashir et al., 2001b; Hamilton and Baulcombe, 1999; Hammond et al., 2000; 
Zamore et al., 2000) led to its extension to cultured mammalian cells (Caplen et al., 2001; 
Elbashir et al., 2001a).  In this approach, small interfering RNAs (siRNAs), 21 nt, 
double-stranded RNA intermediates in the RNAi pathway, are used to trigger the
destruction of an mRNA containing the siRNA sequence.  More recent experiments
indicate that small hairpin RNAs (shRNAs) transcribed in vivo can trigger degradation of 
a corresponding mRNA, because shRNAs are processed into siRNAs in cells
(Brummelkamp et al., 2002b; Jacque et al., 2002; Lee et al., 2002; McManus et al., 2002; 
Miyagishi and Taira, 2002; Paddison et al., 2002; Paul et al., 2002; Sui et al., 2002; Yu et 
al., 2002; Zeng et al., 2002).  These technical advances raise the possibility that siRNA 
duplexes or viruses expressing shRNA may be used to block the expression of a mutant 
gene.
Because the vast majority of ALS-causing SOD1 mutations are single-nucleotide
point mutations that alter a single amino acid in the protein (http://www.alsod.org/), the 
first step in developing RNAi therapy is to identify siRNA and shRNA sequences that 
can selectively silence the expression of mutant, but not wild-type, protein with single-
nucleotide specificity.  RNAi is a promising strategy for allele-specific silencing, but the 
design of siRNAs with single-nucleotide specificity is not straightforward.  siRNAs that 
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differ from the sequence of their target RNA at one or more nucleotides retain efficacy in 
some cases (Boutla et al., 2001; Holen et al., 2002) and lose activity in others (Boutla et 
al., 2001; Brummelkamp et al., 2002a; Brummelkamp et al., 2002b; Elbashir et al.,
2001c; Yu et al., 2002).  Here we coupled rational design with validation in RNAi 
reactions in vitro and in vivo, and developed siRNA and shRNA sequences that
selectively silence two mutant SOD1 alleles but not the wild-type.  These sequences can 
be developed further to treat ALS caused by these SOD1 mutations.
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Results
Mechanistic studies suggest that formation of an A-form helix between the siRNA and its 
mRNA target is required for mRNA cleavage (Chiu and Rana, 2002).  We reasoned that 
mismatches at or near the site of target cleavage would disrupt the required A-form helix.
We targeted an allele of SOD1 in which guanosine 256 (G256, relative to the start of 
translation) is mutated to cytosine, generating a glycine-to-arginine mutation (G85R).
We placed the mismatch at positions 9, 10, and 11 from the 5´  end of the siRNA.  The 
G256C mutant/wild-type pair produces the largest possible clash (purine:purine) between 
the mutant siRNA and the wild-type gene and the greatest hydrogen-bonding (G:C) 
between the mutant siRNA and the mutant SOD1 allele (Fig. 1A).  As controls, we 
synthesized comparable siRNAs to target wild-type but not mutant SOD1 mRNA (Fig. 
1A).  In the controls, the siRNAs contain a G:C base pair at the selective site, but the 
mismatch between wild-type siRNA and mutant allele is a smaller pyrimidine:pyrimidine
clash (C:C).  The selectivity of each siRNA was tested in a cell-free RNAi reaction 
containing Drosophila embryo lysate (Tuschl et al., 1999; Zamore et al., 2000) (Fig. 1B 
and 1C).
Each of the six siRNAs cleaved the corresponding target RNA, although with 
dramatically different efficiency (Fig. 1B).  For example, neither mutant nor wild-type
p11 siRNAs cut their respective RNA targets with a rate expected to be effective in vivo.
On the other hand, the p10 mutant siRNA efficiently cleaved the mutant SOD1 mRNA.
In all cases, destruction of full-length target mRNA was accompanied by a corresponding 
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accumulation of a ~288 nt 5´ cleavage product, demonstrating that the siRNAs trigger 
RNAi, rather than non-specific RNA degradation (Fig. 1B).  In the absence of siRNA or 
in the presence of an unrelated siRNA, the mutant SOD1 target RNA was stable in the 
Drosophila embryo lysate (data not shown).  Data for both the destruction of target RNA 
and the accumulation of 5´ cleavage product fit well to a single exponential equation, 
indicating that the reaction follows pseudo first-order kinetics (Fig. 1C).
To determine the selectivity of the six siRNAs, each siRNA corresponding to the 
mutant SOD1 sequence was tested for its ability to cleave wild-type SOD1 mRNA, and 
each wild-type siRNA was tested for its ability to cleave mutant mRNA.  Some but not 
all of the siRNA duplexes effectively discriminated between the target to which they 
were perfectly matched and the target with which they had a single-nucleotide mismatch 
(Fig. 1B).  We observed two types of defects for a subset of siRNAs.  Both wild-type and 
mutant p11 siRNA did not trigger efficient target cleavage of either the perfectly matched 
or the mismatched RNA target (Fig. 1B). Thus, these siRNA sequences are inherently 
poor triggers of RNAi.  The p9 and p10 wild-type siRNAs not only triggered rapid
cleavage of their corresponding wild-type target, but also produced significant cleavage 
of the mutant RNA (Fig. 1B).  These siRNAs are good triggers of RNAi but show poor 
selectivity.  In contrast, the p10 mutant siRNA showed both efficient RNAi and robust 
discrimination between mutant and wild-type SOD1 RNAs, cleaving the mutant far more 
efficiently than the wild-type RNA in the cell-free reaction (Fig. 1B and 1C).  Because 
this siRNA showed nearly complete discrimination between mutant and wild-type SOD1 
mRNA targets (Fig. 1B and 1C), it is an ideal candidate for therapeutic application.
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Figure V - 1. siRNA duplexes can discriminate between mutant and wild-type SOD1 in 
vitro.  (A) siRNA duplexes used.  (B) In vitro RNAi experiments targeting mutant or 
wild-type SOD1 mRNA with mutant or wild-type siRNAs.  (C) Mutant siRNA p10 
targets mutant (red curves) but not wild-type SOD1 (blue curves) mRNA for destruction
by the RNAi pathway.
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To test whether the cell-free reactions accurately predict siRNA efficacy and 
selectivity in mammalian cells, we analyzed the siRNAs in a HeLa cell assay.  We 
prepared plasmids that expressed either SOD1WT or SOD1G85R with GFP fused to their 
carboxyl terminus.  Each construct was transfected into HeLa cells together with both 
siRNA and a dsRed-expressing vector that served as a transfection control.  The
expression of either mutant or wild-type SOD1 was monitored by fluorescence-activated
cell sorting (FACS).  Transfection of p9, p10 and p11 siRNAs with their corresponding 
mutant or wild-type targets suppressed gene expression, although with distinctly different 
efficiency and selectivity (Fig. 2).  Co-transfection with an siRNA complementary to 
firefly luciferase did not suppress either SOD1 allele (Fig. 2).  As observed in the cell-
free reactions, the p10 siRNA against wild-type SOD1 showed no selectivity and
suppressed both wild-type and mutant SOD1 mRNA (Fig. 2).  The other siRNAs all
showed some degree of selectivity, but the p10 siRNA directed against the SOD1 mutant 
mRNA showed both the greatest efficacy and selectivity, in agreement with the results of 
the cell-free reactions.  Thus, some but not all siRNAs can efficiently discriminate
between mRNA targets with a single-nucleotide difference.
Recently, it has been shown that shRNAs can trigger RNAi in vivo.  To test
whether shRNA against mutant SOD1 can selectively block the expression of the mutant, 
but not the wild-type, SOD1 expression, we constructed a plasmid that synthesizes a 
shRNA homologous to another disease-causing mutant SOD1G93A (Sui et al., 2002).  This 
mutant was examined because, like the SOD1G85R, it is a guanosine to cytosine change at 
281st neucleotide, thus placing a G:G mismatch at the selective site between the shRNA
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Figure V - 2. Selective inhibition of mutant SOD1G85R expression by siRNA in Hela 
cells. SOD1WT-GFP or SOD1G85R-GFP was cotransfected with various siRNAs.  DsRed 
was cotransfected as a transfection control.  Green and red fluorescent cells were
quantified using FACS.  (A) Raw FACS cell counts, (B) relative number of green and red 
cells in the transfections (n=3). Error bars represent standard deviation.
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and wild type SOD1 (Fig. 3A).  When co-transfected separately with mutant SOD1-GFP
or wild-type expressing plasmid, this hairpin construct inhibited mutant, but not the wild-
type, expression (Fig. 3).  Thus, hairpin constructs can be used to trigger single-
nucleotide selective RNAi of mutant SOD1 in cultured cells.  To test if mutant-selective
inhibition can be achieved in neuronal cells, we separately transfected the wild-type or 
mutant SOD1-GFP constructs with either siRNA p10 against SOD1G85R or shRNA-
synthesizing vector against SOD1G93A into the neuroblastoma cell line N2a.  As in HeLa 
cells, both synthetic siRNAs and shRNA constructs directed the selective inhibition of 
mutant SOD1 expression in N2a cells (Fig. 4A, B).
To be therapeutically relevant, single-nucleotide selective siRNAs must
discriminate between mutant and wild-type SOD1 when both mRNAs are present in the 
same cell.  We transfected HeLa cells with p10 siRNAs and mutant SOD1G85R -GFP, and 
analyzed SOD1 protein expression by immunoblotting with anti-SOD1 antibody that
recognizes both the transfected SOD1G85R -GFP fusion protein and endogenous wild-type
SOD1.  As expected, p10 siRNA against wild-type SOD1 inhibited both the endogenous 
wild-type SOD1 and the transfected SOD1G85R –GFP (Fig. 5).  The near 50% inhibition 
of the endogenous wild-type SOD1 expression probably reflected the transfection
efficiency, which was ~50%.  In contrast to the p10 wild-type siRNA, at two different 
doses, p10 siRNA against the mutant inhibited expression of the mutant, but had no effect 
on the expression of endogenous wild-type SOD1 (Fig. 5).  No additional selectivity was 
seen with a 3 -´blocked siRNA, consistent with reports that siRNAs do not function as 
primers to trigger the production of ‘secondary siRNAs’ in human cells (Chiu and Rana,
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Figure V - 3.  Selective inhibition of mutant SOD1G93A expression by U6-G93A vector in 
Hela cells.  (A) Design of the G93A shRNA.  Bold letters mark nucleotides that match 
SOD1 sequence.  The pink letter marks the mismatched nucleotide.  (B) SOD1WT-GFP or 
SOD1G93A-GFP was cotransfected with U6-empty or U6-G93A (U6 constructs:SOD1-
GFP = 5:1).  DsRed was cotransfected as a transfection control (SOD1-GFP:DsRed = 
4:1).  Green and red fluorescent cells were quantified using FACS.  Results from four 
experiments were averaged.  Error bars represent standard deviation.
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Figure V - 4. Selective inhibition of mutant SOD1 expression by siRNA and U6-G93A
vector in neuroblastoma N2a cells.  Green and red fluorescent cells were quantified using 
FACS.  (A) siRNA against SOD1G85R (n=4), (B) U6-G93A vector (n=3). Error bars 
represent standard deviation.
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Figure V - 5. Selective inhibition of mutant SOD1 G85R but not the wild type SOD1 
expression by siRNA in the same cells.  (A) Protein blots of the transfected Hela cells 
detecting mutant SOD1G85R-GFP and endogenous human SOD1.  (B) Relative levels of 
SOD1 measured from the protein blots (average of 4 transfections).  Error bars are
standard error.
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2002; Holen et al., 2002; Schwarz et al., 2002), as they do in nematodes (Sijen et al., 
2001).
Finally, to test whether this selective inhibition can occur in vivo, we transfected 
SOD1 reporters and shRNA plasmid into mice using the hydrodynamic transfection
protocol.  Mutant SOD1G93A-GFP and myc-tagged wild-type human SOD1 expression 
plasmids were used, enabling detection of mutant and wild-type human SOD1 proteins, 
as well as the endogenous mouse SOD1 by immunoblotting.  We analyzed SOD1
expression in liver, a tissue readily transfectable by the hydrodynamic method.  Under 
these conditions, the shRNA-expressing plasmid selectively decreased mutant but not
wild-type human SOD1 expression (Fig. 6).
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Figure V - 6. Selective inhibition of mutant SOD1 expression by U6-G93A vector in 
vivo.  (A) SOD1G93A-GFP was cotransfected with a C-terminal myc tagged wild type 
human SOD1 in mice using the hydrodynamic transfection method.  Liver proteins were 
resolved on SDS-PAGE and detected using anti-SOD1 antibody.  (B) The relative band 
intensities were quantified. The ratio of SOD1G93A-GFP to wild type SOD1myc is shown. 
Eight animals were used in each group.  The U6-G93A group is significantly different 
from the other two groups (p < 0.05) by Hohm’s modified Bonferroni procedure for 
multiple t tests.
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Discussion
We have found siRNA and shRNA sequences that selectively silence two dominant
mutant SOD1 genes.  Using multiple siRNAs matching either wild-type or mutant SOD1, 
we show that a subset of siRNAs against mutant SOD1 cleave the mutant, but not the 
wild-type SOD1 RNA efficiently in vitro (Fig. 1).  Those siRNAs that show both efficacy 
and selectivity in vitro also selectively inhibit mutant but not wild-type SOD1 protein 
expression in mammalian cells (Fig. 2, 4), even when both the mutant and the wild-type
proteins are present in the same cells (Fig. 5).  Furthermore, a vector expressing shRNA 
similarly designed according to the optimal siRNA also selectively inhibited mutant but 
not wild-type SOD1 expression in mouse liver (Figs. 3, 4, 6). These results demonstrate 
that selective inhibition of dominant mutant SOD1 alleles can be achieved using RNAi 
and the optimal siRNA and shRNA sequences can be identified by a preclinical screen in 
vitro and in vivo.
Our search for siRNA sequences optimized for selective silencing of the mutant 
but not the wild-type SOD1 reveal that single nucleotide discrimination is not guaranteed.
Some siRNAs can discriminate between alleles that differ at a single nucleotide, whereas 
others cannot.  Our results point to two different types of deficiencies for siRNAs 
designed to target mutant, disease-causing alleles.  First, not all siRNAs silence with the 
same efficiency.  Among the siRNAs directed against wild-type SOD1, p9 and p10 
cleave the target more efficiently than p11 (Fig. 1).  As predicted by analysis in cell-free
RNAi reaction, the p10 siRNA inhibited target gene expression most efficiently in
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mammalian cells (Fig. 2).  Among the siRNAs against the mutant SOD1G85R, p9 and p10 
cleave the mutant far more than P11 (Fig. 1).  As in the cell-free assay, p10 was the most 
efficient siRNA in inhibiting the mutant SOD1 expression in mammalian cells (Fig. 2).  It 
is intriguing that displacing the siRNA along the target sequence by a single nucleotide 
results in such a dramatic change in silencing efficiency.  Second, significant differences
in selectivity between the perfectly matched target RNA and the RNA bearing a single-
nucleotide mismatch were observed among the six siRNAs used.  For example, wild-type
p10 siRNA had poor selectivity; it cleaved both wild-type and mutant SOD1 RNA in the 
cell-free assay and efficiently inhibited the expression of both alleles in mammalian cells 
(Figs 1, 2, 4, 5).  In contrast, the p10 siRNA directed against mutant SOD1 showed 
nearly perfect selectivity.  It cleaved mutant SOD1 RNA but not wild-type, in the cell-
free assay, and inhibited mutant but not wild-type SOD1 expression in mammalian cells 
(Figs 1, 2, 4, 5).
Our results raise questions regarding the rules in designing optimal siRNAs or 
shRNAs for single nucleotide discrimination.  Among the contributing factors is the type 
of mismatch at the critical site p10.  We predict that a purine:purine mismatch disrupts 
the A-form helix that is required between the anti-sense strand of the siRNA and its 
mRNA target (Chiu and Rana, 2002).  In contrast, a pyrimidine:pyrimidine mismatch 
may more readily be accommodated within an A-form helix.   Thus, the G:G clash
between the siRNA and the wild-type target RNA discriminates against the wild-type
target, producing greater selectivity for the mutant target, whereas the presence of a G:C 
basepair between the mutant siRNA and the mutant target mRNA at the selective site 
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may serve to maximize the energy difference between mismatch and perfect pairing (see 
Figs. 1A, 3A).  Consistent with this view, in Drosophila embryos, an siRNA having a 
pyrimidine:purine mismatch (C:A) with its target mRNA was only slightly less effective 
than the perfectly matched siRNA (Boutla et al., 2001).  Moreover, an siRNA directed 
against firefly luciferase failed to produce detectable RNAi in vitro when it contained at 
position 9 or 10 of its guide strand a purine:purine (A:A) mismatch with its target
RNA(Elbashir et al., 2001d).  Likewise, an siRNA that showed good selectivity for a 
mutant Ras mRNA created a purine:purine (A:G) clash with the wild-type allele (Elbashir 
et al., 2001c).  Similarly, an siRNA that showed good selectivity for a mutant Ras mRNA 
created a purine:purine (A:G) clash with the wild-type allele (Brummelkamp et al., 
2002a).  Arguing against this view, one experiment using siRNA against hTF suggests 
that a G:G mismatch can still mediate RNAi, albeit with reduced efficiency (Holen et al., 
2002).  It is possible that this was due to high concentration of siRNA used.  Another 
experiment using shRNA against CDH-1 suggest that a U:C or a U:G mismatch
abolished RNAi (Boutla et al., 2001).  In light of our demonstration that small differences 
in siRNA sequence can produce dramatic differences in efficacy, rather than selectivity, it 
remains to be shown if these inactive shRNAs were active against a perfectly matched 
target, and not merely poor triggers of RNAi in general.  Clearly, further work is required 
to clarify the rules in designing siRNA and shRNA sequences optimized for selective 
silencing of mutant alleles with single nucleotide specificity.
Taken together, we have identified siRNA and shRNA sequences that can
selectively down-regulate the expression of mutant but not the wild type SOD1, even 
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when the mutant mRNA differs from wild-type by a single nucleotide.  Because the
shRNA-synthesizing plasmid construct can be readily incorporated into viral vectors
(Brummelkamp et al., 2002a; Devroe and Silver, 2002; Xia et al., 2002), these siRNA 
and shRNA sequences can be readily placed in virus-based delivery systems to treat ALS 
caused by mutant SOD1 expression.  In broad terms, our results show the promise of 
RNAi as a therapeutic strategy to diseases caused by dominant, gain-of-function gene 
mutations.
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Materials and Methods
RNA and DNA constructs
Twenty one nucleotide single strand RNAs (Fig. 1) were purchased from
Dharmacon Research, deprotected according to manufacturer’s instructions, and annealed 
as described (Nykanen et al., 2001). The 3'-block siRNA was synthesized a 2',3'-dideoxy
cytidine at the 3' terminus of the antisense strand. To create wild type and mutant SOD1-
GFP fusion proteins, SOD1WT, SOD1G85R and SOD1G93A cDNAs (kind gifts of Dr.
Joseph Beckman) were PCR cloned between the PmlI and PstI sites of
pCMV/myc/mito/GFP (Invitrogen). This cloning step deleted the mi tochondrial targeting 
sequence. To create myc tagged wild type SOD1, SOD1wt cDNA was PCR cloned
between the PstI and XhoI sites of pCMV/myc/mito/GFP. The mitochondrial targeting 
sequence was then deleted by digestion with BssHII and PmlI and blunt ligation. All 
constructs were verified by sequencing. DsRed (pDsRed2-C1) was purchased from
Clontech (Palo Alto, CA). U6-G93A was constructed as described (Sui et al., 2002) (Fig. 
3).
In vitro RNAi assay
Drosophila embryo lysates were prepared as previously described (Tuschl et al., 
1999; Zamore et al., 2000).  Five hundred and sixty nucleotide human SOD1 target
RNAs containing either wild-type or mutant SOD1 G85R coding sequence were cap-
labeled using Guanylyl transferase as described previously (Zamore et al., 2000).  In vitro 
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RNAi reactions were carried out in Drosophila embryo lysate by incubating ~5 nM of the 
5´, 32P-cap-radiolabeled target RNA with 100 nM duplex siRNA at 25°C in a standard 
reaction (Tuschl et al., 1999; Zamore et al., 2000).  Cleavage products were analyzed on 
5% denaturing acrylamide gels, dried, and exposed on image plates (Fuji).  Plates were 
scanned using a Molecular Imager FX (Biorad), and images were analyzed using
Quantity One version 4.0.3 (Biorad).
Cell culture and transfection
Hela cells were cultured in DMEM and N2A cells in DMED and Opti-MEM
(1:1), both supplemented with 10% fetal bovine serum (FBS), 100 units ml -1 penicillin, 
and 100 ug ml-1 streptomycin. Twenty-four hours before transfection, cells (70-90%
confluency) detached by trituration, transferred to 6-well plates and cultured in fresh 
medium without antibiotics. Transfection was carried out using lipofectamine 2000
(invitrogen) according to manufacturer’s instructions. The amounts of the constructs used 
in transfections are 4 μg each of mutant or wild type SOD1-GFP and DsRed plasmids, 
4x10-11 or 4x10-12 mole siRNAs, and 20 or 8 μg U6-G93A, unless stated otherwise.
In vivo transfection
Twenty four mice 6-8 weeks old were divided into three groups.  The first group 
received no shRNA vector, the second group received 20 μg empty vector and the third 
group received 20 μg U6-shRNA vector against SOD1 G93A.  All groups received both 
20 μg of myc tagged human wild type SOD1 and 20 μg GFP tagged SOD1.  The vectors 
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were diluted in Ringer’s solution so that the total volume equaled 2.5 ml per mouse. Mice 
were anaesthetized with avertin (240mg/kg) and the vectors were injected into the tail 
vein using a 26-gauge needle in less than 10 seconds. Forty eight hours following
injection animals were perfused with 5ml PBS in order to remove blood from the liver.
Livers were dissected and quickly frozen on dry ice. Samples were placed in 25 mM PBS 
buffer (pH 7.2) containing 1% SDS, 1 mM DTT, 1 mM phenylmethylsufonyl fluoride 
(PMSF), and protease inhibitor cocktail (Sigma, diluted 1:100) and homogenized using a 
hand held polytrone (Pro-scientific).
Western blot analysis
Protein concentrations were determined using a BCA protein assay kit (Pierce;
Rockville IL).  Twenty five μg Hela cell proteins or 100 μg liver proteins were separated 
on a 15% SDS-PAGE gel and transferred onto Genescreen Plus membrane (Perkin
Elmer). Rabbit anti-SOD1 (Biodesign) or Sheep anti-SOD1 was the primary and HRP-
labeled goat anti-rabbit IgG (Amersham) or donkey anti-sheep IgG was the secondary 
antibodies.  The protein bands were visualized using SuperSignal kit (Pierce) and Kodak 
Digital Image Station 440CF. The intensity of the bands was quantified using Kodak 1D 
software.
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Application of Functionally Asymmetric siRNA Design 
to Single Nucleotide Discrimination
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The work presented in Chapter 5 was a collaborative effort among three labs.
Specifically, Hongliu Ding in Zuoshang Xu's lab conducted HEK293T cells transfections
to study the SOD1 point mutations.  Lori Kennington and Jess Moore performed the 
HeLa cell transfections to look at the siRNAs targeting Huntingtin, as well as artificial 
point mutations designed to study additional siRNAs. Rosetta performed real-time and
microarray experiments assaying wildtype SOD1 levels. I performed all in vitro RNAi 
experiments, as well as data analysis, experimental design, writing of the manuscript and 
figure preparation.
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CHAPTER VI
Summary
The discovery of RNA interference (RNAi), a sequence-specific post-
transcriptional silencing pathway found in eukaryotes, offers a means to target mutant 
alleles of genes causing dominant, gain of function human disease. Specifically, small 
interfering RNAs (siRNAs) can be used to knock-down the expression of an allele that 
differs by a single nucleotide.  Although this approach is promising, the exact details of 
single nucleotide discrimination have not been studied on an extensive basis.  Here we 
identify several siRNAs that are capable of discriminating between a single nucleotide 
mismatch in the wild-type and mutant alleles in the human Cu, Zn superoxide dismutase 
(SOD1) gene, which contributes to the progression of amyotrophic lateral sclerosis (ALS) 
through the gain of a toxic property, as well as single nucleotide polymorphisms in the 
huntingtin (htt) gene which may be linked to CAG-repeat expansion leading to
Huntington's disease. In addition, by designing artificial point mutations we show that 
siRNAs in which the mismatch is located in the region responsible for binding display 
lower levels of selectivity.  In contrast, when the mismatch is located in the region critical 
for catalysis or in the 3´ region of the siRNA, it results in a higher probability of
discriminating between alleles.
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Introduction
In principle, RNA interference (RNAi), a conserved, sequence-specific pathway found in 
eukaryotes, provides a means to selectively inhibit expression of a mutant form of a gene 
while leaving expression of the wild-type copy unperturbed.  RNAi is mediated by small 
interfering RNAs (siRNAs), 21–22 nt double-stranded RNAs.  Synthetic siRNAs provide 
a straightforward means to knock-down gene expression in cultured cells (Elbashir et al., 
2001a) through incorporation as single strands (Martinez et al., 2002a) into a protein-
RNA complex known as the RNA-Induced Silencing Complex (RISC) (Hammond et al., 
2000; Martinez et al., 2002a; Nykanen et al., 2001).  When the siRNA is complimentary 
to its mRNA target, the siRNA will direct endonucleolytic cleavage of the mRNA at a 
single scissile phosphate across from nucleotides 10 and 11 in the siRNA, triggering
mRNA destruction (Elbashir et al., 2001b; Hamilton and Baulcombe, 1999; Hammond et 
al., 2000; Zamore et al., 2000).  Both strands of an siRNA can be competent in directing 
endonucleolytic cleavage if a cognate mRNA is present (Elbashir et al., 2001b; Harborth 
et al., 2001; Nykanen et al., 2001; Schwarz et al., 2003).
However, it has recently been shown that the thermodynamics of the 5´ ends of
the siRNA strands determine the degree to which each of the siRNA strands can enter 
RISC leading to target mRNA destruction (Khvorova et al., 2003; Schwarz et al., 2003).
Some siRNAs exhibit near absolute asymmetry, termed functional asymmetry, in which
only one strand of the siRNA is capable of entry into the RISC with the exclusion of the 
other strand (Schwarz et al., 2003).
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It has been shown that certain mismatches between an siRNA and an mRNA can 
block mRNA cleavage by RISC (Amarzguioui et al., 2003; Boutla et al., 2001;
Brummelkamp et al., 2002a; Brummelkamp et al., 2002b; Elbashir et al., 2001c; Harborth 
et al., 2001; Holen et al., 2002; Yu et al., 2002). Thus, siRNAs can discriminate between 
mRNAs that differ at a single base pair, suggesting the potential application of this 
mechanism in suppressing dominant mutant genes in diseases including ALS (Ding et al., 
2003; Maxwell et al., 2004; Ralph et al., 2005; Raoul et al., 2005), Huntington's (Harper 
et al., 2005), Alzheimer’s (Miller et al., 2004), human immunodeficiency disorder (HIV) 
(Lee et al., 2005; Li et al., 2005), slow channel congenital myasthenic syndrome
(SCCMS) (Abdelgany et al., 2003) and cancer (Martinez et al., 2002b).  Because these 
siRNAs target single nucleotide polymorphisms, their design is limited to the region
surrounding the mutation.
Previous studies have examined whether mismatches at the central region of the 
siRNA, positions 9 to 11 (Ding et al., 2003), can prevent cleavage of the target mRNA by 
RISC through potential disruptions to the A-form helix (Chiu and Rana, 2002).
However, the understanding of the selectivity of these siRNAs was unclear because even 
perfectly paired siRNAs (mutant siRNA sequence targeting a mRNA harboring the
mutant sequence) displayed varying degrees of silencing.  Thus, comparing
discrimination among siRNAs capable of varying levels of silencing under perfectly
paired conditions complicated the analysis.  In addition, another subset of small non-
coding RNAs known as microRNAs (miRNAs), normally pair with their target genes in 
an imperfect fashion leading to translational repression (Olsen and Ambros, 1999).  One 
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group reported that siRNAs displaying imperfect pairing to target mRNAs lead to
translational repression (Saxena et al., 2003).  Therefore, it was also unclear at what level 
single nuncleotide mismatched siRNA:mRNA target pairs were disrupting gene
expression.
Amyotrophic lateral sclerosis (ALS) is an age-dependent neurodegenerative
disease that can be caused by sporadic or dominantly inherited point mutations in the Cu, 
Zn superoxide dismutatse gene (SOD1) (Rosen et al., 1993) which prevents cellular
damage by destroying free oxygen radicals released from metabolic processes (Kinouchi 
et al., 1991).  Point mutations in the SOD1 gene have been linked to the acquisition of a 
toxic property of the mutant protein, the mechanism of which is not yet understood 
(Cleveland and Rothstein, 2001).  With several point mutations clinically identified, one 
possible therapy to ameliorate the symptoms of ALS would be to selectively eliminate 
the mutant copy of the SOD1 gene.  It is imperative to only target and destroy the mutant 
allele, because destruction of the wild-type gene has been shown to lead to developmental 
and neuronal defects (Flood et al., 1999; McFadden et al., 2001; Shefner et al., 1999), as 
well as reduced fertility (Matzuk et al., 1998), as seen in knockout mice.  Huntington's 
disease is a neurodegenerative disorder characterized by motor and cognitive symptoms, 
and cell death in the cortex and striatum (Vonsattel and DiFiglia, 1998).  The onset of the 
disease is linked to the expansion of a CAG repeat in exon 1, which is postulated to be 
linked to point mutation within the coding region of the htt gene (1993).
By examining various siRNA parameters (sequences, positions, and mismatches), 
we have identified siRNAs that silence the G85R point mutation in SOD1 which causes 
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the familial form of ALS, but leave the wild-type copy intact.  In addition, siRNAs were 
designed to target known htt SNPs that may be correlated with the CAG repeat
expansion.  In this study we utilize frayed siRNAs that incorporate more efficiently into 
RISC to compare the ability of each siRNA to discriminate between alleles.  In addition, 
we examine different nucleotide mismatches (purine:purine, purine:pyrimidine, or
pyrimidine:pyrimidine), either based on sod1 or htt mutant alleles, as well as engineered 
point mutations, between an siRNA and its target mRNA to determine the level of
discrimination that can be achieved based on sequence content in both cultured cells and 
Drosophila embryo lysate.  By placing the mismatch at every position along the
siRNA:target RNA pair, we show that the selectivity of the siRNA is based on the region 
in which that mismatch is located, in addition to the nature of the mismatch.  Regions 
contributing to binding of RISC to the target RNA are not optimal for designing
discriminating siRNAs as these siRNAs can be capable of silencing either allele.
However, regions critical for catalysis and maintenance of a central A-form helix display 
a higher probability of support single nucleotide discrimination.   We conclude that the 
nature of the mismatch, as well as the location of the siRNA mismatch with the target 
mRNA, determines the level of discrimination that can be achieved between alleles
differing in a single nucleotide.
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Results
A tiled set of siRNAs targeting mutant SOD1
A set of 19 siRNAs was designed to recognize the G85R point mutation of human SOD1 
(Figure 1A).  Each siRNA was shifted one nucleotide down across the region of the 
mutation site to create a tiled set such that the region each siRNA targeted was shifted 
over 1 nucleotide.  Since siRNA strands incorporate into RISC asymmetrically
(Khvorova et al., 2003; Schwarz et al., 2003), we designed the siRNA strands in this 
study to have “frayed”, or unpaired, 5´ ends such that they require less energy to unwind 
and facilitate the entry of that strand into RISC.  This allows for high levels of RISC to be 
made which contain the strand of the siRNA complementary to the mRNA, or the guide 
strand, and to minimize any differential effects of RISC entry when comparing the
efficacies of different siRNAs.
Using this strategy we were able to make each siRNA containing the mutant
sequence effective at targeting a perfectly matched mutant target, and in turn allows for 
the assessment of each siRNA in its ability to discriminate between alleles that differ at a 
single nucleotide (Figure 1B).  These siRNAs were specifically designed to target the 
mutant sequence, which contains a C, as opposed to the wild-type sequence which
contains a G at that position.  These siRNAs perfectly match the mutant target, but
contain a G:G mismatch when introduced to the wild-type target.  We have previously 
shown that mismatches placed at the central position of the siRNA, nucleotides 9, 10, and 
11, display allele-specific discrimination (Ding et al., 2003).  Here, using the highly
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Figure VI - 1. In vitro analysis of tiled siRNAs.  (A)  Sequences of the guide strands of 
the siRNAs used.  The third nucleotide from the 3´ end of the sense strand of the siRNA 
(not shown) was altered to result in a frayed siRNA facilitating the entry of the guide 
strand into RISC.  If the 5´ end of the guide strand was a U, the sense strand was changed 
to a C and vise versa.  If the 5´ end of the guide strand was a G, the sense strand was 
changed to an A and vise versa.  Each siRNA is shifted down one nucleotide across the 
site of the point mutation resulting in a set of 19 siRNAs. The mutant and wild-type
mRNA sequences that are targeted by the siRNAs are shown at the bottom.  Mutant 
siRNAs match mutant targets, but mutant siRNAs resulting a G:G mismatch when
presented to the wild-type target mRNA.  (B)  Rates of cleavage as determi ned by the 
fraction target cleaved by each siRNA when introduced to a mutant target (filled circle) 
or a wild-type target (open circle) in Drosophila embryo lysate.  (C)  Comparison of an 
unfrayed p11 siRNA and frayed p11 siRNA as a means to determine levels of single 
nucleotide discrimination.
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effective frayed siRNAs we show that additional positions can also display
discrimination using our in vitro Drosophila embryo lysate system.
An unfrayed siRNA (p11) that was used in our previous studies appeared to 
exhibit high levels discrimination because the perfectly paired mutant mRNA is cleaved, 
while non-cognate wild-type mRNA that results in a single nucleotide mismatch is not 
cleaved (Figure 1C).  However, this mutant siRNA was not highly active when it was
introduced to the perfectly matched, mutant target.  This result complicates the analysis 
of siRNA discrimination because siRNA specificity was masked by the unfavorable
incorporation of the guide strand into RISC.  Here, when the 5´ end of the guide strand is 
frayed, facilitating the incorporation of the guide strand into RISC to a greater extent, it 
becomes clear that this siRNA does not display high levels of discrimination.  By
analyzing the complete tiled set of frayed siRNAs, specifically nucleotides 5, 9, 10, 13, 
14, 15, and 16, siRNAs that show high levels of discrimination can be identified (Figure 
1B).  Additionally, nucleotides 12 and 19 display discrimination, but these siRNAs do not 
show robust silencing against a perfectly matched mutant target even when the 5´ end of 
the guide strand is frayed.
Using the same tiled set of siRNAs, we analyzed the initial rate of cleavage, in the 
linear range, using single turnover conditions (Figure 2).  This results in a more
quantitative measure of activity, or rate of reaction, because most siRNAs are near the 
point of saturation (Figure 1) by 15 minutes.  In addition, shorter time points performed 
in enzyme excess gives an indication of the active amounts of RISC formed from each
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Figure VI - 2.  Initial rates of siRNA-mediated cleavage. In vitro reactions were
performed in vast excess of RISC over substrate RNA in order to ensure single turnover 
conditions.  The linear rate of the reaction (solid line) was determined and the slopes, or 
rate of reaction, are displayed.  Filled circles indicate mutant siRNA and mutant target; 
open circles indicate reactions in which mutant siRNAs were incubated with a wild-type
target.  In these conditions, the concentration of RISC was in great excess over substrate, 
or target RNA, with concentration determined by the first 300 seconds of the reaction.
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individual siRNA.  In this analysis, p12, p15, p16 and p19 exhibited slow initial rates of 
reaction.  Of these siRNAs, p12 and p19 also showed poor cleavage in Figure 1B.
However, p15 and p16, although silenced well over time, also showed a slower rate of 
initial cleavage as reflected in Figure 1B.
A rigorous test for siRNA selectivity
While some of the siRNAs assayed in this study exhibit high levels of discrimination 
over the original reaction time of 2 hours, we decided to analyze the discrimination over 
an extended reaction time as some of these siRNAs may give misleading results in the 
short term and cleavage may be detected if given ample time (Figure 3).  RISC was 
present in great excess over target RNA in order to establish the level of sequence
discrimination.  Over a 24 hour period, some of the siRNAs which originally showed 
high levels of discrimination start to show low levels of cleavage of the wild-type,
mismatched target, but certain siRNAs, in particular p12 and p16, still do not exhibit
cleavage of the wild-type target.  Although p12 did not show high levels of activity as a 
perfectly paired siRNA, and therefore may result in a misleading conclusion, p16 was
extremely effective in recognizing and cleaving a perfectly paired mRNA.
Analysis of tiled siRNAs in cultured cells
Does our in vitro analysis using Drosophila embryo lysate accurately predict the behavior 
of these siRNAs in cultured cells?  The siRNAs were co-transfected into HEK 293 cells 
with a plasmid expressing a Firefly (Pp) luc-SOD1 fusion target.  A co-transfected
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Figure VI - 3.  Analysis of discrimination over time.  RISC was present at high levels 
over target RNA in order to increase the probability that the target mRNA would be
recognized.  siRNAs (p5, p9, p10, p12, p13, p14, p15, p16, and p19) that showed high 
levels of discrimination were used in this extended analysis. 
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Renilla (Rr) luciferase-expressing plasmid served as an internal control.  Efficiency and 
discrimination were determined by assaying for the presence of the Pp luciferase protein, 
normalized to Rr luciferase, following co-transfection with either 2 nM or 20 nM siRNA 
(Figure 4).  In addition, siRNAs were introduced to a third target containing a uridine 
residue in place of the G (wild-type) or C (mutant) in the SOD1 mRNA sequence.
Previous studies show that G:U wobbles are not tolerated at certain positions along the 
siRNA:mRNA helix (Doench and Sharp, 2004).  As seen in Figure 4A, siRNAs that 
perfectly match the target RNA (mutant siRNA and mutant target sequence) are effective, 
albeit some more than others.  For example, p13, p14, and p18 do not exhibit as high a 
level of silencing efficiency as the rest of the set of siRNAs, even though these siRNAs 
displayed a high level of activity in vitro.
When the same set of siRNAs was introduced to a wild-type sequence, creating a 
G:G clash, several of the siRNAs exhibited high levels of discrimination (Figure 4B).
siRNAs capable of discrimination in which less than 40% of the mismatched target was 
down-regulated included p3 – p6, p8, p10 – p13, and p16.  When compared to the results 
obtained in the in vitro system, it appears that most of the siRNAs that exhibit high levels 
of discrimination in Drosophila also discriminate in cultured human cells, including p5, 
p9, p10, p12 – p14, and p16.  In addition, when the same set of siRNAs were co-
transfected into cells with a plasmid that contains a U at this position, some of the 
siRNAs show increased levels of mRNA cleavage and show only moderate levels of
discrimination (Figure 4C).  For example, siRNAs that were previously shown to be 
selective (Figure 4B) now appear to display a higher degree of silencing and less
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Figure VI - 4.  Analysis of tiled siRNAs against a SOD1-luciferase fusion in
mammalian cells.  (A)  siRNAs (Figure 1A) were co-transfected at either 2nM (gray bar) 
or 20nM (white bar) in conjunction with plasmids containing the mutant, or perfectly 
matched, SOD1 sequence fused to the luciferase coding sequence.  The level of silencing 
was determined by measuring the levels of firefly luciferase expression.  (B)  The same 
set of siRNAs were co-transfected with plasmids containing the wild-type sequence, 
creating a G:G clash, or (C) a U at that position creating a G:U wobble.  Each experiment 
was performed in triplicate along with an unrelated GFP siRNA and an untransfected 
control.
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discrimination, in particular p4 – p7, and p10 and p12 to a lesser extent.  Therefore, 
mismatches that are less disruptive to the overall conformation of the central helix,
particularly in the 'seed' region appear to lose the ability to discriminate among alleles
when confronted with a GU mismatch.  In contrast, p3, p8, p11, p13, p14 and p16 
retained the ability to discriminate and therefore may be regions less tolerant of
mismatches.  In addition, p13, p14, and p18 also show low levels of efficiency, but when 
these siRNAs encountered a perfectly matched mRNA they showed lower levels of
silencing than expected (Figure 4A).
Specificity and off-target effects of tiled, frayed siRNAs against mutant SOD1
The frayed siRNAs utilized in Figures 1 - 4 were transfected at 100 nM final
concentration into HeLa cultured cells to maximize off-target effects, which allows for 
the identification of the active strand in RISC by analyzing targets that share homology 
with the seed sequence of the siRNAs.  Total RNA was isolated from these cells and 
hybridized to microarrays (Figure 5).  While the siRNAs are only 1 nucleotide apart, the 
off-target signatures are different for each siRNA.
In addition, this experiment can predict which siRNA is not capable of silencing 
the wild-type gene that is present on the array, even at concentrations more than 5 times 
the standard concentration of siRNAs for transfection, and 50 times the lowest
concentration (2 nM) used in Figure 3.  For example, p8, p9, and p16 are not capable of 
cleaving the wild-type mRNA as seen by the gray area on the array (Figure 5).  These 
siRNAs were also shown to have either the guide strand of the frayed siRNA
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Figure VI - 5.  Microarray analysis of frayed SOD1 siRNAs. siRNAs from Figure 1A 
were transfected into HeLa cells at 100 nM final concentration.  (A) Total RNA was
isolated and hybridized to the microarray  Green represents a decrease in gene expression 
level, red indicates an increase in gene expression level, both as compared to a mock 
HeLa cell transfection.  (B) Total RNA was isolated from transfections of the tiled,
frayed set of siRNAs as described.  Real-time PCR was performed using AP Biosystems 
Taqman.
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incorporated into RISC (p9, p16), or mixed sense and guide strand incorporation into 
RISC (p8) (data not shown).  These three siRNAs all show high levels of activity against 
the perfectly matched mRNA in fly embryo lysate (Figures 1-3) and HEK 293 co-
transfections (Figure 4), although p8 only showed moderate selectivity in the lysate and 
cultured cell experiments.  In addition, p16 was not capable of silencing the wild-type
mRNA in the lysate system over a long incubation and retained the ability to discriminate 
in various examples and contexts (Figure 4, Figure 7, Table 1).  Notably, the pattern of 
discrimination observed in the real-time assays (Figure 5) reflect some of the patterns 
seen when this tiled set of frayed siRNAs were co-transfected with the luc-SOD1 fusion 
targets (Figure 4) when observed at the RNA level (real-time), and not the protein level
(luciferase assay).  Specifically, p8, p10, p13, and p16 siRNAs in the tiled set that did not 
down-regulate the mismatched target in the HEK 293 cells did not mediate high levels of 
target RNA destruction as indicated in the real-time assay from HeLa transfections.  Of 
note, the transfections in Figure 5 were carried out at concentrations of at least 5 times 
the highest level used in HEK 293 co-transfections, which contained plasmids driving 
high levels of the Pp luc-SOD1 fusion constructs instead of targeting an endogenous gene 
as in the microarray and real-time experiments. 
Analysis of additional mismatches using the p10 siRNA
In the case of the G85R SOD1 point mutation, the mismatch between the mutant siRNA 
and the wild-type mRNA sequence results in a G:G clash.  In order to understand which 
other mismatches could also potentially display discrimination in other contexts, we
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Figure VI - 6.  Purine:Purine mismatches are most disruptive.  (A)  The p10 siRNA 
is intrinsically asymmetric.  Here, the same siRNA was introduced to a sense target (to 
measure the ability of the guide strand of the siRNA to enter RISC and mediate target 
mRNA destruction in cells) or an anti-sense target (containing the complementary
sequence and therefore to measure the ability of the sense strand to enter RISC and 
mediate target mRNA destruction).  Even at high concentrations of siRNA, only the 
sense target (open squares) is cleaved at appreciable levels, compared to the anti-sense
target (filled squares), and therefore the guide strand of the p10 siRNA is entering RISC.
(B)  Luciferase activity was measured for each siRNA:mRNA pair.  Perfectly
complementary siRNA:mRNA pairs show high levels of silencing, purine:pyrimidine 
mismatches display intermediate levels of silencing, and therefore intermediate levels of 
discrimination, but purine:purine mismatches show the highest levels of discrimination.
(C)  Over a range of concentrations, the pyrimidine:purine mismatches show moderate 
levels of discrimination compared to the perfectly matched siRNA:mRNA pair.  U:C 
mismatches, triangles; U:U mismatches, diamonds; U:G mismatches, circles; U:A
matched pair, squares.  (D)  Purine:purine mismatches can not be overcome by high
concentration of siRNAs and is therefore not an artifact of low concentration.  A:G 
mismatches, circles; A:A mismatches, squares; A:C mismatches, triangles; A:U matched 
pair, diamonds.
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designed four siRNAs based on the original p10 siRNA sequence (Figure 1A) with either 
a G, a C, a U, or an A at position 10.  In addition, we created four targets containing each 
possible nucleotide across from p10 in the siRNA. This allowed us to study the effects of 
the various combinations of mismatches that might occur in a disease and to analyze 
which mismatches result in discrimination between two alleles.  In this experiment we 
used a non-frayed siRNA because this sequence is intrinsically asymmetric (Figure 6A) 
as shown by the silencing potential against a sense and anti-sense target RNA.  This 
shows that only the guide strand of the siRNA enters RISC and is capable of mRNA 
destruction.  Since we are only comparing among p10 siRNAs that all share the same free 
energies at the 5´ ends of the siRNA we decided to use the non-frayed siRNAs.
When these p10 siRNAs were co-transfected with plasmids containing every
possible nucleotide at p10, resulting in every possible nucleotide combination, the
perfectly matched siRNAs (G:C, C:G, A:U, and U:A) displayeded high levels of
silencing.  Conversely, the purine:purine mismatches (A:G, A:A, G:G, and G:A) showed
high levels of discrimination, whereas all other mismatches (pyrimidine:pyrimdine,
pyrimidine:purine, or purine:pyrimidine) displayed intermediate levels of discrimination 
(Figure 6B).  In addition, when the pyrimidine:purine mismatches were analyzed over a 
range of siRNA concentrations, the level of silencing increased (Figure 6C), but when the 
siRNA:mRNA pairs that result in the various purine:purine clashes are analyzed over the 
same concentration range the discrimination remains constant (Figure 6D circles and 
squares), and therefore can not be overcome by high concentrations of siRNA.
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Analysis of purine:purine mismatches across the siRNA sequence
After discovering that purine:purine mismatches result in the highest level of
discrimination, we decided to determine which position along the siRNA elicited the best 
discrimination.  Again the original p10 sequence was utilized, but this time mismatches 
were placed at each position within the siRNA and SOD1 targets were constructed that 
would result in purine:purine mismatches (Figure 7A).  siRNAs displaying the highest
level of knock-down, or were unaffected by the mismatch, were more prevalent in the 3´ 
half or middle of the siRNA.  In this analysis, p4, p7, p9 – p11, p13 and p16 exhibited 
selectivity with less than 40% silencing of the mismatched, or wild-type, target.
Similar analysis was employed when testing purine:purine mismatches in another 
context, this time utilizing frayed siRNA design rules applied to the original p4 siRNA 
(Figure 1).  Again, luciferase activity was determined and, in general, siRNAs retaining 
the ability to cleave even in the presence of purine:purine mismatches are located in the 
middle or 3´ half of the siRNA (Figure 7B).  For the p4 analysis, p3 – p5, p9 – p13 and 
p16 showed discrimination.  Of note, p10 G:G and A:G mismatches were more selective 
than the A:A and G:A mismatches, potentially indicating that the nature of the mismatch 
may also be affected by surrounding nucleotide composition and may depend on which 
nucleotide is present in the mRNA or siRNA sequence.  Combined, Figure 7 shows that 
p4, p9 – p11, p13 and p16 were capable of discrimination.
In depth analysis of p16 mismatches
Based on results from Figures 1 – 7, we decided to take a closer look at the p16
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Figure VI - 7.  Purine:purine mismatches display varying degrees of specificity. (A)
Purine residues were placed at each position along the p10 siRNA.  Targets were
constructed so that siRNA:mRNA target pairs would result in purine:purine mismatches.
Luciferase activity was measured for each pair.  (B)  The original p4 siRNA sequence 
was the basis for analysis with the 5´ end of the siRNA guide strand frayed to ensure 
entry into RISC.  Targets were constructed such that siRNA:mRNA target pairs would 
result in purine:purine mismatches. 
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mismatches in co-transfection experiments.  Through fly embryo lysate, HEK 293
transfections, and microarray and real-time data from HeLa transfections, p16 was most 
consistent in its ability to discriminate.  Ten separate siRNA-mRNA pairs bearing G:G, 
A:G, or A:A mismatches against the wildtype sequence were designed to target sod1 or 
htt naturally occurring point mutations or SNPs, or point mutations engineered into the 3´ 
UTR of Renilla firefly luciferase (Table 1).  siRNAs were transfected over a
concentration range from 0.001nM to 20nM, and renilla/firefly ratios were normalized to 
an unrelated control (for htt), or firefly/renilla ratios were normalized to an unrelated 
control (for sod1).  IC 50's were determined for the match or mismatched siRNAs by 
fitting the curves to a Hill equation with a coefficient of 1.  For siRNAs in which the half 
maximal concentration for silencing was not reached at the highest concentration tested, 
IC 50 values were estimated as > than the highest concentration.
For the ten siRNAs tested, 6 had an IC 50 of greater than 20nM for the
mismatched siRNA and one had an IC 50 of greater than 10nM.  All of the mismatches 
displayed greater IC 50's than the perfectly paired siRNA:mRNA pair.  siRNAs bearing 
3´ dTdT tails appeared to have a greater ability to discriminate, but the siRNAs that 
consisted of all ribonucleotides were designed to contain dTdT tails and showed very 
little (< 0.1 nM) difference between dTdT and all RNA (data not shown).  In addition, we 
tested whether the level of discrimination was dependent on the cell line and saw no 
difference between HeLa and 293 cells for the siRNAs in this study (data not shown).
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    Table 1
IC 50 (nM)
siRNA guide strand    match mismatch
5´ UCACAUUGCCCAAGUAUCCdTdT 3´ < 1.0 > 20
5´ UGCCCAAGUCUCCAAGAUGdTdT 3´ < 0.2 > 20
5´ CAGCAGUCACAUUGCGCAAdTdT 3´ < 1.0 > 20
5´ AGUCACAUUGCCCAAGUCUdTdT 3´ < 0.4 > 20
5´ CCAAGUCUCCAACAUGCCUdTdT 3´ < 1.0 > 20
5´ UGAAGUGCACACAGUGGAUGA 3´ < 0.2 > 0.4
5´ UGAAGUGCACACAGUAGAUGA 3´ < 0.2 > 0.3
5´ GAUGAAGUGCACACAGUGGAU 3´ < 0.4 > 2
5´ GUGCACACAGUGGAUGAGGGA 3´ < 0.2 > 10
5´ AGGGUCAAGAUGACAAUGGAC 3´ < 1.0 > 20
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Table VI - 1.  Mismatches at position 16 confer high levels of discrimination.
siRNAs at the top of the table are targeted to sod 1, while siRNAs at the bottom of the 
table are targeted to htt.  Mismatches result in a G:G, A:G, or A:A mismatch with the 
wildtype sequence.  SOD1 siRNAs were transfected into HEK293T cells, n=4.  HTT 
siRNAs were transfected into HeLa cells, n=9 for siRNAs 1, 2, and 5; n=6 for siRNA 4; 
n=15 for siRNA 3.  siRNAs targeting sod1 were designed with the mutant sequence and 
were targeted to plasmids bearing either the mutant or the wildtype sequence.  siRNAs 
targeting htt were designed either the same as sod1 or 2 siRNAs were designed bearing
either the SNP sequence or the wildtype sequence to target a plasmid bearing mutant 
sequence.  Luciferase ratios were normalized to controls containing an unrelated GFP 
siRNA.  IC 50's were determined by plotting the concentration gradient versus percent
knock-down and fit to a Hill equation with a rate = 1.  IC 50's for siRNAs that did not 
reach half-maximal silencing were estimated from the graph to be greater than the highest 
concentration of siRNA transfected.
247
Discussion
The use of RNAi to knock-down the expression of single mutant alleles holds promise in 
the treatment of various dominant negative diseases caused by point mutations in specific 
genes.  The data presented here brings us closer to the identification of parameters for 
designing optimal siRNAs that suppress specific deleterious alleles.  Mismatches
between siRNAs and target mRNAs where a purine:purine mismatch occurs leads to the 
greatest level of discrimination, probably the result of a greater disruption in the central
A-form helix that is required between the siRNA and mRNA (Chiu and Rana, 2002;
Haley and Zamore, 2004).  Therefore, a point mutation that is the result of a pyrimidine 
to a purine change increases the probability of discrimination through siRNA-mediated
silencing.
In addition, while the region in the target RNA in which one can design siRNAs 
against a point mutation is limited, the level of discrimination can be increased based on 
where the mismatch is placed along the RNA:RNA helix between siRNA and target
mRNA.  The combination of in vitro systems and cultured cell transfections shows that 
certain positions can increase the chances of discrimination between two alleles that
differ at a single nucleotide.  This finding is consistent through three strategies of analysis
(Figures 1 - 7) using frayed and unfrayed siRNAs, and by tiling the siRNA sequences or 
by changing each position of a fixed siRNA sequence.  In general, more of the positions 
located in the 5´ region of the siRNA, which has been shown to responsible for binding
and recognition (Doench and Sharp, 2004; Haley and Zamore, 2004), are only
moderately affected by the presence of a single mismatch and can still mediate silencing,
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but this depends on the nature and context of the mismatched nucleotides.  When the
mismatch is located in the 3´ region of the siRNA, which has been demonstrated to 
contribute to catalysis and maintenance of the required central A-form helix (Haley and 
Zamore, 2004), specifically positions 10 and 16, the loss of silencing of the wild-type
gene is observed and the discrimination is fairly constant through all experiments
(Figures 1 – 5, 7, Table 1, and data not shown).  Our lab has previously shown that the 
first 2 nucleotides (p1 and p2) and the last 5 nucleotides (p17 – p21) contribute little to 
the binding of an siRNA to its target mRNA (Haley and Zamore, 2004).  Specifically, 
bioinformatic analysis predicted that the first nucleotide of a miRNA does not contribute 
to conservation (Lewis et al., 2005; Lewis et al., 2003), and a first nucleotide mismatch 
between an siRNA and mRNA as observed in an in vitro target cleavage assay indicated
that the first nucleotide does not contribute to silencing (Haley and Zamore, 2004).  The 
crystal structure of an Archae Piwi protein indicates that the 5´ phosphate of the first 
nucleotide in the siRNA is anchored in a binding pocket of the protein and does not 
contribute to siRNA function (Ma et al., 2005).  Therefore, current evidence in the field, 
combined with results presented here, show that the first nucleotide probably plays a role 
in positioning the siRNA within the silencing complex and should not be a position
selected for targeting single nucleotide polymorphisms.
The findings presented here are slightly inconsistent with the results that siRNAs
designed to function as miRNAs are more affected by mismatches in the 5´ end of the 
molecule (Doench and Sharp, 2004), and in fact are the same bases that are used to 
predict miRNA targets by computational approaches (Enright et al., 2003; Lewis et al.,
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2003; Rajewsky and Socci, 2004; Stark et al., 2003).  But it should be noted that the 
actual mode of translational repression as mediated by miRNAs is still a source of debate 
in the RNAi field, and the proteins and interactions may be functioning differently than 
previously expected, therefore strict comparison to siRNA function may be complicated.
While purine:purine mismatches display this selectivity, G:U wobbles display a 
slightly different mode of regulation where G:U wobbles placed in the 5´ region of the 
siRNA mediate gene silencing to a greater degree (Figure 4C).  This result is inconsistent 
for G:U wobble pairs in which recent findings suggest that G:U wobbles, which are 
widely found in miRNAs, are capable of eliminating activity in miRNA:mRNA pairing
(Doench and Sharp, 2004), but this may be distinct in that respect to siRNA-mediated
silencing.
Additional experiments conducted using high concentrations of siRNAs
transfected into HeLa cells and hybridizing total RNA isolated from those cells shows
that specific siRNAs are capable of not destroying the wild-type SOD1 mRNA, including 
p16.  Even at high levels of siRNA, some sequences are capable of discriminating alleles 
that differ by a single nucleotide as these siRNAs were shown to be active against a 
cognate, mutant G85R SOD1 sequence in transfections with luciferase readout analysis 
(Figure 4).  In addition, it is important to note that when the discrimination was analyzed 
at the level of RNA from these same experiments, the pattern of silencing observed for 
p16 in particular was consistent with the results obtained from the co-transfections with 
the luc-SOD1 expressing plasmids. The real-time results show that greater than 75% of 
the wild-type mRNA remained, even under conditions of high siRNA concentration.
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This shows that the level of silencing occurs at the RNA level, and that siRNA:mRNA 
target pairs that differ at a single nucleotide probably result in the blockage of RNA
cleavage, not in the repression of translation by acting as miRNAs (Figure 5), although 
the siRNAs, and miRNAs for that matter, are capable of mediating target cleavage and 
can enter RISC that contains human Ago2 (Meister et al., 2004), the Argonaute that
functions as the endonuclease (Liu et al., 2004; Meister et al., 2004).
Through multiple modes of analysis, p16 was selected as the best candidate for an 
in depth analysis because it consistently showed high levels of discrimination in various 
contexts.  It is important to note that while some position of mismatches show
discrimination in one context, they may not be as efficient when the mismatch is
incorporated into another siRNA sequence.  It is important to note that differences did 
exist between the analysis of sod1 and htt point mutations and SNPs, including
transfections in different cell lines, the use of siRNAs that consisted entirely of RNA or 
siRNAs that has 3? dTdT tails, and cloning of the fragment of interest into firefly or 
renilla luciferase vectors.  The cell line into which these siRNAs were transfected, as well 
as the RNA or dTdT-containing siRNA design, did not affect silencing and
discrimination (data not shown).
Another group found that using a fixed target region, with each position mutated 
to each of the four nucleotides, with a single siRNA that positions 5 – 11 did not tolerate 
mismatches (Du et al., 2005), although they did not test various different sequences in 
different contexts as we did in this analysis.  While they tested mismatches along the 
length of the siRNA, they were limited to what nucleotide was in the siRNA, therefore, if 
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a pyrimidine was present in the siRNA they were not able to test that position in the 
context of a purine:purine mismatch as we did, noting that this type mismatch is the most 
disruptive to the helix.
The information presented here greatly aids in the design of siRNAs that are 
capable of discriminating among alleles.  Therefore, an siRNA that can cleave a mutant 
mRNA but leave the wild-type copy intact would result in the expression of functional 
protein, but prevent the mutated form of the protein to be synthesized, potentially
decreasing the symptoms of the disease.  Specifically, through three different
experimental systems, position 16 relative to the 5´ end of the siRNA guide strand
provided the greatest chance of discrimination.  Mismatches that result in a purine:purine 
clash displayed the greatest possibility of discrimination.  Therefore, placement of the 
mismatch, and the nature of the mismatch should be considered when designing SNP-
specific siRNAs.  These findings can hopefully be translated to other dominant negative 
diseases where allele specific differentiation is required to ameliorate symptoms.
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Methods
General methods
Preparation of Drosophila embryo lysate, target RNA preparation, cap labeling, siRNA 
(Dharmacon) annealing, and in vitro RNAi reactions were carried out as previously
described (Haley et al., 2003; Tuschl et al., 1999; Zamore et al., 2000). sod1 mutant and 
wild-type RNAs were transcribed from BamHI-linearized plasmids (Crow et al., 1997)
with recombinant histidine-tagged T7 RNA polymerase.  Target RNAs and siRNAs were 
used at ~5nM and 50nM final concentrations, respectively (Figure 1) or ~0.5nM and 
100nM, respectively, for single turnover conditions (Figure 2).  Gels were dried and 
exposed to phosphorimager plates (Fuji) and developed using a FLA-5000
phosphorimager (Fuji).  Gels were analyzed and quantitated using Image Guage version 
3.45 (Fuji), results were analyzed in Excel X (Microsoft) and graphed using Igor Pro 5.01 
(Wavemetrics).
Cell culture, transfections, and luciferase assays 
HeLa cells were propagated and maintained as previously described (Schwarz et al., 
2002).  HEK 293 cells were maintained in Dulbecco's Modified Eagle Media (DMEM) 
(Invitrogen), supplemented with 10% Fetal Bovine Serum, 100 U/ml penicillin, and 100 
μg/ml streptomycin.  htt sequences were engineered into the 3´ UTR of the pRLTK 
Renilla luciferase vector (Promega) using 55 nucleotide DNA oligos annealed in 1x lysis 
buffer (100 mM potassium acetate, 30 mM Hepes-KOH, pH 7.4, 2 mM magnesium
acetate) to create 5´ overhangs and inserted into the XbaI site.  Proper orientation was 
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verified by sequencing in both directions.  Sod1 sequences were cloned into the 3´ UTR 
of the Firefly lusicferase vector (pGL2 control, Promega) into NdeI and SpeI sites
engineered into the plasmid by annealing two 39 nucleotide DNA oligos and ligating 
them into the vector.  Transfections were carried out using Lipofectamine 2000
(Invitrogen) in 24 well plates using 0.25 μg pGL2 Firefly luciferase (Promega) and 0.1 
μg Renilla-Htt constructs or in 96 well plates using 2 μg/ml firefly fusion vector and 0.1 
μg/ml renilla vector.  Cells were washed in 1x PBS (Invitrogen) and harvested 24 hours 
post-transfection in 2x passive lysis buffer (Promega).  Luciferase levels were determined 
using the Dual Luciferase kit (Promega) and read on a Veritas Microplate Luminometer 
(Turner Biosystems). Renilla luciferase/firefly luciferase ratios were normalized to a 
sample containing an unrelated GFP siRNA (Qiagen) in addition to the luciferase vectors 
for htt experiments, and Firefly luciferase/Renilla luciferase ratios were calculated for 
sod1 experiments.  Results were analyzed in Excel (Microsoft) and graphed in IGOR Pro 
5.0 (Wavemetrics).  Curves were fit to a Hill Equation with a coefficient of 1.
HeLa cell transfections, RNA isolation, microarray hybridization, real-time PCR
HeLa cell transfections were carried out at 100 nM final concentration as described 
(Jackson et al., 2003).  RNA isolation, microarray hybridization, and real-time assays 
were carried out as described (Jackson et al., 2003).
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This perspective was written based on the article:
Mourelatos, Z., J. Dostie, S. Paushkin, A.K. Sharma, B. Charroux, L. Abel, J. Rappsilber, 
M. Mann, and G. Dreyfuss. 2002. miRNPs: a novel class of Ribonucleoproteins
containing numerous microRNAs. Genes Dev 16: 720-728.
The purpose of this perspective was to summarize what was known about the recently 
identified class of small, non-coding RNAs called microRNAs (miRNAs), and why
various members of this class, including previously unidentified miRNAs, might reside in 
a protein RNA complex.  In addition, this perspective gives insight into what biochemical 
function this protein complex contributes to cellular and developmental regulation.
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APPENDIX
Do tiny RNAs now have a home?  Non-coding RNAs function in diverse
pathways—dosage compensation, gene imprinting, transcriptional regulation, pre-mRNA
splicing, and the control of mRNA translation—and they carry out these roles from
within specific RNA-protein complexes that ensure each non-coding RNA is in the right 
cellular compartment with the appropriate proteins needed to accomplish its biochemical 
function.  Thus, identifying the ribonucleoprotein complex (RNP) associated with a non-
coding RNA gives clues to its cellular function and biochemical mechanism by revealing 
the proteins whose company it keeps.  The discovery by Dreyfuss and coworkers that 
microRNAs reside in a ~550 kDa (15S) particle provides new clues toward the functions 
of this novel and surprisingly large class of tiny, non-coding RNAs (Mourelatos et al. 
2002).
The first microRNA (miRNA), lin-4, was identified in 1983 (Lee et al. 1993).
Ambros and coworkers positionally cloned the lin-4 gene, a locus required for the correct 
timing of developme nt in Caenorhabditis elegans, only to find that the gene encodes no 
protein.  Instead, lin-4 comprises two small non-coding RNAs, one 22 nt long, and a 
longer form, lin-4L, that can fold into a hairpin structure.  Seven years later, Ruvkun and 
colleagues discovered that let-7, which likewise regulates developmental timing in
worms, is also a tiny, non-coding RNA (Reinhart et al. 2000).  Because lin-4 and let-7
control developmental timing, they have been dubbed small temporal RNAs (stRNAs). 
Recently, three laboratories succeeded in cloning additional stRNA-like RNAs from
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worms, flies, and human cells (Lagos-Quintana et al. 2001; Lau et al. 2001; Lee and 
Ambros 2001).  These efforts uncovered a wealth of 19-25 nt RNAs, including lin-4 and 
let-7, that are collectively known as miRNAs (reviewed in Moss 2001; Ruvkun 2001; 
Banerjee and Slack 2002).  These efforts added an additional 100 tiny RNAs to the 
original pair of stRNAs.  As anticipated by Ambros, stRNAs and miRNAs derive from 
longer stem-loop precursor RNAs.  Thus, the longer lin-4L is the precursor of mature lin-
4.  While many of the new miRNAs are produced constitutively, some are temporally 
regulated or expressed only in specific tissues.  A few appear to be transcribed in
coordinately regulated operons, suggesting that they are cleaved from their stem-loop
precursors from within a long, common transcript.  Others are found only in the germ line 
or in the early embryo, where translational control dominates the hierarchy of regulatory 
mechanisms.
The 21-25 nt size of miRNAs is remarkably similar to that of small interfering 
RNAs (siRNAs), the 21-25 nt double-stranded RNAs that mediate RNA interference 
(reviewed in Bernstein et al. 2001b; Carthew 2001; Sharp 2001; Vaucheret et al. 2001; 
Waterhouse et al. 2001).  siRNAs are generated by the endonucleolytic cleavage of long 
double-stranded RNA by the multi-domain RNase III enzyme, Dicer (Bernstein et al. 
2001a).  siRNAs are then incorporated into a ~500 kDa RNP complex, the RISC, where 
they provide the specificity determinants that direct an as yet unidentified protein
nuclease to cleave mRNAs complementary to the siRNA (Hammond et al. 2000). lin-4
and let-7, as well as the new miRNAs, are encoded by ~70 nt stem-loop structures (Lee et 
al. 1993; Pasquinelli et al. 2000) whose stems are also substrates for processing by Dicer 
264
(Grishok et al. 2001; Hutvágner et al. 2001; Ketting et al. 2001).  Dicer liberates miRNAs 
from the larger stem-loop precursors in much the same way it generates siRNAs from 
long dsRNA, leaving the signature 3’ hydroxyl and 5’ phosphate termini of an RNase III 
cleavage reaction.  Both siRNA and stRNA production by Dicer requires ATP, consistent 
with the presence of an ATP-dependent helicase domain at the N-terminus of Dicer
(Zamore et al. 2000; Bernstein et al. 2001a; Hutvágner et al. 2001; Nykänen et al. 2001).
Mature lin-4 and let-7 are thought to bind partially complementary sequences in the 3´ 
untranslated regions of their target mRNAs (Lee et al. 1993; Reinhart et al. 2000).
Unlike the binding of siRNAs, which triggers target RNA destruction, binding of the 
stRNA lin-4, and likely let-7, leads to translational repression of their natural mRNA 
targets (Olsen and Ambros 1999; Reinhart et al. 2000; Slack et al. 2000).  In worms, 
translational repression of lin-4 and let-7 target mRNAs is required for the progression 
from one stage of development to the next.
In addition to Dicer, two members of the PPD family of proteins, ALG-1 and 
ALG-2, are required for the biogenesis or function of lin-4 and let-7 in worms (Grishok et 
al. 2001).  PPD proteins, so named because they contain ‘PAZ’ and ‘Piwi’ domains, 
protein sequence motifs of unknown biochemical function, are required for diverse array 
of developmental functions in plants and animals. alg-1/alg-2 mutants accumulate lin-4
and let-7 precursors and display striking defects in developmental timing (Grishok et al. 
2001).  Worms lacking alg-2 also fail to form a normal germ line (Cikaluk et al. 1999). A 
role for PPD proteins in the biogenesis or function of miRNAs has only been
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demonstrated for the PPD proteins ALG-1 and ALG-2 in worms, but it seems likely that 
PPD proteins will be needed for miRNA biogenesis in other organisms. 
PPD proteins function not only in miRNA maturation, but are also required in 
animals, plants, and fungi for a variety of RNA silencing phenomena, including RNAi 
and cosuppression, the RNAi-like silencing of an endogenous gene by a transgenic copy 
of the same sequence (Tabara et al. 1999; Catalanotto et al. 2000; Fagard et al. 2000; 
Hammond et al. 2001; Pal-Bhadra et al. 2002). In C. elegans, the PPD protein RDE-1 is 
required for RNAi (but not cosuppression; Tabara et al. 1999; Dernburg et al. 2000;
Ketting and Plasterk 2000); QDE2 is required for cosuppression in the fungus
Neurospora crassa (Catalanotto et al. 2000); and Argonaute is required both for RNA 
silencing and for normal meristem function in plants (Bohmert et al. 1998; Fagard et al. 
2000).  In flies, the PPD protein, Piwi, is required for the maintenance of germ line stem 
cells, for the post-transcriptional silencing of endogenous genes by transgenes encoding 
the same mRNA, and even for some aspects of transcriptional silencing (Cox et al. 1998; 
Pal-Bhadra et al. 2002).  Intriguingly, Piwi localizes to the nucleoplasm, not the
cytoplasm, in Drosophila ovaries and testes, but disperses to the cytoplasm during
mitosis (Cox et al. 2000).  The role of Piwi in post-transcriptional silencing—a
phenomenon that all current evidence suggests occurs in the cytoplasm—implies that at 
least a subpopulation of Piwi functions outside the nucleus.  Might Piwi associate with 
miRNAs in the cytoplasm, then move as a Piwi-containing miRNP to the nucleus to 
regulate transcription or nuclear mRNA stability?
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The human homolog of Piwi, Hiwi, plays a role in maintaining hematopoetic stem 
cells, and the mouse homolog, Miwi, is expressed in primordial germ cells, suggesting its 
function in mammals may parallel that of Piwi in flies (Kuramochi-Miyagawa et al. 2001; 
Sharma et al. 2001).  Another Drosophila PPD protein, Aubergine, is required for the 
RNAi-like silencing of the Stellate locus in testes, for antero-posterior patterning in the 
developing embryo, where it is required for the translation of the developmental regulator 
Oskar, and for the formation of pole cells, the progenitors of both male and female germ 
cells (Wilson et al. 1996; Aravin et al. 2001; Harris and Macdonald 2001). Perhaps all of 
the phenotypes observed for PPD protein mutants arise from their failure to produce 
specific sets of miRNAs required for germ line development, stem cell maintenance, or 
patterning.  Reinforcing this view, worms mutant for Dicer (dcr-1), like those lacking 
ALG-2, show germ line defects (Knight and Bass 2001).  Dreyfuss and coworkers now 
find that many human miRNAs are present in a ~550 kDa complex, the miRNP, and that 
this complex contains the PPD protein eIF2C2 (Mourelatos et al. 2002).
Current evidence supports the view that in metazoans, both the RNAi and miRNA 
pathways require the activity of Dicer and PPD proteins.  The RNAi and miRNA
pathways are clearly related, but there are features that differentiate them.  First, siRNAs 
are processed from perfectly complementary, long dsRNA into double-stranded siRNAs 
that guide the destruction of a target mRNA (Hamilton and Baulcombe 1999; Hammond 
et al. 2000; Zamore et al. 2000; Bernstein et al. 2001a; Elbashir et al. 2001a; Elbashir et 
al. 2001b; Nykänen et al. 2001).  In contrast, miRNAs are single-stranded, processed 
from ~70 nucleotide precursors that have the ability to form stem loop structures
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containing loops and bulges of unpaired nucleotides.  Only one strand of the stem of the 
miRNA precursor accumulates, indicating that the other strand must either not be
produced or is differentially degraded. The fact that multiple PPD proteins are found in 
various organisms that exhibit RNAi may be an indication that different classes of these 
proteins play a specialized role in the two pathways.  But reality must be more complex 
than this simple model, which predicts that two PPD proteins—one for RNAi and one for 
miRNAs—would suffice.  Instead, the number of PPD proteins is large and varies greatly 
in different organisms (Figure 1): flies have five, humans, four, and Arabidopsis, six, but 
worms have at least 24!
Why so many PPD proteins?  One explanation is that not all PPD proteins
function in the RNAi or miRNA pathways.  This seems unlikely, since three of the five 
Drosophila family members have already been implicated in one or another RNA
silencing phenomenon.  Perhaps different subclasses of miRNAs require distinct PPD 
proteins for their production, stability, or function.  Such a requirement might reflect the 
individual peculiarities of a miRNA’s sequence or precursor structure, or perhaps the 
subcellular localization of its target mRNAs.  Consistent with this notion, human eIF2C1 
(also known as GERp95) is associated with the golgi and ER, where it might play a 
specialized role in mediating miRNA-based translational regulation of secreted proteins 
(Cikaluk et al. 1999; Tahbaz et al. 2001).  Alternatively, all PPD proteins might be 
biochemically interchangeable, but be distinguished by distinct patterns of developmental 
or tissue-specific expression.  For example, in worms, a subset of PPD proteins are more 
abundant in the germ line than the soma (Reinke et al. 2000).  The finding that PPD
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Figure A - 1.  Sequence relationship among PPD proteins.  At, Arabidopsis thaliana; Ce, 
Caenorhabditis elegans; Dm, Drosophila melanogaster; Nc, Neurospora crassa; Hs,
Homo sapien; Sp, Schizosaccharomyces pombe.  Red, PIWI subfamily; green, AGO1 
subfamily.  Protein alignments were performed using ClustalX and illustrated by
TreeView.
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proteins play important roles in stem cell production, gametogenesis and patterning may 
be an indication that different classes of tissue-specific miRNAs regulate gene expression 
in these key developmental events.
In addition to the PPD protein eIF2C2, the recently discovered miRNP contains at 
least two more proteins, Gemin3 and Gemin4 (Mourelatos et al. 2002).  These proteins 
may interact directly with eIF2C2, since in vitro translated Gemin3 and Gemin4 bind an 
eIF2C2-glutathione-S-transferase fusion protein (and vice versa).  These interactions may 
be direct or they may be bridged by proteins present in the reticulocyte lysate used for 
translation.  Gemin3 and Gemin4 were previously identified as part of a multi-protein
complex containing the Survival of Motor Neurons (SMN) protein, Gemin2 (Charroux et 
al. 1999; Charroux et al. 2000; Mourelatos et al. 2001), Gemin5 (Meister et al. 2001; 
Gubitz et al. 2002), and Gemin 6 (Pellizzoni et al. 2002).  The SMN-containing complex 
is distinct from the miRNP.  The SMN complex—comprising SMN, Gemin2, Gemin3, 
Gemin4, Gemin5, and Gemin6—is found in the nucleus in discrete foci known as ‘gems.’
The SMN complex functions in the assembly and restructuring of diverse RNP particles, 
including spliceosomal snRNPs.  SMN protein is defective in the neurodegenerative 
disease, spinal muscular atrophy (SMA).  It is, therefore, presumed that the underlying 
cause of SMA is a failure in snRNP biogenesis or recycling.  The sequences of the 
proteins in the SMN complex has thus far failed to reveal their biochemical function, 
with the exception of Gemin3, a 105 kDa member of the DEAD-box family of putative 
ATP-dependent RNA helicases.
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Gemin3 may provide a catalytic function in the assembly of RNPs (Charroux et 
al. 1999).  Previously, Gemin3 was detected together with Gemin4 in a second complex 
of approximately 550 kDa (Charroux et al. 1999).  In their present work, Dreyfuss and 
coworkers characterized this second, less abundant complex through a series of co-
immunoprecipitations, identifying it as the miRNP (Mourelatos et al. 2002).  Two anti-
Gemini3-specific monoclonal antibodies were used to characterize Gemin3-containing
complexes in total lysates prepared by sonnicating human HeLa cells.  One antibody 
recognizes Gemin3 in the SMN complex, while the second detects only Gemini3 protein 
that is not associated with SMN (Mourelatos et al. 2002).  It is this second antibody that 
immunoprecipates the miRNP.  In addition to Gemin3 and 4, this antibody co-
immunoprecipitates two proteins with apparent molecular masses of 115 kDa and 95 
kDa, neither of which is found in the SMN complex. Mass spectrometry revealed the 95 
kDa protein to be the PPD protein eIF2C2, making the first tentative link between the 
~550 kDa complex and the miRNA and RNAi pathways.  Since the SMN complex
contains non-coding RNAs (e.g., snRNA), the ~550 kDa complex was scrutinized for 
associated non-coding RNA.  Remarkably, miRNAs were found to be tightly associated 
with the non-SMN, Gemin3-containing complex.  In fact, this miRNP appears to be home 
to at least 40 different miRNAs, all but nine of them not identified in the original screen 
to clone and sequence human miRNAs (Lagos-Quintana et al. 2001).  Like the original 
tiny RNAs, lin-4 and let-7, each of the new miRNAs is encoded in genomic sequence that 
can fold to form a ~70 nt precursor RNA.
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In addition to co-localizing with the SMN protein in nuclear ‘gems,’ Gemin3 
exhibits a diffuse cytoplasmic staining pattern that may correspond to the miRNPs.  In 
the recent Dreyfuss study employed  total cell lysates, so the intracellular localization of 
miRNPs could not be inferred, but Dicer is a cytoplasmic protein in human cells (Billy et 
al. 2001), suggesting that miRNA precursors are processed in the cytoplasm by Dicer, 
which then pass the single-stranded miRNAs to the miRNP.  In extracts from cultured 
Drosophila cells, the PPD protein Ago-2 binds Dicer, directly or indirectly, suggesting 
that the transfer of mature miRNA from Dicer to the miRNP might be mediated by PPD 
proteins (Hammond et al. 2001).  Dicer does not appear to be a stable component of the 
miRNP, since no appropriately sized protein (~250 kDa) co-immunoprecipitates with 
either anti-eIF2C2 or Gemin3 antibodies, although as an enzyme Dicer might be present 
in the miRNP in substoichiometric amounts (Mourelatos et al. 2002).  In fact, antibodies 
to both Gemin3 and eIF2C2 immunoprecipitate ~76 nt long RNA in addition to the 
miRNAs, suggesting that miRNA precursors might be present in the miRNP.  Might the 
miRNPs therefore be miRNA birthing centers (Figure 2)?  Like siRNAs, miRNAs are 
generated by cleavage of a structured RNA precursor by the double-stranded RNA-
specific endonuclease Dicer.  However, siRNAs are double-stranded, whereas miRNAs 
are single-stranded.  Are miRNAs single-stranded because Dicer cleaves miRNA
precursors only at the 5´ and 3´ ends of the mature miRNA sequence?  Or are miRNAs 
initially double-stranded like siRNAs, but then the anti-sense miRNA strand is rapidly 
destroyed?  In this second model, the miRNP might play a role in the dissociation of the 
two strands, perhaps catalyzed by the putative ATP-dependent helicase Gemin3, with the
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Figure A - 2.  Models for miRNA biogenesis and function.  (A) Dicer may cleave a 
single-stranded miRNA directly from its stem-loop precursor RNA, then transfer the 
mature miRNA to components of the miRNP.  Alternatively, Dicer may initially generate 
a double-stranded siRNA, then transfer it to the miRNP.  Protein components of the 
miRNP would then unwind the siRNA, select one strand of the siRNA to become the 
mature, single-stranded miRNA and catalyze degradation of the other siRNA strand.  (B) 
In the RNAi pathway, a perfectly complementary siRNA targets mRNA for
endonucleolytic cleavage.  In contrast, miRNAs pair only imperfectly with sequences in 
the 3′ untranslated regions of their target RNAs and are believed to repress mRNA 
translation without altering mRNA stability.
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PPD protein eIF2C2 acting to stabilize the mature miRNA against degradation.  The 
miRNP might even promote degradation of the non-miRNA strand and the rest of the 
precursor.
What do miRNAs do?  One-hundred thirty-three distinct miRNAs have been
identified thus far in worms, flies, or humans, yet the regulatory function and mRNA 
targets are known for only C. elegans lin-4 and let-7.  The presence of a putative ATP-
dependent RNA helicase suggests that the miRNP might catalyze miRNA target
recognition.  In this regard, it is important to note that target recognition by siRNAs 
requires no ATP (Nykänen et al. 2001).  siRNA-mRNA interactions encompass 21 
perfectly complementary base pairs, whereas lin-4 and let-7 form only 14 to 17 Watson-
Crick base pairs with their target mRNAs.  Therefore, the weaker stRNA-mRNA and 
putative miRNA-mRNA interactions may require the aid of an ATP-dependent helicase 
to remove local secondary structure in the target mRNA or perhaps even to zipper the 
miRNA to its target sequence.  Finally, a helicase might in principle act to recycle
miRNAs, although if miRNAs function as translational regulators, they would likely
form a stoichiometric complex with their regulatory targets and turnover infrequently.  If, 
like lin-4 and let-7, miRNAs are sequence-specific translational repressors that bind their 
targets through 3´ UTR sequences, the miRNP might correspond to the actual mediator of 
translational repression.  In support of this idea, a significant fraction of human eIF2C2, 
Gemin3, and Gemin4 co-sediment in a sucrose gradient with the ribosomal pellet
(Mourelatos et al. 2002), as has also been reported for the RNAi-associated PPD protein 
Ago-2 from extracts of cultured fly cells (Hammond et al. 2001).  It has not yet been 
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determined if this co-sedimentation reflects an actual association of either eIF2C2 or 
Ago-2 with ribosomes, although the miRNA lin-4 has been shown to be directly
associated with polysomal lin-14 mRNA, whose translation it represses (Olsen and
Ambros 1999).  Furthermore, eIF2C2 is 85% identical to eIF2C1, which was originally 
identified as a translational initiation cofactor (Zou et al. 1998; Koesters et al. 1999).  It is 
important to note that although purified fractions containing the eIF2C1 protein were
shown to enhance translational initiation in vitro, no biochemical activity has yet been 
demonstrated for the protein that was cloned as eIF2C1 and that mRNA repression by lin-
4 occurs at a step after translational initiation.  It is also important to recall that outside of 
C. elegans, no function has been ascribed to any miRNA, including Drosophila and 
human let-7.  Thus, miRNAs may act not only as translational regulators, but also to 
modulate mRNA stability or to direct mRNA localization.  It is conceivable that some 
may even provide sequence-specificity to regulators of transcription.
Of the 133 miRNAs identified thus far, none is perfectly complementary to any 
known mRNA in the worm, fly, or human genome.  It is therefore unlikely that miRNAs 
act in the destruction of mRNA in vivo, since effective RNAi requires a high degree of 
complementarity between the siRNA and the target RNA (Elbashir et al. 2001b).  Since 
the RNAi pathway is thought to defend eukaryotic cells against colonization by parasitic 
DNA, it is surprising that not a single miRNA corresponding to a transposon has been 
cloned from C. elegans or human cells.  In contrast, small RNA cloning from
trypanosomes, which also contain the RNAi machinery, revealed abundant siRNAs
corresponding to retrotransposons (Djikeng et al. 2001).  Why have miRNA screens from 
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higher organisms failed to detect such siRNAs?  One possibility is that the RNAi
pathway plays a major role in silencing transposons only at a highly specific time in 
development or in a specialized tissue such as germ cell progenitors.  In support of this 
idea, Tuschl and colleagues reported cloning a small number of siRNAs derived from 
retrotransposon sequences from syncitial blastoderm stage Drosophila embryos, a stage 
in development when germ cell progenitors are formed (Elbashir et al. 2001a).
There are several tantalizing similarities between the miRNP discovered by
Dreyfuss and colleagues and the RISC, the RNP that mediates RNAi.  First, the sizes of 
the miRNP (~550 kDa; Mourelatos et al. 2002) and the RISC (~500 kDa; Hammond et al. 
2000) are quite similar.  Second, a helicase like Gemin3 must play a role in RNAi, 
because ATP-dependent unwinding of an siRNA duplex is a prerequisite for formation of
an active RISC (Nykänen et al. 2001).  The putative DEAD-box helicase protein, Spindle 
E, is required for the RNAi-like silencing of the endogenous Stellate locus in Drosophila
testes (Aravin et al. 2001; Stapleton et al. 2001), and it will be important to determine if 
Spindle E is a component of either a Drosophila miRNP or the RISC or both.  Finally, 
PPD proteins are found in both the miRNP (human eIF2C2) and the RISC (Drosophila
Ago-2).  Might the miRNP and the RISC be one-and-the-same, a single RNP with
multiple functions?  If so, it is tempting to predict that the as-yet-unidentified 115 kDa 
miRNP protein is the elusive ‘Slicer,’ the ribonuclease postulated to cleave target RNA in 
the RNAi pathway.  Alternatively, the miRNP and the RISC may be distinct complexes 
containing pathway-specific proteins drawn from the same protein families.  In either 
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case, the search for what miRNAs do and how they do it is easier now that we know 
where they live.
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